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ABSTRACT 
 
Ectopic calcification can cause pain and limit mobility. Studies suggest that 
circadian genes may play a role in the calcification process. Core circadian genes Clock, 
Npas2, and Bmal1 are transcription factors that form CLOCK:BMAL1 or 
NPAS2:BMAL1 transactivator complexes that drive the rhythmic expression of circadian 
oscillator genes and output genes. Circadian oscillator genes Period1-3 and 
Cryptochrome1-2 encode proteins that form transcription repressor complexes that 
feedback to inhibit CLOCK/NPAS2:BMAL1 activity, thus completing the feedback loop 
that is the basis of the molecular circadian clockwork. Arrhythmic Bmal1
-/-
 mice exhibit 
site-specific, age-dependent arthropathy. While studying the circadian phenotype of 
Clock
-/-
;Npas2
m/m
 double mutant mice, we discovered that these double mutant mice 
develop site-specific arthropathy similar to the arthropathy described in Bmal1
-/-
 mice. 
Based on the circadian clockwork mechanism, we hypothesized that 
CLOCK/NPAS2:BMAL1 transactivator complexes drive the expression of a gene (or 
genes) that prevents age-dependent arthropathy. To investigate Clock
-/-
;Npas2
m/m
 double 
mutant mouse arthropathy, we evaluated mutant mice using X-ray, micro-computed 
tomography, and histology, and found that Clock
-/-
;Npas2
m/m
 double mutant mice exhibit 
age-dependent, site-specific arthropathy that phenocopies that of Bmal1
-/-
 mice. The 
costosternal junction and calcaneal tendon are most prominently affected, in that 
calcification of those tissues is detectable as early as 4-5 weeks and 11-12 weeks, 
respectively. The arthropathic lesions in these tissues consist of calcium phosphate 
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deposits, and in Bmal1
-/-
 costosternal junction calcifications, the deposits contain calcium 
pyrophosphate dihydrate crystals. Mechanical stress, disregulation of centrally-regulated 
circadian rhythms, and systemic serum mineral imbalances likely do not contribute to this 
pathology. In vitro micromass cultures generated from Clock
-/-
;Npas2
m/m
 double mutant 
mouse embryonic fibroblasts do not exhibit irregular chondrocyte differentiation 
compared to wild-type cultures, suggesting that chondrocyte cell-autonomous 
mechanisms are insufficient to induce this arthropathy. Analysis of Clock
-/-
;Npas2
m/m
 
double mutant intersternebral tissue RNA did not reveal significant changes in 
chondrocyte or calcification-related gene expression. Histological stains showed an 
absence of osteoblasts and osteoclasts around costosternal junction calcifications, 
suggesting that these cell types are not contributing to this pathology. Instead, 
chondrocytes are localized to the costosternal junction but there were no significant 
changes in the distribution of chondrocyte markers in this tissue, as evaluated by 
immunohistochemistry. These findings suggest that Clock or Npas2, and Bmal1, regulate 
ectopic calcification through a combination of systemic and local factors, and that the 
cells affected by Clock and Npas2, or Bmal1, disruption are a subset of the cells 
distributed in specific tissues that develop age-dependent arthropathy. The significance of 
these findings is that “circadian genes” play a role in the regulation of ectopic 
calcification in a non-oscillator capacity. Understanding this new mechanism by which 
ectopic calcification is controlled could lead to novel approaches for the treatment of 
some human calcification diseases.  
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CHAPTER I 
Introduction 
 
An arrhythmic, circadian mutant mouse model was created in our laboratory to 
study circadian rhythms and unexpectedly these mice develop site-specific ectopic 
calcification. These initial findings formed the basis of my thesis project. The purpose of 
this introduction is to familiarize the reader to the two topics bridged together in this 
dissertation: calcification and circadian rhythms. Relevant mutant mouse models are also 
discussed, as are select genes involved in the regulation of calcification and possible 
mechanisms of this pathology. 
 
Calcification 
 
Ectopic calcification and ossification. 
Ectopic calcification is the abnormal calcification of soft tissues and can be a sign 
of aging 
1, 2
. Ectopic calcifications are typically composed of calcium phosphate salts, 
such as hydroxyapatite (HA) or calcium pyrophosphate dihydrate (CPPD), and can arise 
by two mechanisms: metastatic and dystrophic calcification. Metastatic calcification is 
widespread ectopic mineralization that occurs secondary to systemic mineral imbalances, 
such as hyperparathyroidism. In the absence of systemic mineral imbalances, ectopic 
calcification is localized and referred to as dystrophic calcification, which typically 
occurs as a result of trauma, disease, or aging.  
 2 
Ossification, on the other hand, is the formation of true bone tissue, which is 
organized into cortical bone and medullary space. Calcification occurs in ossification, but 
not vice versa. The main cells responsible for true bone tissue formation are 
osteoprogenitor cells, chondrocytes, osteoblasts, osteocytes, and osteoclasts. 
Osteoprogenitor cells are immature progenitor cells derived from undifferentiated 
mesenchymal stem cells and are located in the periosteum. They can differentiate into 
osteoblasts, which form bone, or chondrocytes, which form cartilage 
3, 4
. Once osteoblasts 
become trapped in the bone matrix that they secrete, they are termed osteocytes 
5
. 
Osteoclasts originate from a mononuclear, hematopoetic cell lineage and are responsible 
for resorbing bone 
5
.
 
Healthy bone depends upon constant turnover; a homeostasis 
between osteoblast (bone formation) and osteoclast (bone resorption) activity. There are 
three types of ossification: endochondral, intramembranous, and heterotopic (or ectopic) 
ossification. Endochondral and intramembranous ossification are normal physiologic 
processes resulting in the appropriate formation of healthy bone tissue. Endochondral 
ossification is marked by the presence of a hyaline cartilage scaffolding intermediate on 
which bone is formed, while intramembranous ossification does not incorporate a 
cartilage intermediate. Heterotopic ossification (HO) is pathological endochondral 
ossification in soft tissue where bone does not normally exist. HO is commonly 
associated with trauma, such as neurological injury, major joint surgery, or burns 
6, 7
. 
Although the exact mechanisms of HO remain unclear, it is thought that mesenchymal 
stem cells present in soft tissue transform into osteogenic cells after appropriate inducing 
events, leading to bone formation in abnormal locations. An example is Achilles tendon 
 3 
ossification in humans, which is rare but can occur secondary to injury 
8
. 
Cartilage is a connective tissue closely associated with bone. It provides a 
cushioning effect in joints, and structure and support in other tissues. In endochondral 
ossification, the hyaline cartilage scaffold on which osteoblasts deposit bone matrix is 
created by chondrocytes. Chondrocytes are normally present in cartilage and growth 
plates and originate from the same mesenchymal stem cell as osteoblasts. As part of their 
physiologic differentiation, chondrocytes transition through four stages: resting, 
proliferating, pre-hypertrophic, and hypertrophic chondrocytes (Figure 1.1). All four 
stages are present in the growth plate of long bones, where endochondral ossification 
occurs, and there are well-described gene expression patterns at each stage of 
differentiation. Resting and proliferating chondrocytes express Sox9 and Col2a1, pre-
hypertrophic chondrocytes express Indian hedgehog (Ihh), and hypertrophic 
chondrocytes express Col10a1 and alkaline phosphatase (ALP, Akp2, or TNAP). Runx2 is 
expressed in all four stages, although to a lesser extent in hypertrophic chondrocytes. 
3, 4, 
9-11
. SOX9 is a transcription factor that regulates the expression of Col2a1, which 
encodes Type II collagen, the main cartilage matrix protein in hyaline cartilage. Sox9 
expression is essential for chondrocyte differentiation and cartilage formation, as Sox9
+/-
 
mice die perinatally and suffer from a variety of skeletal abnormalities, including 
hypoplasia of nearly all skeletal elements formed via endochondral ossification and 
premature mineralization of the vertebrae and some craniofacial bones 
12, 13
. Ihh regulates 
the proliferation of chondrocytes in the prehypertrophic zone by way of a local feedback 
loop involving parathyroid hormone-related peptide (PTHrP). IHH stimulates the 
 4 
expression of PTHrP, which then stimulates chondrocyte proliferation 
9
. Runx2 (also 
known as Cbfa1 or Aml3) is the master gene of osteoblast differentiation but it also plays 
a role in chondrogenesis: it is expressed in chondrocytes and stimulates chondrocyte 
hypertrophy 
4
. Alkaline phosphatase (ALP) is responsible for mineralizing extracellular 
matrix and is expressed in hypertrophic chondrocytes as well as osteoblasts 
14, 15
. 
Hypertrophic chondrocytes calcify the surrounding cartilage and eventually apoptose, 
leaving enlarged lacunal spaces into which osteoblasts and blood vessels can migrate. In 
osteoarthritis (OA), aging articular cartilage becomes progressively calcified. Apoptotic 
chondrocytes in OA cartilage have been proposed to contribute to these abnormal, age-
related calcifications 
16-18
. It has also been reported that chondrocyte apoptosis increases 
with age in rodent models, both in calcified and uncalcified regions of articular cartilage 
19
. Taken together, these findings suggest that abnormal chondrocyte apoptosis, which is 
age-dependent, could contribute to ectopic calcifications.  
 
Hydroxyapatite (HA) and calcium pyrophosphate dihydrate (CPPD) 
The two main types of calcium phosphate salts are hydroxyapatite (HA) and 
calcium pyrophosphate dihydrate (CPPD). HA is present in normal, healthy bone and 
makes up the majority of inorganic material in bone matrix 
20
. HA has a P:Ca atomic 
weight ratio of 0.45 and its chemical formula is Ca10(PO4)6(OH)2 
21
. CPPD, on the other 
hand, is typically only present pathologically, has a P:Ca atomic weight ratio of 0.75, and 
its chemical formula is Ca2O7P2•2H2O 
21
. Several calcification diseases, such as OA and 
CPPD crystal deposition disease (CPPD-CDD), are characterized by the deposition of 
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calcium phosphate salts in joints 
21-23
. In OA, chondrocytes produce matrix vesicles, 
which are extracellular vesicles that bud from the surface membrane of chondrocytes 
21
. 
Matrix vesicles contain enzymes that produce inorganic pyrophosphate (PPi) and 
orthophosphate (Pi) 
24
. At low concentrations, PPi is an inhibitor of HA formation but at 
high concentrations can induce CPPD crystal deposition 
25
. The key molecules involved 
in regulating extracellular PPi levels, and thus the balance between HA versus CPPD 
deposition, are nucleotide pyrophosphatase phosphodiesterase 1 (NPP1 or PC-1, encoded 
by Enpp1), tissue-nonspecific alkaline phosphatase (TNAP, encoded by Akp2), and 
progressive ankylosis protein (ANK, encoded by Ank) 
26
 (Figure 1.2). NPP1 generates 
PPi from the hydrolysis of ATP and TNAP hydrolyzes PPi to yield Pi, which crystallizes 
with calcium to form HA 
25-27
. ANK is a multiple-pass transmembrane protein that 
mediates intracellular to extracellular channeling of PPi 
28-30
. Careful homeostasis 
between the activities of these three proteins dictates whether or not there is calcification, 
and if there is, whether HA or CPPD crystals are deposited (Figure 1.2). 
 
Circadian rhythms 
 
Overview of circadian rhythms 
Circadian rhythms are self-sustaining, endogenous, biological rhythms with a 
cycle length of approximately 24 hours. They respond to external cues but are maintained 
under constant conditions. For instance, human corticosteroid release is rhythmic (peaks 
after waking and decreases at the onset of sleep) and maintains its rhythmicity under 
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constant conditions, such as constant darkness 
31
. Circadian rhythms govern changes in 
physiology and behavior in most organisms and their disruption can impair health and 
well-being. Shift work is a common cause of disrupted circadian rhythms and can 
increase the risk of heart disease and other major diseases in people 
32
. 
The mammalian circadian clockwork consists of a central pacemaker in the 
hypothalamus and peripheral pacemakers in other tissues 
33
. The central pacemaker in the 
mammalian brain is bilateral suprachiasmatic nuclei (SCN), which receive photic input 
from the retina and send signals to synchronize peripheral tissues. The SCN are 
responsible for generating behavioral rhythmicity, which can be visualized by running 
wheel actograms, while peripheral rhythms govern changes in physiology and behavior in 
their respective tissues. It has been shown that circadian oscillators are present within 
individual cells, such as fibroblasts 
34, 35
, neurons 
36
, and osteoblasts 
37
. 
 
Actograms 
Mice can be individually housed in cages with running wheels and every 
revolution of the wheel is documented electronically and plotted in an actogram. While in 
a 12 hour light:dark cycle, wild-type mice will entrain to the external light source by 
being inactive during the light phase and active during the dark phase (Figure 1.3A, left). 
Arrhythmic circadian mutant mice will also be inactive during the light phase but active 
in the dark phase, but this seemingly normal activity pattern is due to masking effects of 
light (Figure 1.3A, right). Arrhythmic circadian mutants lack a functioning circadian 
clock and so are unable to truly entrain to any external cues.  
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In constant darkness, wild-type mice maintain rhythmicity with a slightly less 
than 24-hour period length (Figure 1.3A, left). Arrhythmic mice are unable to maintain 
rhythms in the absence of an external light cue and so exhibit irregular activity patterns 
when put into constant darkness (Figure 1.3A, right).  
 
Mammalian circadian clockwork model 
The molecular basis of circadian rhythms involves interconnected transcriptional 
feedback loops (Figure 1.3B). Basic helix-loop-helix-PAS-containing transcription 
factors Clock (Circadian Locomotor Output Cycles Kaput), Npas2 (Neuronal PAS 
domain-containing protein 2, also known as Mop4), and Bmal1 (Brain and Muscle Arnt-
like protein-1, also known as Mop3) encode proteins that are part of the transcriptional 
activator complex of the circadian oscillator. CLOCK, NPAS2, and BMAL1 
heterodimerize to form CLOCK:BMAL1 or NPAS2:BMAL1 complexes that drive 
rhythmic expression of core clock and clock output genes (COGs) 
33, 38, 39
. Core clock 
genes are part of the circadian oscillator feedback loop while most COGs do not feed 
back into the oscillator. Core clock genes include two period genes (mPer1 & 2), two 
cryptochrome genes (mCry1 & 2), Rev-Erb!, and Ror!. PER and CRY form heterotypic 
complexes that translocate into the nucleus and repress transcription by inhibiting the 
activity of CLOCK/NPAS2:BMAL1, thus completing a negative feedback loop 
40
. REV-
ERB! suppresses Bmal1 transcription through a response element on the Bmal1 promoter 
41
 while ROR! drives Bmal1 transcription 42, thus completing the other feedback loop. 
COGs are rhythmically expressed and initiate changes in physiology. For instance, D-
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binding protein (Dbp) is a rhythmically expressed clock output gene 
43
 that regulates the 
expression of liver enzymes 
44
. 
 
Disrupting the clock 
Several mice with mutations in core clock genes have been generated to study 
circadian rhythms. Combinations of double mutant mice have been generated as well.  
Arrhythmic mutant mice discussed here have mutations in Bmal1, Clock, Crys, Pers, 
and/or Npas2 
39, 45-49
. Mice lacking both Crys (Cry1
-/-
;Cry2
-/-
) or both Pers (Per1
-/-
;Per2
-/-
) are arrhythmic under constant darkness, as are Bmal1
-/-
 mice. Clock"
19/"19 mutants 
express a dominant negative form of CLOCK that is capable of binding BMAL1 and 
DNA, but unable to drive transcription 
38, 46, 50
. Clock"
19/"19 mutant mice are arrhythmic 
under constant darkness, and so it was concluded that Clock, in addition to Bmal1, are 
essential components of the circadian oscillator. Thus, it was a surprise to learn that 
Clock
-/-
 mice are still rhythmic under constant darkness 
51
. In the SCN, Clock and Npas2 
are functionally redundant and both genes must be disrupted in order to disrupt 
behavioral rhythmicity 
39
. A different story is told for peripheral tissue, however. In liver 
tissue of Clock
-/-
 mice, core clock proteins, such as PERs and CRYs, continue to be 
rhythmically expressed in vivo due to imposed rhythmicity from the SCN 
51
. However, 
when Clock
-/-
 liver and lung tissue are cultured ex vivo, they are arrhythmic 
52
. Npas2
m/m
 
liver and lung tissue are rhythmic ex vivo just like wild-type tissue. These findings show 
that in Clock
-/-
 mice, functioning SCN (due to the ability of NPAS2 to functionally 
substitute for CLOCK in the SCN) are able to impose rhythmicity upon peripheral tissue 
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oscillators, but once liver or lung tissue is disconnected from the central pacemaker, those 
peripheral tissues are unable to maintain synchronized rhythms. Thus, peripheral 
circadian oscillators require CLOCK, but not NPAS2, in order to function properly. 
These arrhythmic genotypes illustrate the necessity of functioning Bmal1, Clock 
or Npas2, Crys, and Pers for the regulation of circadian rhythms in the SCN. Many 
studies investigating the effects of core clock gene disruption in peripheral tissues have 
been performed. In Clock"
19/"19 mutant and Bmal1
-/-
 mice, pancreatic islets are altered 
leading to impaired glucose tolerance, reduced insulin secretion, and diabetes mellitus 
53
. 
Pancreas-specific Bmal1 disruption causes severe glucose intolerance and defective 
insulin production despite normal activity and feeding behavior 
53, 54
. Disrupting Bmal1 in 
retina causes visual defects, similar to retinal pathology observed in whole body Bmal1
-/-
 
mice 
55
. Liver-specific Bmal1
-/-
 mice are unable to properly regulate glucose homeostasis 
and exhibit metabolism defects in a circadian manner 
56
. Mice exhibit rhythmic responses 
to a variety of drugs, which can be explained by the rhythmic expression of cytochrome 
P450, an enzyme important for metabolism of xenobiotics, in the liver 
57, 58
. Clock"
19/"19 
mutant and Bmal1
-/-
 mice are hypersensitive to cyclophosphamide, an anti-cancer drug, 
and Clock
-/-
 mice have altered responses to pentobarbital and ethanol 
59, 60
. Clearly, 
peripheral oscillator genes regulate peripheral tissue physiology, as disruption of these 
genes can cause drastic phenotypes. 
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Musculoskeletal phenotypes of circadian mutant mice 
 
There is mounting evidence that circadian genes are involved in musculoskeletal 
phenotypes. Core clock genes are rhythmically expressed in osteoblasts, chondrocytes, 
bone, and teeth, as well as osteoblastic and chondrogenic cell lines 
37, 61-63
.  
 
Bmal1
-/-
 mice 
Bmal1
-/-
 mice display dramatic age-progressive non-inflammatory arthropathy 
64
. 
These mice develop joint ankylosis due to calcification of ligaments and tendons. By 35 
weeks of age, essentially all Bmal1
-/-
 animals have complete immobilization of weight-
bearing and non-weight-bearing joints. These effects are site-specific; the areas primarily 
affected in Bmal1
-/-
 mice are the calcaneal tendon, longitudinal ligaments of the 
vertebrae, and costosternal junctions while articular cartilage is spared. Bmal1
-/-
 mice 
have also been shown to have altered skeletal muscle structure and function 
65
.  
 
Per and Cry mutant mice 
Per1
-/-
;Per2
-/-
 double knockout and Cry1
-/-
;Cry2
-/-
 double knockout mice display 
subtle skeletal defects. Starting at six weeks of age, these mice display age-progressive 
high bone mass (HBM) in both vertebrae and long bones 
37
. Per2
-/-
 and Cry2
-/-
 single 
knockout mice also display subtle HBM in vertebrae and long bones 
66
. However, soft 
tissue calcification has not been noted in Per1
-/-
;Per2
-/-
 or Cry1
-/-
;Cry2
-/-
 double mutants, 
or Per2
-/-
 or Cry2
-/-
 single mutants, even in animals of advanced age (our lab’s 
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unpublished data)
37, 67
. 
 
Bmal1
-/-
 versus Per1
-/-
;Per2
-/-
 double knockout mice 
Clearly core clock genes are involved in the regulation of calcification. However, 
the effects of Bmal1 disruption are most likely not related to its role in circadian rhythms 
because other arrhythmic circadian mutants, namely the Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 
mutant mice, do not exhibit the same phenotype. If this arthropic phenotype were due to 
disruption of the circadian oscillator, one would expect to see the same phenotype 
regardless of how the oscillator was broken. Instead, arrhythmic Bmal1
-/-
 mice exhibit 
calcification in specific soft tissues 
64
, while arrhythmic Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 
double knockout and Per2
-/-
 or Cry2
-/-
 single mutant mice exhibit increased calcification 
within vertebrae and long bone 
37, 66
.  
Also, the phenotype of Bmal1
-/-
 mice is much more dramatic than the subtle 
phenotype of Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double knockout mice. Bmal1
-/-
 mice 
exhibit gross calcifications detectable by X-ray, a rather insensitive tool, while Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double knockout mice reveal subtle increases in bone volume 
detected by micro-computed tomography (micro-CT), a very sensitive method. These 
phenotypic differences suggest the mechanism of calcification in these mouse strains is 
different and unrelated to circadian rhythms.  
Tissue-specific rescue of Bmal1 lends additional evidence to support this idea 
68
. 
In this study, Bmal1 expression was rescued in brain or muscle of Bmal1
-/-
 mice. Brain-
specific Bmal1 rescue restored behavioral circadian rhythmicity but did not prevent 
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calcaneal tendon calcification. This result shows that restoration of central circadian 
rhythms is not sufficient to prevent peripheral ectopic calcification. Muscle-specific 
Bmal1 rescue was not sufficient to prevent ectopic calcification either, further supporting 
the finding that ectopic calcification in Bmal1
-/-
 mice is site- and tissue-specific 
68
. 
 
Clock
-/-
;Npas2
m/m
 double mutant mice 
In the course of studying Clock, Npas2, and Bmal1, our laboratory observed that 
Clock
-/-
;Npas2
m/m
 double mutant mice develop severe, site-specific arthropathy similar to 
that observed in Bmal1
-/-
 mice. Due to the overlapping roles of Clock and Npas2 in the 
SCN clock 
39
, the emergence of such a similar phenotype is not surprising from a 
molecular standpoint. Disrupting Clock and Npas2, or Bmal1, leads to the same 
molecular effect: lack of CLOCK/NPAS2:BMAL1 transcription factor heterodimers. My 
hypothesis is that CLOCK or NPAS2, and BMAL1, drive the expression of a gene or 
genes that prevents age-dependent ectopic calcification in a pathway separate from the 
one in which PER and CRY act, because disruption of Per1/2 and Cry1/2, the circadian 
oscillator repressors, leads to a different skeletal phenotype.  
 
Musculoskeletal phenotypes of other mutant mice 
 
Multiple mutant mouse lines have been developed to study bone development. 
While many exhibit robust calcification phenotypes, none phenocopy Bmal1
-/-
 mice to the 
same extent as Clock
-/-
;Npas2
m/m
 double mutant mice (Table 1.1). Nevertheless, mutant 
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mice with varying degrees of phenotypic similarity to Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 
double mutant mice can be used to identify genes possibly involved in the ectopic 
calcification observed in Clock
-/-
;Npas2
m/m
 double mutant mice. Of the three molecules 
central to PPi regulation, Enpp1
-/-
 and Ank
-/-
 mice exhibit interesting ectopic calcification 
phenotypes that mirror aspects of the arthropic phenotype observed in Bmal1
-/-
 and Clock
-
/-
;Npas2
m/m
 double mutant mice. Akp2
-/-
 mice do not develop ectopic calcification, but the 
combined roles of Enpp1, Ank, and Akp2 in extracellular PPi regulation make Akp2 a 
gene of interest as well.  
 
Enpp1
-/-
 mice 
Enpp1
-/-
 mice, also known as “tiptoe walking” (or ttw/ttw) mice, are an animal 
model for ossification of the posterior longitudinal ligament (OPLL) of the spine, which 
is a common form of human myelopathy that results from the ectopic ossification of 
spinal ligaments 
69
. Enpp1
-/-
 mice develop progressive ankylosing intervertebral and 
peripheral joint hyperostosis, as well as arterial and articular cartilage calcification and 
increased vertebral cortical bone formation 
26, 69-72
. There is a dramatic decrease in 
extracellular PPi in Enpp1
-/-
 mice and the calcification observed in these mutants is 
consistent with both membranous and endochondral ossification, rather than dystrophic 
calcification 
72
. Of particular interest is the finding that Enpp1
-/-
 mice display ectopic 
calcification of their calcaneal tendon 
26
, a site-specific effect also observed in Bmal1
-/-
 
mice 
64
. If Enpp1 gene dysregulation is involved in the arthropic pathogenesis of Bmal1
-/-
 
and Clock
-/-
;Npas2
m/m
 double mutant mice, we would expect to see down regulation of 
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Enpp1 and/or decreased NPP1 activity in the circadian mutant mice. 
 
ank/ank and Ank
-/-
 mice 
Mice carrying the ank mutation have been studied as a model of arthritis and this 
autosomal recessive mutation causes loss of joint mobility that spreads to most joints 
throughout the limbs and vertebral column as the animals age, ultimately leading to 
complete rigidity and death around six months of age 
73
. These animals exhibit an 
inflammatory arthropathy with HA crystals deposited in joints 
74, 75
. Although the 
distribution of phenotypes in ank/ank mutant mice does not precisely resemble any single 
form of human arthritis, many pathologic features in ank/ank mutant mice mirror classic 
features of other arthritic diseases, such as ectopic calcification seen in mineral 
deposition disease, cartilage erosion and osteophyte formation seen in OA, and vertebral 
fusion seen in ankylosing spondylitis 
28, 76
. The ank/ank mutant carries a single nucleotide 
nonsense mutation in the Ank locus and it has been shown that Ank
-/-
 mice exhibit the 
same phenotype as ank/ank mutant mice, suggesting that ANK is required to inhibit 
ectopic calcification 
73, 77
. The human form of this protein is called ankylosis protein 
homolog (ANKH). There is striking similarity between Enpp1
-/-
 and ank/ank mutant mice 
in terms of their enthesopathy, ankylosing hyperostosis of the spine, articular cartilage 
calcification, and peripheral joint fusion. This similarity is consistent with their shared 
ability to generate extracellular PPi: ANK transports PPi from the intracellular to 
extracellular environment and NPP1 cleaves ATP to generate PPi (Figure 1.2). Therefore, 
PPi regulation is critical to the regulation of ectopic calcification. Similarly with Enpp1 
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gene dysregulation, if Ank is involved in the arthropic phenotype of Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice, we would expect to see down regulation of Ank 
expression and/or ANK activity in Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice. 
 
Akp2
-/-
 mice 
The Akp2
-/-
 mouse is a mutant model of infantile hypophosphatasia, a human 
disease marked by osteomalacia associated with reduced serum TNAP activity 
78, 79
. 
Akp2
-/-
 mice lack functional TNAP, leading to hypomineralized cartilage and bone, and 
increased extracellular PPi. It is unclear why the increase in PPi does not lead to ectopic 
calcification in this mutant mouse model. Mutations in Enpp1 and Ank lead to decreased 
extracellular PPi levels while mutating Akp2 increases extracellular PPi levels, so it seems 
logical that inhibiting TNAP activity could rescue the bone mineralization phenotype in 
Enpp1
-/-
 and Ank
-/-
 mice. Interestingly, Akp2
-/-
;Enpp1
-/-
 double mutant mice have normal 
bone mineralization and extracellular PPi levels 
27
, and Akp2
-/-
;ank/ank double mutant 
mice have partial normalization of mineralization and PPi levels 
26
, showing that these 
three molecules are key regulators of bone mineralization. If PPi dysregulation is 
involved in age-dependent arthropathy of Bmal1
-/- 
or Clock
-/-
;Npas2
m/m
 double mutant 
mice, we could see changes in ALP activity, in addition to Enpp1 and Ank expression 
levels.  
 
HDAC4
-/-
 mice 
Another gene of interest is histone deacetylase (HDAC) 4, which is a class II 
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HDAC capable of responding to a variety of signal transduction pathways 
80
. Histone 
deacetylases favor chromatin condensation and transcriptional repression, 
counterbalancing the transcriptional activation of histone acetylation, which promotes 
gene transcription by relaxing chromatin structure by facilitating access of the 
transcriptional machinery to DNA target sequences 
81
. It has been shown that H3 histone 
acetylation is rhythmic and under the influence of core circadian oscillator genes, namely 
Cry, in regulating the circadian negative feedback loop. CRY disrupts the CLOCK-
BMAL1-coactivator complex and this disruption reduces histone acetyltransferase 
activity, which reduces transcriptional activation 
82
. In the case of Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice, the lack of a transcriptional activator complex leads to 
decreased levels of Per and Cry expression and thus decreased transcriptional repression. 
Because Per expression is decreased in Bmal1
-/-
 mice 
45
, it is possible that the subtle 
HBM phenotype characteristic of Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double knockout mice 
is included among the more impressive ectopic calcifications observed in Bmal1
-/-
 and 
Clock
-/-
;Npas2
m/m
 double mutant mice. 
HDAC4 is expressed in prehypertrophic chondrocytes and regulates chondrocyte 
hypertrophy and endochondral bone formation by inhibiting Runx2 expression 
80
. 
HDAC4
-/-
 mice display premature ossification of developing bones secondary to ectopic 
and precocious chondrocyte hypertrophy and do not survive to weaning. HDAC4
-/-
 mice 
phenocopy Runx2-overexpressing mice, and overexpression of HDAC4 results in a 
phenotype similar to that of dominant-negative Runx2 mutants 
80, 83
. Of particular interest 
is the finding that HDAC4
-/-
 mice display costosternal junction calcification 
80
 similar to 
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that observed in Bmal1
-/-
 mice 
64
. Because HDACs favor transcriptional repression, it is 
possible that the lack of transcriptional repression in HDAC4
-/-
 mice relates to the lack of 
transcriptional activation in Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice. Perhaps 
HDAC4 represses a molecule that promotes arthropathy, whereas 
CLOCK/NPAS2:BMAL1 complexes drive the expression of a competing molecule that 
prevents arthropathy. If HDAC4 is involved in the development of arthropathy in Bmal1
-
/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice, we would expect to see less HDAC4 activity 
in our circadian mutant mice. 
 
Mglap
-/-
 mice 
The fourth mutant mouse that exhibits a possibly related ectopic calcification 
phenotype is the Mglap
-/-
 mouse. Matrix GLA protein (MGP) is an inhibitor of ectopic 
calcification expressed predominantly by chondrocytes and vascular smooth muscle cells 
and is encoded by Mglap in mice and MGP in humans 
84, 85
. Mglap
-/-
 mice exhibit 
spontaneous calcification of arteries and cartilage and die within two months of birth due 
to blood vessel rupture secondary to arterial calcification. The extent of their ectopic 
calcification extends to various cartilages, including the growth plate, which leads to 
short stature, osteopenia, and fractures 
84
. MGP is a part of a small family of proteins that 
contain "-carboxylated glutamate residues. The carboxylation of glutamate residues on 
MGP is dependent on vitamin K and confers a high affinity for mineral ions, thus 
inhibiting mineral deposition 
85
. In humans, nonsense mutations in MGP cause Keutel 
syndrome, a rare autosomal recessive disorder characterized by ectopic calcification in 
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cartilage (including the costosternal junctions), the spinal column, and epiphyses of long 
bones 
86
. People with Keutel syndrome additionally suffer from tracheobronchial and 
pulmonary stenosis and midfacial hypoplasia. The idea that pathological extracellular 
matrix calcification could be due to the lack of inhibitors of calcification 
85
, such as 
MGP, raises the possibility that the site-specificity of arthropathy observed in Bmal1
-/-
 
and Clock
-/-
;Npas2
m/m
 double mutant mice could be due to site-specific loss of MGP 
function. Mglap expression could be expressed in tissues unaffected by ectopic 
calcification, while tissues like costosternal junction and calcaneal tendon lack the 
transcription factors necessary to drive the expression of Mglap. If this is the case, then 
we would expect to see down regulation of Mglap function in tissues undergoing ectopic 
calcification in Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 double mutant mice. 
 
The mutant mouse models discussed here are merely a subset of the many mutant 
lines created to study bone formation and homeostasis. Many other genes could also be 
involved in the pathogenesis of ectopic calcification in Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 
double mutant mice, but the genes and mutant lines discussed here are highlighted due to 
the similarities in their calcification phenotypes to those of Bmal1
-/-
 and Clock
-/-
;Npas2
m/m
 
double mutant mice.  
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Possible mechanisms of age-dependent arthropathy in circadian mutant mice 
 
Dysfunctional chondrocyte maturation  
As previously stated, chondrocytes are responsible for cartilage formation and 
calcification during endochondral ossification. However, inappropriate chondrocyte 
activity can lead to abnormal calcification. One possible mechanism of abnormal 
calcification is the inappropriate differentiation of resting chondrocytes into osteogenic 
cells, which then calcify the surrounding tissue. For example, chondrocytes are normally 
found in the costal cartilage but if they become dysregulated, they could inappropriately 
differentiate into hypertrophic chondrocytes and calcify the costal cartilage. This 
mechanism could be applicable to tendon because chondrocytes are found, albeit in small 
numbers, at the enthesis of tendon and bone 
87
. In this mechanism, chondrocytes would 
also undergo apoptosis, which is part of the physiologic maturation program of 
chondrocytes. While apoptosing, hypertrophic chondrocytes could release apoptotic 
bodies that contribute to calcification of surrounding tissue, which is a proposed 
mechanism of OA 
18
.  
 
Progenitor cell dysfunction 
Another possible mechanism involves adult progenitor cells. Progenitor cells 
could inappropriately differentiate into osteogenic cells that then calcify the surrounding 
tissue, which is the hypothesized mechanism of HO 
7
. Progenitor cells are present in adult 
cartilage 
88, 89
 and tendons 
90
, so it is possible that progenitor cells in these tissues 
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inappropriately differentiate into osteogenic cells secondary to disruption of Clock and 
Npas2 expression and cause HO.  
 
De-differentiation and systemic dysregulation 
A third possible mechanism is the de-differentiation of chondrocytes or tenocytes 
followed by differentiation into an osteogenic cell; this mechanism is not experimentally 
separable from the others described above. A fourth possible mechanism is systemic 
dysregulation, either of circadian rhythms or serum minerals that could cause abnormal 
calcification in these mice. However, the site-specific phenotype observed in Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice, the lack of phenotypic similarity with other 
arrhythmic mutant mice (namely, the Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double knockout 
mice), and the lack of serum calcium and phosphorous changes in Bmal1
-/-
 mice 
64
 do not 
support systemic dysregulation; instead these characteristics suggest a more localized 
mechanism. Nevertheless, it is possible that an interaction between site-specific 
mechanisms and systemic hormonal or mineral imbalances could contribute to this age-
dependent, site-specific arthropathy.  
 
Extracellular PPi dysregulation 
A fifth possible mechanism involves extracellular PPi dysregulation. Enpp1
-/-
 
70
 
and Ank
-/-
 mice 
73
 have abnormal extracellular PPi levels and exhibit ectopic calcification 
phenotypes of varying similarity to that described for Bmal1
-/-
 mice 
64
. If there is too 
much extracellular PPi, then CPPD crystals precipitate in tissue. If there is too little 
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extracellular PPi, then HA crystals precipitate. Thus, depending on the type of crystals 
deposited in Clock
-/-
;Npas2
m/m
 double mutant mice, it could suggest that disruption of 
extracellular PPi homeostasis contributes to site-specific arthropathy. 
 
Osteoclast or osteoblast dysfunction 
Lastly, an imbalance in bone homeostasis could cause abnormal calcification. If 
osteoblast activity is inappropriately high or osteoclast activity is inappropriately low, 
bone formation would be favored. Bmal1
-/-
 mice exhibit increased bone formation 
rate/tissue volume (BFR/TV) ratios, mineral apposition rates, and number of osteoblasts 
per square millimeter, all suggestive of an increase in osteoblast function 
37
.  
 
Concluding remarks 
 
Through the course of this dissertation, these possible mechanisms will be 
discussed and it will be shown that local factors, possibly interacting with systemic 
factors, likely cause the dramatic arthropic phenotype in Clock
-/-
;Npas2
m/m
 double mutant 
mice, and that the local effects are anatomically very specific. 
Ectopic calcification and ossification are abnormal (and in the case of ectopic 
calcification, age-related) processes that can limit mobility. Abnormal calcifications can 
cause discomfort and, in extreme cases, severe pain for patients. Recent data suggest that 
an absence of Clock and Npas2, or Bmal1 leads to the formation of ectopic calcifications. 
The studies outlined in this dissertation aim to characterize and investigate mechanisms 
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of age-related arthropathy observed in Clock
-/-
;Npas2
m/m
 double mutant mice. 
Understanding these mechanisms will not only identify a novel pathway connecting 
circadian clock genes and genes of matrix mineralization, but may also identify possible 
therapeutic targets to treat some types of age-related ectopic calcification.  
 23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Chondrocyte maturation. Chondrocytes go through the 
following stages of maturation: resting, proliferating, pre-hypertrophic, and 
hypertrophic chondrocytes. There are characteristic gene expression patterns 
at each of these stages, as discussed in the text. The hatched box represents 
decreased Runx2 expression in hypertrophic chondrocytes. 
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Figure 1.2. Diagrammatic representation of TNAP, ANK, and NPP1 in the regulation 
of extracellular PPi levels. (A) Normal, low, physiologic levels of PPi inhibit HA crystal 
deposition. NPP1 hydrolyzes ATP to form PPi. ANK transports intracellular PPi to the 
extracellular space. TNAP hydrolyzes PPi to form Pi, which crystallizes with calcium to 
form HA. (B) Too little PPi leads to HA crystal deposition (left) while too much PPi leads to 
CPPD crystal deposition (right). Careful homeostasis among these three proteins dictate 
extracellular PPi levels. 
HA 
deposition 
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Figure 1.3. Locomotor actograms and the mammalian circadian clockwork model.  
(A) Double plotted locomotor activity records (also known as actograms) of rhythmic wild-
type and arrhythmic Clock
-/-
;Npas2
m/m
 double mutant mice. Horizontal white bars represent 
when lights are on and horizontal black bars represent when lights are off. Activity is 
documented as revolutions of the running wheel and represented as black marks on the 
actogram. The yellow line is drawn to emphasize the slightly less than 24-hour period length 
of the wild-type mouse. Note the arrhythmic activity of the Clock
-/-
;Npas2
m/m
 double mutant 
mouse in DD. Adapted from DeBruyne et al., 2007 (ref. 39). (B) Model of the mammalian 
circadian clock. See text for details. Red lines represent transcriptional inhibition, green lines 
represent transcriptional activation. Adapted from Yu et al., 2011 (ref. 126). ( LD: 
light:dark; DD: constant darkness Clk: Clock; N: Npas2; C/N: Clock or Npas2; B: Bmal1; 
R: Rev-erb!; r: Ror!; COG: clock output gene; X: unknown clock output protein.  
B. 
A. 
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 Table 1.1. Summary of calcification-related mutant mouse models. 
 
 Bone mass Age-dep Inflamm Ectopic 
calcification 
Crystal 
deposits  
Serum Ca
2+
 
or P changes 
Premature 
death 
Bmal1
-/-
 NC (64) Yes (64) No (64) Yes (64) CPPD 
(OU)  
No (64, 95)  Yes  
(95, 96)  
Clock
-/-
; 
Npas2
m/m 
IC (OU) Yes  Probably 
no (OU) 
Yes  Unknown No  Yes (OU) 
Enpp1
-/-
 No change 
(70) 
Yes (70) No (26) Yes (69, 26) HA (147) Unknown Yes (70) 
Ank
-/-
 & 
ank/ank 
Increase 
(29) 
Yes (73) Yes  
(74, 75) 
Yes (73) HA  
(74, 75) 
Unknown Yes (73) 
Akp2
-/-
 Decrease 
(78, 79) 
Yes (79) No  
(78, 79) 
No (78, 79) N/A No (79) Yes  
(78, 79) 
Mgp
-/-
 NC (84) Yes (84) No (84) Yes (84) HA (84) Unknown Yes (84) 
HDAC4
-/- 
Unknown Yes (80) No (80) Yes (80) Unknown Unknown Yes (80) 
Prrx1
-/-
 Decrease 
(114) 
Yes (114) Probably 
no (114) 
No (114) N/A Unknown Yes (114) 
Hyp mice Decrease 
(148) 
Yes (148) No (135) Yes (135) Unknown Yes  
(148, 130) 
No (148) 
kl/kl Decrease 
(93) 
Yes (93) Probably 
no (93) 
Yes (93) Unknown Yes (93) Yes (93) 
FGF23
-/-
 Decrease 
(98) 
Yes (98) Unknown Yes (99) Unknown Yes (98) Yes (98) 
Runx2
-/-
 Decrease 
(149) 
No (149) Probably 
no (149) 
No (149) N/A Unknown Yes (149) 
Sox9
+/-
 Both* (13)  Yes (13) Unknown Yes – heart 
valves (152) 
Unknown Unknown Yes (13) 
Ihh
-/-
 Decrease 
(150) 
Yes (150) No (150) No (150) N/A Unknown Yes {(150) 
Col10a1
-/-
 NC (151)  N/A Unknown No (151) N/A Unknown No (151) 
Per1
-/-
; 
Per2
m/m
 
Increase 
(37)  
Yes (37) Unknown No (37) Unknown No (37) No  
(37, OU) 
Cry1
-/-
; 
Cry2
-/-
 
Increase 
(37) 
Yes (37) Unknown No (37) Unknown Probably no 
(37) 
No  
(37, OU) 
Age-dep: age-dependent; Inflamm: inflammatory; NC: no change; OU: our unpublished data/observations; 
N/A: not applicable; IC: inconclusive data; HA: hydroxyapatite; CPPD: calcium pyrophosphate dihydrate. 
*Sox9
+/-
 mice exhibit hypoplasia of most bones derived from endochondral ossification but also display 
premature mineralization of vertebrae & craniofacial bones 
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Chapter II 
Characterizing arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice 
 
Summary 
 
Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice are arrhythmic circadian 
mutant mice used to study circadian rhythms. CLOCK and NPAS2 are functionally 
redundant in the SCN, in that either can bind to BMAL1 to form a heterodimer 
transcription factor complex that drives rhythmic gene expression. In the course of other 
studies, it was found that 35+ week-old Clock
-/-
;Npas2
m/m
 double mutant mice exhibit 
calcification similar with that of 35 week-old Bmal1
-/-
 mice. Here we further explore that 
finding and show that Clock
-/-
;Npas2
m/m
 double mutant mice manifest an overall 
arthropathy similar to that of Bmal1
-/-
 mice. This arthropathy is site-specific, age-
progressive, and consists of ectopic calcifications. In Clock
-/-
;Npas2
m/m
 double mutant 
mice, several different sites are affected, both weight-bearing and non-weight-bearing. 
The sites with the most prominent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice 
are the calcaneal tendon and costosternal junction. These calcifications contain calcium 
and phosphate, and in Bmal1
-/-
 costosternal junction consist of CPPD crystal deposits. 
The consistency of phenotypes between Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 
mice strongly suggests that disruption of the transcriptional activator complex leads to 
gene dysregulation that causes age-dependent, site-specific ectopic calcification.  
 28 
Acknowledgements 
 
This chapter is a result of collaboration between our laboratory and the 
laboratories of Jane Lian and Paul Fanning in the Department of Cell Biology at the 
University of Massachusetts Medical School (UMMS). As such, I would like to 
acknowledge the appropriate people for their contribution to the work presented here.  
Drs. Robert Dallmann and Jason DeBruyne were responsible for first recognizing 
arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice, and Robert performed the first X-
rays to identify ectopic calcification in 44-48 week-old mutant mice. Stacey Russell 
performed all of the micro-CT scans and showed me how to create 3-D reconstructed 
images. Sadiq Hussain and April Mason-Savas taught me everything I know about 
histology, and also performed some of the histological stains. Sadiq performed toluidine 
blue stains of decalcified 11-12 week-old tissues and April performed von Kossa and 
safranin-O stains of non-decalcified sterna tissues, and von Kossa, safranin-O, and 
alizarin red stains of non-decalcified calcaneal tendon. Jennifer Colby and Sadiq also 
showed me how to collect, dissect, and X-ray mice. Sadiq additionally taught me how to 
use the microscope and software associated with imaging slides. Lastly, Dr. Gregory 
Hendricks of the Core Electron Microscopy Facility operated the scanning electron 
microscope (SEM) to calculate P:Ca atomic weight ratios and stoichiometric analysis of 
crystal deposits in ectopic calcification and bone.  
 
 
 
 
 29 
Figure 2.1. Distribution of ectopic calcification in 41-42 week-old Clock
-/-
;Npas2
m/m
 
double mutant mice.  
Elizabeth Yu – Department of Neurobiology, UMMS 
Stacey Russell – Musculoskeletal Center Imaging Core, Department of Cell 
Biology, UMMS 
 
Figure 2.2. X-ray images of Clock
-/-
;Npas2
m/m
 internal organs do not reveal ectopic 
calcification.  
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 2.3. Clock
-/-
;Npas2
m/m
 double mutant mice exhibit age-dependent weight loss. 
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 2.4. Age-progressive calcification of calcaneal tendon in Clock
-/-
;Npas2
m/m
 double 
mutant mice. 
Elizabeth Yu and Dr. David Weaver – Department of Neurobiology, UMMS 
 
Figure 2.5. Age-progressive calcification of costosternal junction in Clock
-/-
;Npas2
m/m
 
double mutant mice.  
Elizabeth Yu and Dr. David Weaver – Department of Neurobiology, UMMS 
 
Figure 2.6. No ectopic calcification in calcaneal tendon or costosternal junction of 76 
week-old Per1
-/-
;Per2
-/-
 double mutant mice.  
Elizabeth Yu and Dr. David Weaver – Department of Neurobiology, UMMS 
 
Figure 2.7. Ectopic calcification of costosternal junction and calcaneal tendon in 11-12 
week-old Clock
-/-
;Npas2
m/m
 double mutant mice. 
Stacey Russell – Musculoskeletal Center Imaging Core, Department of Cell 
Biology, UMMS 
 
Figure 2.8. Acellular lesions in decalcified costosternal sections of young Clock
-/-
;Npas2
m/m
 double mutant mice.  
Elizabeth Yu – Department of Neurobiology, UMMS 
Sadiq Hussain – Department of Cell Biology, UMMS 
 
Figure 2.9. Lesions in costosternal junction and calcaneal tendon of Clock
-/-
;Npas2
m/m
 
double mutant mice contain calcium phosphate deposits.  
Elizabeth Yu – Department of Neurobiology, UMMS 
April Mason-Savas – Department of Cell Biology, UMMS 
 
Figure 2.10. Calcaneal tendon of 6-7 and 11-12 week-old Clock
-/-
;Npas2
m/m
 double 
mutant mice. 
Elizabeth Yu – Department of Neurobiology, UMMS 
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Figure 2.11. Ectopic calcification in the sternum of a 53 week-old Bmal1
-/-
 mouse 
contains CPPD crystal deposits.  
Elizabeth Yu – Department of Neurobiology, UMMS 
Dr. Gregory Hendricks – Core Electron Microscopy Facility 
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Introduction 
 
The mammalian circadian clock is based on interconnected feedback loops that 
take approximately 24 hours to complete 
33
. At the center of these feedback loops are the 
transcription factors Clock, Npas2, and Bmal1, which form a transcription activator 
complex to drive the expression of Period 1-3 and Cryptochrome 1-2. PERs and CRYs 
form transcriptional repressor complexes that inhibit CLOCK:BMAL1 or 
NPAS2:BMAL1, and thus their own transcription 
40
. Disruption of these core clock genes 
causes arrhythmicity in constant darkness. Specifically, Bmal1
-/-
 mice are arrhythmic 
45
. 
Bmal1
-/-
 mice also exhibit age-dependent arthropathy, characterized by ectopic 
calcification of the costosternal junction, calcaneal tendon, and longitudinal spinal 
ligaments 
64
.  
While using Clock
-/-
;Npas2
m/m
 double mutant mice to study the roles of Clock and 
Npas2 in behavioral circadian rhythmicity, our lab discovered an arthropic phenotype in 
35+ week-old Clock
-/-
;Npas2
m/m
 double mutant mice. These double mutant mice exhibit 
gross motor deficits, such as severe stiffness of the hind legs and distorted tail postures 
(our unpublished data). They are also unable to balance on a raised beam or hang upside 
down from a wire cage, which are indicative of diminished motor coordination and paw 
grip strength, respectively (our unpublished observations) 
91
. Upon closer inspection of 
appendicular and axial skeletons using X-ray, it was discovered that 35+ week-old Clock
-
/-
;Npas2
m/m
 double mutant mice exhibited site-specific arthropathy similar to that of 35 
week-old Bmal1
-/-
 mice 
64
.  
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NPAS2 can substitute for CLOCK in the SCN: either molecule can bind to 
BMAL1 to form a heterodimer transcription complex that binds to E-box elements and 
drives rhythmic gene expression. This complex can drive core circadian oscillator genes, 
such as the Pers and Crys, or clock output genes, such as Dbp 
33, 43
. Given the functional 
redundancy of Clock and Npas2 in the SCN and their shared ability to bind to BMAL1, 
we postulated that disruption of the transcriptional activator (CLOCK:BMAL1 or 
NPAS2:BMAL1) causes site-specific arthropathy. To investigate this phenotype, we used 
a combination of X-ray, micro-computed tomography (micro-CT), and histological 
techniques to characterize the extent of arthropathy in Clock
-/-
;Npas2
m/m
 double mutant 
mice and mice of other circadian genotypes. 
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Experimental procedures 
 
Generation and maintenance of study animals 
All animal studies were reviewed and approved by the Institutional Animal Care 
and Use Committee at the University of Massachusetts Medical School. Mice used for 
these studies had been backcrossed at least 10 generations to the C57BL/6J background, 
except for Per mutant and respective control mice, which were on the 129/sv 
background. Wild-type controls were studied simultaneously in each experiment. Unless 
otherwise stated, multiple mice were housed in gender-segregated, ventilated 
191x279x127mm cages in a pathogen-free barrier facility maintained on a 12-hour 
light/12-hour dark cycle with food and water ad libitum. Light was provided by 
fluorescent tubes and was ~200 lux at the level of the cages. Dim red light from 
fluorescent tubes was on continuously, including periods referred to as constant darkness.  
 Clock
-/-
 mice were generated by our lab, as previously described 
51
. Bmal1 
founder mice were a kind gift from Dr. Christopher A. Bradfield (University of 
Wisconsin) 
45
. Npas2
 
founder mice were a kind gift from Dr. Steven L. McKnight 
(University of Texas – Southwestern Medical Center) 
92
. To generate Clock
-/-
;Npas2
m/m
 
double mutant mice, Clock
+/-
;Npas2
m/m
 three-allele mutant mice were crossed to one 
another to obtain Clock
-/-
;Npas2
m/m
 double mutant mice. Clock
-/-
;Npas2
+/m
 three-allele 
mutant mice were also intercrossed to obtain Clock
-/-
;Npas2
m/m
 double mutant mice, 
although with less success than Clock
+/-
;Npas2
m/m
 three-allele mutant mice intercrosses. 
Clock
+/-
;Npas2
m/m
 three-allele mutant mice intercrosses also generated Clock
+/-
;Npas2
m/m
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three-allele and (Clock
+/+
;)Npas2
m/m
 mice. Clock
-/-
 mice were obtained by crossing Clock
-
/-
 or Clock
+/-
 heterozygote with Clock
+/-
 heterozygote mice. Npas2
m/m
 mice were obtained 
by intercrossing Npas2
m/m
 mice. Clock
-/-
;Npas2
+/-
 three-allele mutant mice were 
generated by crossing Clock
+/-
;Npas2
m/m
 three-allele mutant mice with Clock
-/-
 mice. 
Bmal1
+/-
 heterozygote mice were intercrossed to generate Bmal1
-/-
 mice. With the 
exception of Bmal1
-/-
 crosses, the crosses did not generate wild-type littermates, 
necessitating separate wild-type C57BL/6J mouse crosses to generate age-matched 
controls.  
 
Genotyping 
For polymerase chain reaction (PCR) genotyping at the Clock locus, a three-
primer set was used to distinguish wild-type, floxed, and deleted alleles 
51
. This primer 
set consists of two forward primers (Clock 5F3, CAGCTTCATTTGAAATCTGCAT; 
Clock 3loxF2: AGCTGGGGTCTATGCTTCCT) and a common reverse primer (Clock 
3loxR, CGCTGAGAGCCAAGACAAT). Reactions were performed using the following 
cycling protocol: 95
o
C for 3 minutes, 35 cycles of 95
o
C for 30 seconds, 53
o
C for 60 
seconds, and 72
o
C for 60 seconds, followed by a final extension phase at 72
o
C for 7 
minutes. Product sizes were 220 nucleotides (nt) for wild-type, 380 nt for floxed, and 450 
nt for Clock
-/-
.  
For PCR genotyping at the Npas2 locus, a three-primer set was used to distinguish 
wild-type and deleted alleles 
39
. This primer set consists of two forward primers (LacZ.4: 
GTGCTGCAAGGCGATTAAGTTGGGT; NP2.5’ intron: 
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GGAACCTCTGCGGCATGACAAAGCCTTCGTG) and a common reverse primer 
(NP2.3’ exon: GGTGGTTTTGTCCATTTTCCGAGTGTT). Reactions were performed 
using the following touch-down cycling protocol: 95
o
C for 3 minutes, 20 cycles of 95
o
C 
for 30 seconds, 63
o
C (-0.5
o
C/cycle) for 60 seconds, 72
o
C for 60 seconds, then 20 cycles 
of 95
o
C for 30 seconds, 53
o
C for 60 seconds, and 72
o
C for 60 seconds, followed by a 
final extension phase at 72
o
C for 7 minutes. Product sizes were 185 nt for wild-type and 
250 nt for Npas2
m/m
.  
For PCR genotyping at the Bmal1 locus, a three-primer set was used to 
distinguish wild-type and deleted alleles. This primer set consists of two forward primers 
(Forward 2 at 3’: CAGAGAAGCAAACTACAAGCC; Neo6-2: 
TGCCCCAAAGGCCTACCCGCTTCC) and a common reverse primer (Reverse 2 at 3’: 
ATGTGCACCTCATGTGTCTGG). Reactions were performed using the same touch-
down cycling protocol as for Npas2. Product sizes were 700 nt for wild-type and 470 nt 
for Bmal1
-/-
.  
For PCR genotyping at the Per1 locus, a three-primer set was used to distinguish 
wild-type and deleted alleles 
49
. This primer set consists of a common forward primer 
(Per1AA-F: ATTAGTCAGCCCTCAGAGACAGGCGTC) and two reverse primers 
(Per1AA-R: TGAGTCCTTGCCATTGCCAGAAGAGG; Neo3B: 
CCAGCTCATTCCTCCACTCATGATCTA). Reactions were performed using the same 
cycling protocol as for Clock. Product sizes were 363 nt for wild-type and 235 nt for 
Per1
-/-
.  
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For PCR genotyping at the Per2 locus, a three-primer set was used to distinguish 
wild-type and deleted alleles 
49
. This primer set consists of two forward primers 
(Per2i5FC: GTATAGTCACCCGATCATACTCTCC; Neo6-2: 
TGCCCCAAAGGCCTACCCGCTTCC) and a common reverse primer (Per2-6eR: 
AAGATGCTGCAGTCAGGACCTCACC). Reactions were performed using the same 
cycling protocol as for Clock. Product sizes were 259 nt for wild-type and 403 nt for 
Per2
-/-
.  
PCR products were separated on 1.5% agarose gels and visualized with ethidium 
bromide. 
 
Animal collection and fixation 
Animals were collected during the daytime, typically mid to late afternoon. Mice 
were asphyxiated in a CO2 chamber, decapitated, skinned, and eviscerated. Some animals 
were weighed in a scale (CS200, Ohaus, Pine Brook, NJ, USA) prior to decapitation 
(Table 2.1 and Table 2.2). The skeleton was dissected into the following sections: 
forelimbs (including scapula), forepaws, hind limbs, pelvis (including proximal 1/3 of 
tail, caudal spinal column, and hip joints), ribcage with sternum, and the remaining spinal 
column. Sterna and forepaws were flattened between two slides and all tissues were fixed 
by immersion in freshly made periodate-lysine-paraformaldehyde solution (PLP: 2% 
paraformaldehyde (PFA) containing 0.075M lysine and 0.01M sodium periodate solution, 
pH 7.4, stored at 4
o
C) for three days at 4
o
C under vacuum before being transferred to 1X 
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phosphate buffered saline (PBS) and stored at 4
o
C. This PLP fixative is compatible with 
all subsequent analysis techniques: X-ray, micro-CT, and histology. 
 
X-rays 
Once skeletal tissues were collected and fixed, they were X-rayed with a high 
resolution MX-20 Faxitron on mammography film (Table 2.3). Organs were dissected 
into the following groups and also X-rayed: heart and lung, liver, spleen, kidneys, and 
stomach and intestines (Table 2.4). Depending on the body part being X-rayed, settings 
were 20kV for 6-20 seconds. 
 
Micro-computed tomography (micro-CT) 
After skeletal tissues were fixed and X-rayed, a subset was analyzed using micro-
computed tomography (micro-CT, Table 2.5).  
Two wild-type and 2 Clock
-/-
;Npas2
m/m
 double mutant mice, 11-12 weeks old, 
were subjected to micro-CT analysis. The scanning of the limbs and sternum was 
performed in air on a Scanco MicroCT 40 at 70kVp, 114µA and a resolution of 15 um. 
The forelimb regions of interest (ROIs) included the metacarpals and the wrist joint in the 
neutral position. The hindlimb ROI included the metatarsals and the lower tibia/ankle 
joint. The sternum and ribs were scanned in air as flat as possible in the ventral-dorsal 
plane. The sternum ROI included the manubrium to the xiphoid cartilage. The spinal 
vertebrae were scanned whole in air in the rostral-caudal plane at a resolution of 6 um. 
The lumbar ROI included the whole trabeculae from the rostral end of L5 to caudal end 
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of L2.  The thoracic ROI included the whole trabeculae from the rostral end of T3 to 
caudal end of T5. The cervical ROI included the whole trabeculae from the rostral end of 
C5 to caudal end of T7. 
Two wild-type and 2 Clock
-/-
;Npas2
m/m
 double mutant mice, 41-42 weeks old, 
were also subjected to micro-CT analysis. In these animals, the scanning of the limbs and 
sternum was performed in air on a Scanco MicroCT40 at 70kVp, 114!A and a resolution 
of 15 um. The forelimb ROI included the elbow joint in midway flexion, the shoulder 
joint in the standing position, and the metacarpals.  The hindlimb ROIs included the knee 
in midway flexion, and the metatarsals and ankle joints. The sternum and ribs were 
scanned in air as flat as possible in the ventral-dorsal plane. The sternum ROI included 
the manubrium to the xiphoid cartilage. The spinal vertebrae were scanned in three 
sections in air in the rostral-caudal plane at a resolution of 6 um. The lumbar ROI 
included the whole trabeculae from the rostral end of L5 to caudal end of L2.  The 
thoracic ROI included the whole trabeculae from the rostral end of T3 to caudal end of 
T5. The cervical ROI included the whole trabeculae from the rostral end of C5 to caudal 
end of T7. The tail vertebrae and hip were scanned together at a resolution of 8 um intact 
in air in the rostral-caudal plane.  A larger diameter sample holder was utilized due to the 
width of the hip. The hip ROI included the pelvic girdle and the sacrum (S1-4). The tail 
vertebrae ROI included the caudal vertebrae CA1-CA3.                                                                                                                                                                    
For ectopic bone imaging, each ROI was utilized with no delineation between 
cortical or trabecular bone.  The segmentation parameters included the values 0.8 Gauss 
sigma, and 1.0 Gauss support, and a threshold of 220-1000 (density range of >500mg of 
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HA/cm
3
) in all joints except the knee and sternum. The 11-12 week-old sterna were 
imaged at a threshold of 170-1000 (density range of >400mg HA/cm
3
), while the 41-42 
week-old sterna and knees were imaged at a threshold of 212-1000 (density range of 
>450mg of HA/cm
3
). The appropriate thresholds were selected by visually comparing the 
gray-level images to the binarized image both in 2-D and 3-D.  
 
Histologic analysis of decalcified tissues 
After being fixed and X-rayed, a subset of sternal (Table 2.6) and hindlimb (Table 
2.7) tissues were decalcified in 18% EDTA, pH 7.4, at 4
o
C with agitation for two weeks. 
During the first week 18% EDTA was changed daily and during the second week 18% 
EDTA was changed every two days. After decalcification, tissues were dehydrated in the 
following solutions for one hour each: 70% ethanol, 80% ethanol, 95% ethanol (twice), 
100% ethanol (three times), xylene (three times), paraffin (twice). After dehydration, 
samples were immediately subjected to vacuum wax infiltration and then embedded in 
paraffin. Samples were sectioned at 6 um and processed for staining. For toluidine blue 
staining, slides were deparaffinized, rehydrated, and stained in 1% toluidine blue, either 
made in isopropanol or distilled water, for one minute and then rinsed in tap water, 
dehydrated, and coverslipped. Toluidine blue made in isopropanol stains everything blue. 
Toluidine blue made in distilled water stains bone and muscle blue but cartilage 
pink/purple. Histological images were captured using a Zeiss Axioskop 40 microscope, 
Zeiss AxioCam HRc camera, and Zeiss AxioVision 4 (version 4.7.2.0) software. 
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Histologic analysis of non-decalcified tissues 
Another subset of tissues was not decalcified prior to histological analysis (Table 
2.8). These tissues were fixed and X-rayed, then embedded in glycol methacrylate and 
sectioned at 3 um. Slides from non-decalcified tissues were used for safranin-O, von 
Kossa, and alizarin red staining.  
For safranin-O staining, slides were placed in Weigert’s iron hematoxylin 
working solution for ten minutes, then washed in tap water and stained with fast green 
solution for five minutes. Slides were then rinsed with 1% acetic acid solution for 10-15 
seconds and then stained in 0.1% safranin-O solution for 10-25 minutes (until red 
staining was visible under the microscope), before being dehydrated and coverslipped. 
Safranin-O stains proteoglycans red/pink.  
For von Kossa staining, slides were placed in 1% silver nitrate for 1.5 hours at 
room temperature under ambient bench top light. Slides were then rinsed in distilled 
water and placed in 5% sodium thiosulfate for five minutes, rinsed again and 
counterstained with 1% toluidine blue made in distilled water for five minutes. After 
being rinsed in tap water, slides were coverslipped. Von Kossa stains phosphate 
brown/black.  
For alizarin red staining, slides were placed in 2% alizarin red for five minutes 
and then rinsed in tap water and coverslipped. Alizarin red stains calcium red.  
For each genotype, there were four to six mice and for each mouse at least one 
slide with three serial sections was examined. Histological images were captured using a 
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Zeiss Axioskop 40 microscope, Zeiss AxioCam HRc camera, and Zeiss AxioVision 4 
(version 4.7.2.0) software. 
 
Scanning electron microscopy (SEM) analysis 
To collect tissue for scanning electron microscopy analysis, a 53 week-old female 
Bmal1
-/-
 mouse was asphyxiated in a CO2 chamber, decapitated, eviscerated, skinned, and 
dissected into the following parts: forelimbs (including scapula), forepaws, hind limbs, 
pelvis (including proximal 1/3 of tail, caudal spinal column, and hip joints), ribcage with 
sternum, and the remaining spinal column. Forepaws and sternum were flattened between 
two slides and tissues, including organs, were fixed by immersion in freshly made 4% 
PFA in 0.2M cacodylate buffer, pH 7.2 overnight at 4
o
C. The next day, the sternum was 
embedded in O.C.T. mounting media and sectioned in a cryostat at 60 um. Sections were 
kept at 4
o
C until SEM processing, which involved air drying the slides and then scoring 
and breaking the slides to isolate one entire section of tissue. This portion of the slide was 
mounted on an aluminum scanning stud with conductive carbon tape and colloidal 
graphite. The specimen was then carbon coated (3 nm) in a vacuum evaporator and 
examined with a FEI Quanta 200 FESEM at 10 KV accelerating voltage at spot size 3. 
Images were acquired in both secondary electron imaging (SEI) and backscatter electron 
imaging (BSI) modes as well as combined imaging mode. X-ray spectroscopy was 
performed using an Oxford-link EDS system with a 30 mm
2
 detector window. All scans 
were collected for 120 seconds in a point and identification. All spectra were normalized 
and analyzed for weight %, atomic %, and stoichiometry. Identification of crystal 
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composition was based on P:Ca ratios and phosphate, calcium, and oxygen stoichiometry, 
as compared to an internal library of standards and best-fit chemical composition in the 
Oxford-link software package. The atomic % for each element was multiplied by its 
atomic weight (P = 30.97, Ca = 40.08) to calculate P:Ca atomic weight ratios. 
 
Statistical analysis 
Male and female weights were analyzed by two-way ANOVA (Prism 5 for Mac 
OS X software). Bonferroni post-tests were done for comparisons among ages and 
genotypes. P-values less than 0.05 were considered statistically significant.  
 
 43 
Results and discussion 
 
Anatomical distribution of arthropathy 
A first step in characterizing a new calcification phenotype in a mutant mouse line 
is to identify the affected areas. To do this, micro-computed tomography (micro-CT), an 
extremely sensitive method to detect calcification, was performed on two 41-42 week-old 
wild-type and two Clock
-/-
;Npas2
m/m
 double mutant mice (Table 2.5). Major joints were 
analyzed and the following areas in Clock
-/-
;Npas2
m/m
 double mutant mice exhibited 
ectopic calcification: elbows, stifles (knee joints), forepaws, hindpaws, calcaneal tendon, 
cervical vertebrae, proximal caudal vertebrae, costovertebral junctions, and costosternal 
junctions (Figure 2.1A and 2.1B). Surprisingly, the shoulder and hip joints were spared 
(Figure 2.1C). Distal femurs were examined to determine if Clock
-/-
;Npas2
m/m
 double 
mutant mice develop high bone mass like Per1
-/-
;Per2
-/-
 double mutant mice 
37
, but there 
was striking variability in bone mass within genotypes, such that conclusions could not 
be drawn from such a small sample size (data not shown). A larger sample size is 
necessary to compare distal femur bone mass of Clock
-/-
;Npas2
m/m
 double mutant and 
wild-type mice. 
Most of the joints containing ectopic calcification are weight-bearing joints in 
quadrupeds. Aside from ectopic joint calcification, it is possible that other soft tissues, 
such as organs, in Clock
-/-
;Npas2
m/m
 double mutant mice could also be inappropriately 
calcified. Several other mutant mouse lines exhibit abnormal calcification of soft tissues, 
such as internal organs and arterial blood vessels 
84, 93, 94
. Diffuse calcification of organs 
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would suggest metastatic calcification as a mechanism. The internal organs of 37-49 
week-old wild-type and Clock
-/-
;Npas2
m/m
 double mutant mice were X-rayed, but no 
visible calcifications were detected (Figure 2.2, Table 2.4).  
 
Age-dependent changes in body weight  
At this advanced age, gross motor deficits are readily apparent in Clock
-/-
;Npas2
m/m
 double mutant mice. Clock
-/-
;Npas2
m/m
 double mutant mice are also noticeably 
smaller than their wild-type counterparts. Statistical analyses revealed a significant effect 
of age and genotype on weight as well as a significant interaction between age and 
genotype. In other words, Clock
-/-
;Npas2
m/m
 double mutant mice lose weight as they age 
while wild-type mice gain weight with age (Figure 2.3, Tables 2.1 and 2.2). This age-
dependent weight loss was also observed in Bmal1
-/-
 mice, consistent with previously 
published studies (Figure 2.3) 
64, 95, 96
. 
 
Age-dependent development of arthropathy 
Given the age-progressive nature of arthropathy in Bmal1
-/-
 mice, we wanted to 
assess age-dependenct of arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice. To do 
this, animals were X-rayed across a wide range of ages (Table 2.3). In order to obtain 
clear X-ray images of joints, animals were sacrificed and joints were isolated. Despite 
being a somewhat insensitive tool, X-ray is both an efficient and cost-effective method to 
assess gross tissue calcification in a large number of animals. Clock
-/-
;Npas2
m/m
 double 
mutant mice exhibit age-dependent arthropathy in both the calcaneal tendon (Figure 2.4) 
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and costosternal junction (Figure 2.5), similar to Bmal1
-/-
 mice. There is 100% penetrance 
of gross phenotypic abnormalities and arthropathy, the latter confirmed by X-ray, in 
Clock
-/-
;Npas2
m/m
 double mutant mice 35 weeks and older (our unpublished data). Per1
-/-
;Per2
-/-
 double mutant mice do not develop arthropathy even at advanced ages (Figure 
2.6, our unpublished observations). Like Bmal1
-/-
 mice 
64, 96
, Clock
-/-
;Npas2
m/m
 double 
mutant mice usually do not survive past 60 weeks of age and so there are no X-ray 
images for 64+ week-old Clock
-/-
;Npas2
m/m
 double mutant or Bmal1
-/-
 mice.  
There does not appear to be a gender-related difference in arthropathy 
development. Clock and Npas2 three-allele (Clock
+/-
;Npas2
m/m
 and Clock
-/-
;Npas2
+/m
) and 
single mutant (Clock
-/-
 and Npas2
m/m
) animals do not develop costosternal junction 
calcification (Figure 2.5). However, in the calcaneal tendon, three-allele and single 
mutant mice all develop an attenuated age-dependent ectopic calcification (Figure 2.4). 
The attenuated calcaneal tendon calcification in three-allele and single mutants could be 
due to a gene dosage effect. Curiously, wild-type mice eventually develop calcaneal 
tendon calcification at advanced ages (64+ weeks) but never develop calcification of 
costosternal junction within the age range examined. Because calcaneal tendon 
calcification eventually appears in very old wild-type mice, it is possible that the 
calcaneal tendon calcification in Clock
-/-
;Npas2
m/m
 double mutant mice is due to 
accelerated aging and the later onset of calcaneal tendon calcification in three-allele and 
single mutants is a reflection of an intermediate phenotype. The hypothesis of accelerated 
aging is consistent with sterility, weight loss, and premature death observed in Clock
-/-
;Npas2
m/m
 double mutant mice (our unpublished observations, Figure 2.3). An 
 46 
accelerated aging phenotype has been described in Bmal1
-/-
 mice 
96
. Bmal1
-/-
 mice exhibit 
ectopic calcification, sarcopenia, cataracts, reduced subcutaneous fat stores, organ 
shrinkage, and altered levels of immune cells in peripheral blood, and undergo premature 
death 
64, 95, 96
. BMAL1 is the binding partner of either CLOCK or NPAS2, such that 
disruption of Bmal1, or Clock and Npas2 expression leads to disruption of 
CLOCK/NPAS2:BMAL1-mediated transcription. Given this molecular interaction and 
the similarity of arthropathy, sterility, weight loss, and premature death in Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice, it is very possible that Clock
-/-
;Npas2
m/m
 
double mutant mice exhibit the same symptoms of accelerated aging as Bmal1
-/-
 mice. 
 
Micro-CT analysis of young adult mice  
An important aspect of ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant 
mice is the age at which these calcifications first appear. Is ectopic calcification a 
developmental process or does it occur post-natally? Identification of the rough age of 
onset also facilitates the design of future experiments. By studying Clock
-/-
;Npas2
m/m
 
double mutants at the age at which ectopic calcifications are just beginning to form, we 
can be more certain that any molecular changes observed cause the arthropathy, rather 
than occur as a result of it.  
In Bmal1
-/-
 mice, calcifications are detectable as early as eight weeks of age 
64
. To 
assess arthropathy in young adult Clock
-/-
;Npas2
m/m
 double mutant mice, micro-CT was 
performed on 11-12 week-old Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice. At 
this younger age, calcifications are clearly visible at the costosternal junction and 
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calcaneal tendon (Figure 2.7). Other sites that are affected in 41-42 week-old Clock
-/-
;Npas2
m/m
 double mutant mice (forepaws, hindpaws, vertebrae) are not as severely 
calcified as compared to the costosternal junction and calcaneal tendon. All future studies 
focused on these two sites for two reasons: first, these are the main sites affected in 
Bmal1
-/-
 mice and second, these are the sites with the earliest visible arthropathy in Clock
-
/-
;Npas2
m/m
 double mutant mice. Studying sites that first develop pathology aids in the 
management of the mouse colony and also reduces any possible interaction with other 
sites of developing pathology.   
 
Histological characterization of arthropathy 
To investigate arthropathy in even younger animals, tissues were analyzed 
histologically. Sternal samples were decalcified, paraffin-embedded, and sectioned. At 4-
5 weeks of age, small lesions are barely noticeable at the costosternal junction of Clock
-/-
;Npas2
m/m
 double mutant mice. These small lesions appear in about 50% 4-5 week-old 
Clock
-/-
;Npas2
m/m
 double mutant mice (Figure 2.8A, data not shown). By 6-7 weeks and 
definitely by 11-12 weeks of age large acellular regions are visible across 85% and 100% 
of Clock
-/-
;Npas2
m/m
 double mutant mice, respectively (Figure 2.8B, data now shown). 
Upon closer inspection, these acellular regions startlingly do not appear to contain cells, 
but possibly contain extracellular matrix-related debris (Figure 2.8C). These histological 
samples were decalcified prior to sectioning and staining so calcification in the acellular 
lesions were removed. However, the lesions are anatomically in the same location as the 
ectopic calcification visible on X-ray.  
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To identify the components of the lesions and confirm the hypothesis that the 
lesions contained ectopic calcification, sternal and hind limb tissues of 6-7 week-old 
Clock
-/-
;Npas2
m/m
 double mutant mice were not subjected to decalcification, embedded in 
glycol methacrylate, and sectioned, thereby preserving any calcified tissue. As expected, 
the acellular costosternal junction lesions stain positive for alizarin red and von Kossa, 
indicative of the presence of calcium and phosphate, respectively (Figure 2.9A&B). The 
lesions do not, however, stain positive for safranin-O, which stains proteoglycans that are 
a main component in cartilage. Notably, there is a layer of calcified, non-cartilage tissue 
on the sternebral surface that faces the intersternebral cartilage. Lesions in the calcaneal 
tendon of 19-22 week-old Clock
-/-
;Npas2
m/m
 double mutant mice also stain positive for 
alizarin red and von Kossa, but negative for safranin-O (Figure 2.9C). Older animals 
were chosen to study calcaneal tendon calcification because toluidine blue stains of 6-7 
and 11-12 week-old calcaneal tendon did not reveal consistent lesions (Figure 2.10). In 
one 11-12 week-old calcaneal tendon, an abnormal lesion is visible (Figure 2.10), but in 
the other Clock
-/-
;Npas2
m/m
 double mutant calcaneal tendon, the mutant tendon looks like 
wild-type tissue tendon (data not shown). However, 100% of 11-12 week-old Clock
-/-
;Npas2
m/m
 double mutant calcaneal tendon contain calcifications on X-ray (data not 
shown). The discrepancy between the histology and X-ray results of Clock
-/-
;Npas2
m/m
 
double mutant calcaneal tendon could be due to variation in tissue section depth. 
Histologically prepared 11-12 week-old calcaneal tendons were not sectioned completely 
through, so it is possible that the histology images of 11-12 week-old Clock
-/-
;Npas2
m/m
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double mutant calcaneal tendon that do not exhibit abnormalities were simply not 
sectioned at the correct depth at which to observe ectopic calcification.  
 
Characterization of crystal deposits 
The presence of calcium and phosphate in the costosternal junction and calcaneal 
tendon ectopic calcification of Clock
-/-
;Npas2
m/m
 double mutant mice has been confirmed 
by histology, but the exact type of crystal within the lesions remains unclear. The two 
most likely possibilities are hydroxyapatite (HA) or calcium pyrophosphate dihydrate 
(CPPD) crystals. HA crystals have a phosphate:calcium (P:Ca) atomic weight ratio of 
0.45 while CPPD crystals have a P:Ca atomic weight ratio of 0.75. By assessing the P:Ca 
atomic weight ratio of ectopic calcification in costosternal junction and calcaneal tendon, 
it is possible to identify the chemical forms within the deposits.  
Due to limited availability of Clock
-/-
;Npas2
m/m
 double mutant mice, a 53 week-
old Bmal1
-/-
 mouse with severe gross motor abnormalities was used to evaluate the P:Ca 
atomic weight ratio of ectopic costosternal junction calcification. Our hypothesis that 
disruption of the CLOCK/NPAS2:BMAL1 complex leads to age-dependent arthropathy 
insinuates that either Clock and Npas2, or Bmal1, disruption can cause age-dependent 
arthropathy, and we have shown that Clock
-/-
;Npas2
m/m
 double mutant mice phenocopy 
the arthropathy observed in Bmal1
-/-
 mice. Thus, it is expected that the crystal deposits in 
Bmal1
-/-
 mice are of the same composition as crystal deposits in Clock
-/-
;Npas2
m/m
 double 
mutant mice. To calculate the P:Ca atomic weight ratio, 60 um sections of sterna were 
subjected to scanning electron microscopy (SEM) and X-ray microscopy. Sternebral 
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trabecular tissue and ectopic calcifications were measured to assess bone mineral content 
(Figure 2.11A). The X-ray spectra of the ectopic calcifications were similar to one 
another but distinct from the X-ray spectrum of trabecular bone (Figure 2.11B). Bmal1
-/-
 
costosternal junction ectopic calcifications consist of deposits with a P:Ca atomic weight 
ratio, and phosphate, calcium, and oxygen stoichiometry consistent with CPPD crystals 
(Figure 2.11C). This ratio and stoichiometry are unlike that of trabecular bone, which has 
a P:Ca atomic weight ratio, and phosphate, calcium, and oxygen stoichiometry consistent 
with tricalcium phosphate, the main crystal found in bone ash, which is the expected 
composition of trabecular bone (Figure 2.11C). This finding suggests that Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice develop CPPD crystal deposition disease 
(CPPD-CDD). Because this experiment included only one study animal, measuring the 
P:Ca atomic weight ratios of ectopic calcification in multiple Clock
-/-
;Npas2
m/m
 double 
mutant mice is necessary to confirm these initial findings.  
 
Concluding remarks 
The findings from these studies show that Clock
-/-
;Npas2
m/m
 double mutant mice 
exhibit site-specific, age-dependent ectopic calcification. Several different joints and 
entheses develop ectopic calcification by 41-42 weeks of age, including the forepaws, 
hindpaws, elbows, stifles, calcaneal tendon, costosternal junctions, costovertebral 
junctions, and cervical, thoracic, and proximal caudal vertebrae. Costosternal junction 
and calcaneal tendon calcification is visible as early as 11-12 weeks on X-ray, and 
costosternal junction calcification is histologically visible as early as 4-5 weeks. The 
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ectopic calcification in Bmal1
-/-
 costosternal junction contain CPPD crystal deposits. As a 
whole, the arthropic phenotype of Clock
-/-
;Npas2
m/m
 double mutant mice appears to 
phenocopy that of Bmal1
-/-
 mice 
64
. The distribution of arthropathy in Clock
-/-
;Npas2
m/m
 
double mutant and Bmal1
-/-
 mice 
64
 is inconsistent with that of Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double mutant mice 
37
. The findings presented here suggest that disruption of the 
transcriptional activator complex leads to an arthropic phenotype distinct from the 
modest increase in bone mass specific to disruption of the transcriptional repressor 
complex. The next step from these findings is to identify possible mechanisms of 
arthropathy and genes dysregulated due to disruption of the CLOCK:BMAL1 or 
NPAS2:BMAL1 transcriptional activator complex.  
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Table 2.1. Sample sizes for male body weight data. 
 
 4-5 wks 6-7 wks 15-22 wks 35-57 wks 
Wild-type 2 17 17 8 
Clock
-/-
;Npas2
m/m 
2 14 9 7 
Bmal1
-/-
 2 14 4 2 
 
 
Table 2.2. Sample sizes for female body weight data. 
 
 6-7 wks  10-13 wks 15-22 wks 35-57 wks 
Wild-type 14 5 18 8 
Clock
-/-
;Npas2
m/m 
11 2 9 2 
Bmal1
-/-
 1 1 3 4 
 
 
Table 2.3. Sample sizes for skeletal X-ray data. 
 
 6-7 wks 10-13 wks 15-22 wks 35-57 wks 64-80 wks 
B6 wild-type M: 8 
F: 8 
M: 11 
F: 7 
M: 14 
F: 12 
M: 11 
F: 8 
M: 5 
F: 3 
Clock
-/-
;Npas2
m/m 
M: 7 
F: 6 
M: 4 
F: 3 
M: 4 
F: 7 
M: 10 
F: 6 
- 
Bmal1
-/-
 M: 6 
F: 1 
M: 2 
F: 3 
M: 4 
F: 3 
M: 1 
F: 5 
- 
Clock
-/-
 M: 4 
F: 3 
M: 3 
F: 3 
M: 4 
F: 4 
M: 3 
F: 4 
M: 4 
F: 2 
Npas2
m/m
 M: 4 
F: 6 
M: 4 
F: 4 
M: 4 
F: 4 
M: 4 
F: 4 
M: 3 
F: 3 
Clock
+/-
;Npas2
m/m
 
M: 4 
F: 4 
M: 3 
F: 3 
M: 3 
F: 3 
M: 3 
F: 3 
M: 4 
F: 2 
Clock
-/-
;Npas2
+/m
 M: 4 
F 4 
M: 3 
F: 4 
M: 3 
F: 4 
M: 3 
F: 4 
M: 4 
F: 3 
129/sv wild-type - - - - M: 1 
Per1
-/-
;Per2
-/-
 - - - - M: 1 
- : did not collect; M: males; F: females 
 
 
Table 2.4. Sample sizes for organ X-ray data. 
 
 37-49 wks 
Wild-type M: 5 
Clock
-/-
;Npas2
m/m 
M: 5 
M: males 
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Table 2.5. Sample sizes for micro-CT data. 
 
 11-12 wks 41-42 wks 
Wild-type M: 3 
F: 0 
M: 1 
F: 1 
Clock
-/-
;Npas2
m/m
 M: 2 
F: 0 
M: 1 
F: 1 
M: males; F: females 
 
 
Table 2.6. Sample sizes for decalcified sternal tissue data. 
 
 4-5 wks 6-7 wks 10-12 wks 
Wild-type M: 2 
F: 2 
M: 4 
F: 1 
M: 3 
F: 0 
Clock
-/-
;Npas2
m/m 
M: 2 
F: 2 
M: 5 
F: 4 
M: 3 
F: 0 
M: males; F: females 
 
 
Table 2.7. Sample sizes for decalcified calcaneal tendon tissue data. 
 
 6-7 wks 11-12 wks 
Wild-type M: 2 M: 2 
Clock
-/-
;Npas2
m/m 
M: 2 M: 2 
M: males 
 
 
Table 2.8. Sample sizes for non-decalcified tissue data. 
 
 6-7 wks (sterna) 19-22 wks (calcaneal tendon) 
Wild-type M: 1 
F: 2 
M: 3 
F: 0 
Clock
-/-
;Npas2
m/m 
M: 2 
F: 2 
M: 2 
F: 1 
M: males; F: females  
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Wild-type 
Clock
-/-
; 
Npas2
m/m
 
Sternum Forepaw Hindpaw 
A. 
Elbow Stifle 
Upper thoracic 
vertebrae 
Lower thoracic 
vertebrae 
Wild-type 
Clock
-/-
; 
Npas2
m/m
 
Pelvis Proximal caudal  
vertebrae 
Wild-type 
Clock
-/-
; 
Npas2
m/m
 
B. 
Wild-type 
Clock
-/-
; 
Npas2
m/m
 
Shoulder Lumbar vertebrae 
C. 
Figure 2.1. Distribution of ectopic calcification in 41-42 week-old Clock
-/-
;Npas2
m/m
 double mutant 
mice. (A) 3-D reconstructed micro-CT images illustrating distribution of ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice. (B) Sagittal 2-D micro-CT images of ectopic calcification in calcaneal 
tendon of Clock
-/-
;Npas2
m/m
 double mutant mice. (C) 3-D micro-CT images illustrating lack of visible 
ectopic calcification in shoulders and lumbar vertebrae of Clock
-/-
;Npas2
m/m
 double mutant mice. Note that 
the clavicle was included in the imaging of wild-type shoulder but not Clock
-/-
;Npas2
m/m
 shoulder (black 
arrow head). Red arrows highlight ectopic calcification.  
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Wild-type 
Clock
-/-
; 
Npas2
m/m
 
Heart + lungs Kidneys Liver Spleen Stomach + intestines 
Figure 2.2. X-ray images of Clock
-/-
;Npas2
m/m
 internal organs do not reveal ectopic 
calcification. Representative X-ray images from a 37 week-old Clock
-/-
;Npas2
m/m
 
double mutant and a 43 week-old wild-type mouse show no visible difference between 
mutant and wild-type tissues. Radio-opacities observed in liver, stomach, and intestines 
are most likely due to the thickness of the tissue or, in the case of the stomach and 
intestines, the presence of undigested food pellets. 
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Figure 2.3. Clock
-/-
;Npas2
m/m
 double mutant mice exhibit age-dependent weight loss. Both 
male and female Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice lose weight as they age 
compared to wild-type mice. **p < 0.01, ****p < 0.0001 
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6-7 wks 11-12 wks 19-22 wks 41-46 wks 64-73 wks 
Wild-type 
Clock
-/-
; 
Npas2
m/m 
Double mutant
 
Bmal1
-/-  
Clock
-/-
 
Single KO 
Npas2
m/m 
Single mutant
 
Clock
+/-
; 
Npas2
m/m 
3-allele mutant
 
Clock
-/-
; 
Npas2
+/m 
3-allele mutant
 
Not available 
for study 
Not available 
for study 
Figure 2.4. Age-progressive calcification of calcaneal tendon in Clock
-/-
;Npas2
m/m
 double mutant 
mice. Representative X-ray images of wild-type, Clock
-/-
;Npas2
m/m
 double mutant, Bmal1
-/-
, single 
mutants (Clock
-/-
 and Npas2
m/m
), and three-allele mutant (Clock
+/-
;Npas2
m/m
 and Clock
-/-
;Npas2
+/m
) 
calcaneal tendon across age groups, illustrating age-dependent progression of calcification at these 
sites. Note the appearance of calcaneal tendon calcification in elderly single mutant and three-allele 
mutants. Red arrows highlight ectopic calcification. 
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Figure 2.5. Age-progressive calcification of costosternal junction in Clock
-/-
;Npas2
m/m
 double 
mutant mice. Representative X-ray images of wild-type, Clock
-/-
;Npas2
m/m
 double mutant, Bmal1
-/-
, 
single mutants (Clock
-/-
 and Npas2
m/m
), and three-allele mutant (Clock
+/-
;Npas2
m/m
 and Clock
-/-
;Npas2
+/m
) costosternal junction across age groups, illustrating age-dependent progression of 
calcification at these sites. Note the lack of calcification in any of the single mutant or three-allele 
costosternal junctions. Red arrows highlight ectopic calcification. 
6-7 wks 11-12 wks 19-22 wks 41-46 wks 64-73 wks 
Wild-type 
Clock
-/-
; 
Npas2
m/m 
Double mutant
 
Bmal1
-/- 
Clock
-/-
 
Single KO 
Npas2
m/m 
Single mutant
 
Clock
+/-
; 
Npas2
m/m 
3-allele mutant
 
Clock
-/-
; 
Npas2
+/m 
3-allele mutant
 
Not available 
for study 
Not available 
for study 
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Wild-type 
76 wks 
Per1
-/-
;Per2
-/- 
Figure 2.6. No ectopic calcification in calcaneal tendon or costosternal 
junction of a 76 week-old Per1
-/-
;Per2
-/-
 double mutant mouse. X-ray images 
of Per1
-/-
;Per2
-/-
 double mutant calcaneal tendon and costosternal junction, 
illustrating a lack of calcification at these sites even at advanced age. 
 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wild-type 
Clock
-/-
;Npas2
m/m
 
Figure 2.7. Ectopic calcification of costosternal junction and calcaneal tendon in 11-12 
week-old Clock
-/-
;Npas2
m/m
 double mutant mice. 3-D reconstructed micro-CT images of 
11-12 week-old wild-type and Clock
-/-
;Npas2
m/m
 double mutant costosternal junction (A) and 
Clock
-/-
;Npas2
m/m
 double mutant calcaneal tendon (B). Red arrows highlight calcification. 
Clock
-/-
;Npas2
m/m
 
A. 
B. 
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Wild-type 
Clock
-/-
; 
Npas2
m/m
 
11-12 wks 6-7 wks B. 
A. 
Wild-type 
Clock
-/-
; 
Npas2
m/m
 
4-5 wks 
Figure 2.8. Acellular lesions in decalcified costosternal sections of young Clock
-/-
;Npas2
m/m
 double 
mutant mice. (A) Toluidine blue (made in water) stain of 4-5 week-old Clock
-/-
;Npas2
m/m
 double 
mutant sternum showing inconsistent, small acellular lesions in the costosternal junction. 5X 
magnifications. (B) Toluidine blue (made in isopropanol) stain of 6-7 and 11-12 week-old Clock
-/-
;Npas2
m/m
 double mutant sternum illustrating age-dependent increase in acellular lesion size at the 
costosternal junction. 5X magnifications. (C) Higher magnification of the edge of an acellular lesion 
from the costosternal junction of an 11-12 week-old Clock
-/-
;Npas2
m/m
 double mutant mouse. Note the 
lack of identifiable cells. 40X image. Red arrows highlight acellular lesions. ST: sternebral trabeculae; 
R: rib cartilage. 
C. 
Clock
-/-
;Npas2
m/m 
Clock
-/-
; 
Npas2
m/m
 
ST 
ST 
ST 
ST 
R 
R R 
R 
R 
R 
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Wild-type 
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-/-
; 
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A. B. 
Wild-type 
Clock
-/-
; 
Npas2
m/m 
Figure 2.9. Lesions in costosternal junction and calcaneal tendon of Clock
-/-
;Npas2
m/m
 double 
mutant mice contain calcium phosphate deposits. (A) Serial sections of non-decalcified, 6-7 week-
old wild-type and Clock
-/-
;Npas2
m/m
 double mutant sternal tissue stained with safranin-O (left) and von 
Kossa (right), the latter of which is counterstained with toluidine blue made up in distilled water.  
(B) Alizarin red stain of non-decalcified, 6-7 week-old wild-type and Clock
-/-
;Npas2
m/m
 double mutant 
sternal tissue. (C) Serial sections of non-decalcified, 19-22 week-old wild-type and Clock
-/-
;Npas2
m/m
 
double mutant calcaneal tendon stained with safranin-O (left), alizarin red (middle), and von Kossa 
(right), the last of which is counterstained with toluidine blue made up in distilled water. Note the 
absence of safranin-O stain but the positive von Kossa and alizarin red stains in the lesions, which are 
denoted by red arrows. All images are 5X magnifications. Black arrowheads identify the calcaneus 
bone, the insertion site of the calcaneal tendon. ST: sternebral trabculae; R: rib cartilage; CT: calcaneal 
tendon. 
C. 
ST 
ST 
R R 
CT CT CT 
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Wild-type 
Clock
-/-
; 
Npas2
m/m
 
6-7 wks 11-12 wks 
Figure 2.10. Calcaneal tendon histology of 6-7 and 11-12 week-old Clock
-/-
;Npas2
m/m
 
double mutant mice. Toluidine blue (made in isopropanol) stains of decalcified 6-7 week-old 
Clock
-/-
;Npas2
m/m
 double mutant calcaneal tendon do not reveal lesions, which is consistent 
with the lack of visible calcification of these same animals on X-ray. In some 11-12 week-old 
Clock
-/-
;Npas2
m/m
 double mutant mice, calcaneal tendon exhibit lesions but this phenotype is 
inconsistent across double mutants of this age. 5X magnifications. Red arrow highlights 
probable calcification. Black arrowheads identify calcaneus bone. CT: calcaneal tendon. 
CT 
CT 
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 Element Atomic % P:Ca ratio Crystal 
Spectrum 1 P 10.27 0.666 Tricalcium  
 Ca 11.50  phosphate (bone ash) 
     
Spectrum 2 P 11.59 0.700 Calcium pyrophosphate 
 Ca 12.41   
     
Spectrum 3 P 3.64 0.855 Calcium pyrophosphate 
 Ca 3.19   
 
 
 
 
 
 
 
 
Figure 2.11. Ectopic calcification in the sternum of a 53 week-old Bmal1
-/-
 mouse 
contains CPPD crystal deposits. (A) A mixed SEI+BSI image of sternum. Carbon 
appears brown while heavier elements, such as calcium (calcifications) and silicon (the 
slide) appear blue. Spectra refer to locations sampled to calculate P:Ca ratios. (B) X-ray 
spectra graph of the three sampled locations. (C) Raw values of calcium and phosphate 
atomic % in sampled tissue locations. Note that Spectra 2 & 3 (ectopic calcifications) have 
P:Ca ratios characteristic of CPPD while Spectrum 1 (bone) does not, and this difference 
is reflected in the X-ray spectra results. ST: sternebral trabeculae; ISS: intersternebral 
space; EC: ectopic calcification; M: muscle. 
ST 
EC 
ST 
M 
EC 
ISS 
A. 
B. 
C. 
Spectrum 1 
Spectrum 2 
Spectrum 3 
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Chapter III 
Investigating possible systemic mechanisms of age-dependent arthropathy in  
Clock
-/-
;Npas2
m/m
 double mutant mice 
 
Summary 
 
Age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice could be due 
to a number of different mechanisms. Three systemic possibilities are mechanical stress, 
disrupted circadian rhythms, and metastatic calcification. Each of these mechanisms 
affects the entire mouse and could explain the broad distribution of ectopic calcification 
observed in Clock
-/-
;Npas2
m/m
 double mutant mice. Weight-bearing joints develop ectopic 
calcification, which supports the hypothesis that musculoskeletal-related mechanical 
stress contributes to the development of arthropathy. The fact that Clock and Npas2 are 
critical components of the SCN circadian oscillator suggests that arrhythmicity could 
cause arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice. Lastly, the site-specificity of 
ectopic calcification insinuates metastatic calcification. To study these three possibilities, 
Clock
-/-
;Npas2
m/m
 double mutant mice were subjected to a series of studies. Some were 
given access to running wheels and then X-rayed to assess ectopic calcification 
development in the presence of increased mechanical stress. There is no visible 
difference in arthropathy of Clock
-/-
;Npas2
m/m
 double mutant mice with access to running 
wheels compared to Clock
-/-
;Npas2
m/m
 double mutant mice without access to running 
wheels, suggesting that mechanical stress does not contribute to the development of age-
 66 
dependent arthropathy in these mutants. In the next experiment, Clock and Npas2 were 
both knocked out in the SCN of transgenic mice, rendering them arrhythmic in constant 
darkness. These arrhythmic transgenic mice do not develop ectopic calcification, showing 
that disruption of centrally regulated circadian rhythms is not sufficient to cause age-
dependent arthropathy. In the last experiment, serum chemistry analyses were performed 
on Clock
-/-
;Npas2
m/m
 double mutant mice. Calcium and phosphorus levels are not 
significantly different in the serum of Clock
-/-
;Npas2
m/m
 double mutant mice compared to 
wild-type serum. This result suggests that metastatic calcification is an unlikely 
mechanism of age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice.  
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Introduction 
 
The site-specificity of arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice leads 
to an obvious question: why do calcifications develop at these specific sites but not 
others? One possibility is mechanical. The main sites affected in 41-42 week-old Clock
-/-
;Npas2
m/m
 double mutant mice are considered weight-bearing. In quadrupeds, a large 
portion of an animal’s weight is supported by the forepaws, hindpaws, stifles (knees), and 
elbows. The sternum and costosternal junctions undergo repetitive movement during 
respiration. The tarsus is a joint that undergoes ubiquitous movement, as contraction of 
the calf muscles (the gastrocnemius and soleus) lifts the calcaneus via the calcaneal 
tendon, which is essential to walking, running, and jumping. It is possible that sheer 
mechanical stress on these joints causes ectopic calcification over time.  
A second possible explanation for the extensive joint calcification in Clock
-/-
;Npas2
m/m
 double mutant mice is disruption of circadian rhythms. Clock, Npas2, and 
Bmal1 are all core components of the circadian oscillator. Disruption of Clock and 
Npas2, or Bmal1 expression is sufficient to cause arrhythmicity in constant darkness 
39, 45
. 
It is possible that disruption of circadian rhythms affects peripheral tissues such that they 
are not able to function properly and calcification ensues. Such is the case with liver 
physiology and rhythmicity. In the liver, transcription factors Dbp, Tef, and Hlf are 
transcriptionally regulated by CLOCK:BMAL1 (and thus are rhythmically expressed) 
and are involved in detoxification and drug metabolism 
58
. Mice lacking all three of these 
transcription factors are hypersensitive to xenobiotic compounds and suffer from 
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premature aging 
58
. Clock"
19/"19 mutant and Bmal1
-/-
 mice are similarly hypersensitive to 
cyclophosphamide, an anti-cancer drug 
59
. Disrupting liver-specific oscillators has also 
been shown to disrupt rhythmicity in pentobarbital metabolism 
60
. Therefore, in the case 
of Clock
-/-
;Npas2
m/m
 double mutant mice, it is possible that disruption of centrally 
regulated circadian rhythms in the SCN causes desynchronization of peripheral 
oscillators in joints, leading to the development of ectopic calcification. Peripheral tissues 
still contain oscillators, but the disruption of centrally regulated rhythms could trickle 
down to disrupt peripheral oscillator function. 
However, an elegant study using brain-specific Bmal1 rescue suggests that the 
arthropathy in Bmal1
-/-
 mice is not related to SCN-related circadian rhythms 
68
. In this 
study, the authors constitutively expressed Bmal1 in the SCN (and other non-SCN brain 
regions) of Bmal1
-/-
 mice. This brain-rescued line employed a tetracycline transactivator 
system that enabled the authors to reversibly remove Bmal1 expression by feeding the 
mice doxycycline. These Bmal1
-/-
 mice spent the majority of their lives with Bmal1 
constitutively expressed in the SCN, and when Bmal1 was expressed these mutants 
displayed rhythmic locomotor behavior in constant darkness. Rhythmic locomotor 
activity is indicative of rhythmically functioning SCN, which impose rhythmicity upon 
peripheral tissues and drive rhythmic expression of peripheral oscillator proteins, even if 
a core clock component, such as Clock, is missing from that peripheral tissue 
51
. In other 
words, in these Bmal1
-/-
 mice with Bmal1 expression in brain, peripheral tissues are 
presumably rhythmic due to imposed rhythmicity from normal, rhythmic SCN. 
Interestingly, four to six month-old Bmal1
-/-
 mice with Bmal1 expression in brain 
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continue to exhibit profound calcaneal tendon calcification. This finding shows that 
restoration of SCN rhythms, and thus peripheral tissue rhythmicity, is not sufficient to 
rescue peripheral tissue arthropathy, suggesting that circadian rhythms do not play a role 
in age-dependent ectopic calcification. It is more likely that Bmal1 is driving the 
expression of non-oscillator genes to regulate ectopic calcification, in a manner unrelated 
to circadian rhythms. 
A third possible systemic mechanism of arthropathy in Clock
-/-
;Npas2
m/m
 double 
mutant mice is serum electrolyte dysfunction. Abnormal calcium and/or phosphorus 
levels can cause metastatic calcification and commonly occur secondary to systemic 
hormone imbalances. For example, people suffering from hyperparathyroidism generate 
excessive parathyroid hormone, which leads to hypercalcemia and metastatic 
calcification 
97
. A mutant mouse model with ectopic calcification secondary to systemic 
mineral imbalances is the FGF23
-/-
 mouse 
98, 99
. FGF23
-/-
 mice have elevated serum 
calcium and phosphorus levels that cause the organ ectopic calcification.   
An imbalance of calcium and/or phosphate in the blood can lead to nonspecific 
calcium phosphate deposition in various soft tissues, such as lungs and blood vessels. 
Because Clock and Npas2 are important regulators of SCN rhythmicity and the SCN 
regulate rhythmic hormone production, it is possible that dysfunctional hormone 
production leads to abnormal serum calcium and phosphorus levels in Clock
-/-
;Npas2
m/m
 
double mutant mice, ultimately leading to ectopic calcification.  
To investigate these three systemic mechanisms, Clock
-/-
;Npas2
m/m
 double mutant 
mice were subjected to a series of experiments. In the first experiment, Clock
-/-
;Npas2
m/m
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double mutant mice were placed in cages with running wheels to test the effect of 
musculoskeletal stress on joints. Mice of the C57BL/6J background are compulsive 
runners and will spend a large portion of their time awake on the running wheel 
100
. In the 
second experiment, Clock expression was exclusively knocked out of the SCN (and other 
non-SCN brain regions) of Npas2
m/m
 mice. These transgenic mice are denoted 
Clock
fl/fl
;Npas2
m/m
, meaning they carry two Clock alleles with loxP sites flanking exon 5 
and 6, as well as two mutated, nonfunctional Npas2 alleles. By crossing these mice with a 
Cre-recombinase mouse, we can knockout Clock expression in a tissue-specific manner, 
depending on the promoter that drives Cre-recombinase expression. Vesicular GABA 
transporter (Vgat)-Cre recombinase was chosen in this study because Vgat is exclusively 
expressed in GABAergic neurons, which includes every SCN neuron as well as some 
non-SCN brain regions 
101
. By generating Vgat-Cre+;Clock
fl/fl
;Npas2
m/m
 mice, we 
effectively knock out Clock and Npas2 expression in GABA-expressing brain tissue, 
including the SCN, while the rest of the tissues are Npas2
m/m
. In the last experiment, 
serum samples from 37-49 week-old Clock
-/-
;Npas2
m/m
 double mutant mice were 
analyzed for calcium and phosphate content.  
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Experimental procedures 
 
Generation, maintenance, and genotyping of study animals 
Clock
fl/fl
 mice were generated in our laboratory, as previously described 
51
. Vgat-
Cre+ mice were a kind gift from Dr. Linh Vong in the laboratory of Dr. Brad Lowell 
(Beth Israel Deaconess Medical Center). Vgat-Cre+ mice were not backcrossed to the 
C57BL/6J background prior to conducting these studies. 
For Cre-recombinase PCR genotyping, a two-primer set was used to identify the 
expression of Cre. This primer set consists of a forward primer (Crelil-F: 
ACCTGAAGATGTTCGCGATTATCT) and a reverse primer (Crelil-R: 
ACCGTCAGTACGTGAGATATCTT). A two-primer set to identify the expression of 
wild-type Clock as an internal control was also included, which consists of a forward 
primer (ClockGTF-63B: GCAAGAAGAACTAAGGAAAATTCAAGAGCAACTTCA 
GATGGTCCATGGTCAAGGGCTACAGTT) and a reverse primer (ClockGTR-inB: 
TAGTGCCCTAGATGGCCCTGTTGG). Reactions were performed using the same 
cycling protocol as for Clock. Cre product size was 370 nt. Wild-type Clock product size 
was 410 nt. 
Please see “Chapter II: Experimental procedures” for additional information on 
generation, maintenance, and genotyping of mutant and wild-type mice used in this 
chapter.  
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Behavioral analysis (running wheels) 
Five Clock
-/-
;Npas2
m/m
 double mutant and six wild-type mice of both genders 
were used in this study. Mice were 4-5 weeks old at the start of the experiment and 
collected and X-rayed at 20-21 weeks of age. Mice were housed individually in rat cages 
equipped with or without running wheels and maintained in light-tight, ventilated closets 
within a temperature- and humidity-controlled facility. Food and water were available ad 
libitum. The animals were maintained on a 12 hour light:12 hour dark (LD) lighting cycle 
before and during the study. White light was emitted from fluorescent bulbs controlled by 
a timer and dim red light (~200 lux) was present continuously. Running wheels were 
equipped with magnets on opposing sides and activity was detected as switch closures 
using a magnetic reed switch mounted on top of each cage. ClockLab Data Collection 
(Actimetrics) software monitored and stored activity in 1-minute bins. ClockLab Data 
Analysis software was used to produce the double-plotted acrograms. Two Clock
-/-
;Npas2
m/m
 double mutant mice (one male, one female) were placed in cages with running 
wheels, three Clock
-/-
;Npas2
m/m
 double mutant mice (all female) were in cages without 
running wheels, three wild-type mice (one male, two female) were in cages with running 
wheels, and three wild-type mice (two male, one female) were in cages without running 
wheels.  
 
X-rays 
Skeletal tissues were X-rayed with a high resolution MX-20 Faxitron on 
mammography film. Please see “Chapter II: Experimental procedures” for details. 
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Serology 
Ten male 37-49 week-old (five wild-type, mean age 40.5 + 3.6 weeks; five Clock
-
/-
;Npas2
m/m
 double mutants, mean age 40.0 + 5.0 weeks) mice were decapitated and trunk 
blood was collected in anti-coagulant-free tubes at room temperature between 12-1pm. 
Within two hours, samples were processed by Michelle Bombard et al. as follows: 
samples were centrifuged at 5500 rpm for 10 minutes at room temperature to isolate 
serum, and then 100 ul of serum were dispensed into Abaxis Comprehensive Diagnostic 
Profile rotors and the rotors were analyzed by an Abaxis VetScan Chemistry Analyzer 
(Abaxis, Union City, CA). Of the ten mice collected in this study, one wild-type mouse 
was excluded from statistical analyses because it exhibited elevated markers of kidney 
function beyond the reference range, indicating that the mouse was undergoing kidney 
failure. One Clock
-/-
;Npas2
m/m
 mouse was also excluded because its blood sample was 
grossly hemolytic.  
 
Statistical analysis 
Serology results were normalized to the average wild-type value for a given 
serum marker. Normalized serology results were analyzed using unpaired t-tests (Prism 5 
for Mac OS X software). P-values less than 0.05 were considered statistically significant. 
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Results and discussion 
 
Assessing effect of mechanical stress on arthropathy 
The hypothesis that mechanical stress contributes to the development of age-
dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice was tested by placing 
animals in cages with and without running wheels. Mice were 4-5 weeks old at the 
beginning of the experiment and 20-21 weeks old at the end, meaning they spent 16 
weeks singly housed in cages with or without running wheels. On X-ray, ectopic 
calcification is detectable at 11-12 weeks in both costosternal junction and calcaneal 
tendon (Figure 2.4) so it was expected that by 20-21 weeks of age calcification would be 
visible.  
Gross visual analysis of X-ray images revealed that Clock
-/-
;Npas2
m/m
 double 
mutant mice with access to running wheels do not develop noticeably more calcification 
than Clock
-/-
;Npas2
m/m
 double mutant mice without access to running wheels (Figure 3.1). 
The vertebrae, pelvis, sternum, forepaws, hindlimbs, and forelimbs were examined 
(Figure 3.1, data not shown). This result suggests that mechanical stress does not play a 
significant role in arthropathy development in Clock
-/-
;Npas2
m/m
 double mutant mice. 
Closer evaluation of Clock
-/-
;Npas2
m/m
 double mutant mice using micro-CT would more 
meticulously evaluate running wheel effects, but these X-ray results suggest that there is 
not a significant effect of running wheel access to the progression of arthropathy. 
However, an important assumption of this experimental design is that access to a 
running wheel leads to more mechanical stress on weight-bearing joints. It has been 
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observed that Clock
-/-
;Npas2
m/m
 double mutant mice are less active than their wild-type 
counterparts when both are given access to running wheels (our unpublished data). 
Control mice in cages without running wheels were not evaluated for overall activity, so 
it is unclear if Clock
-/-
;Npas2
m/m
 double mutant mice with access to running wheels were 
actually more active than Clock
-/-
;Npas2
m/m
 double mutant mice without access to 
running wheels. It is possible that Clock
-/-
;Npas2
m/m
 double mutant mice with running 
wheels did not, in fact, exert more mechanical stress on their weight-bearing joints 
compared to control mice.  
Also, the anatomical distribution of early onset arthropathy, namely the 
costosternal junction and calcaneal tendon, suggests that weight-bearing joints are not 
necessarily specific targets of age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 double 
mutant mice. Granted, costosternal junction and calcaneal tendon undergo mechanical 
stress in quadrupeds, but joints such as the carpus, tarsus, elbows, and stifles undergo 
much more. If this arthropathy is truly specific to weight-bearing joints, then one would 
expect the joints that undergo the most weight and mechanical stress to develop ectopic 
calcifications first. Clearly this is not the case, as ectopic calcification of the carpus, 
tarsus, elbows, and stifles appear later than calcification of costosternal junction and 
calcaneal tendon. So while it cannot be concluded with certainty from this running wheel 
experiment if mechanical stress has no effect on arthropathy development, the lack of 
intensified ectopic calcifications in Clock
-/-
;Npas2
m/m
 double mutant mice with access to 
running wheels coupled with the site-specificity of arthropathy together suggest that 
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mechanical stress does not significantly contribute to the development of age-dependent 
ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice.  
 
Assessing effect of brain-specific gene disruption on arthropathy 
The role of Clock, Npas2, and Bmal1 in the circadian feedback loop suggests that 
disruption of behavioral circadian rhythms in Clock
-/-
;Npas2
m/m
 double mutant mice may 
contribute to the development of arthropathy. However, CLOCK/NPAS2:BMAL1 
transcriptionally regulate both core clock and clock output genes, making it difficult to 
discern between their regulation of core clock versus clock output genes. In an attempt to 
tease apart the role of Clock and Npas2 in the circadian oscillator and their role in 
regulating clock output gene expression, an experiment targeting Clock and Npas2 
disruption in the brain, including the SCN, was conducted. In this experiment, 
Clock
fl/fl
;Npas2
m/m 
mice were crossed with Vgat-Cre+ mice to generate brain-specific 
disruption of Clock and Npas2. The rest of the transgenic animal still expresses functional 
CLOCK, but dysfunctional NPAS2 (Figure 3.2A, right). It has been shown previously 
that Npas2
m/m
 mice do not develop arthropathy or disrupted circadian rhythms (our 
unpublished results) 
39
.  Animals were placed in running wheel cages to assess behavioral 
rhythmicity and then sacrificed and X-rayed to assess ectopic calcification.  
Vgat-Cre+;Clock
fl/fl
;Npas2
m/m
 mice are behaviorally arrhythmic in constant 
darkness and do not develop arthropathy by 20-21 weeks of age (Figure 3.2A&B), 
whereas Clock
-/-
;Npas2
m/m
 double mutant mice exhibit arthropathy by this age (Figure 2.4 
& 2.5). Vgat-Cre-;Clock
fl/fl
;Npas2
m/m
 control mice, which express Clock in every tissue 
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and are equivalent to Npas2
m/m
 mice, are behaviorally rhythmic in constant darkness and 
also do not develop ectopic calcification (Figure 3.2A&B). This finding shows that 
disruption of centrally regulated circadian rhythms, as evidenced by behavioral 
arrhythmicity in constant darkness, is not sufficient to cause age-dependent arthropathy. 
Any rhythmic output from the SCN to peripheral tissues has been disrupted in this 
transgenic mouse model. However, peripheral tissues still contain functional oscillators, 
so it is possible that intact peripheral tissue oscillator function is sufficient to prevent 
arthropathy development. Unfortunately, it is nearly impossible to differentiate between 
the role of Clock and Npas2 in regulating circadian oscillator function and their role in 
regulating non-oscillator output genes. When Clock and Npas2 expression is disrupted, so 
are all of their target genes, both oscillator-related and not. However, the lack of 
arthropathy in other arrhythmic circadian mutant mice supports the conclusion that 
disruption of centrally-regulated rhythms is insufficient to cause arthropathy. Per1
-/-
;Per2
-/- 
and Cry1
-/-
;Cry2
-/-
 double knockout mice are arrhythmic but have not been shown 
to develop age-dependent arthropathy (Figure 2.6) 
37
. The results of this experiment show 
that disruption of centrally regulated circadian rhythms is insufficient to cause 
arthropathy, suggesting that these Clock and Npas2 influence arthropathy through local 
mechanisms, rather than through central circadian function.  
 
Serology of Clock
-/-
;Npas2
m/m
 double mutant mice 
In the study first describing age-dependent arthropathy in Bmal1
-/-
 mice, the 
authors measured serum calcium and phosphorus levels to investigate a systemic cause of 
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arthropathy 
64
. The authors found no significant difference in serum calcium or 
phosphorus levels in Bmal1
-/-
 mice as compared to wild-type mice, fueling their 
conclusion that systemic mineral imbalances are not responsible for age-dependent 
arthropathy in Bmal1
-/-
 mice.  
To investigate this same possibility in Clock
-/-
;Npas2
m/m
 double mutant mice, 
serum chemistry analysis was performed. Serum from 37-49 week-old Clock
-/-
;Npas2
m/m
 
double mutant and wild-type mice were analyzed for a number of markers, including 
calcium, phosphorus, alkaline phosphatase (ALP), and alanine transferase (ALT). ALP 
and ALT together are considered indicators of liver function, but ALP is also a critical 
enzyme involved in calcification. ALP is produced by hypertrophic chondrocytes and 
osteoblasts, and is responsible for calcifying extracellular matrix 
14, 15
.  
In Clock
-/-
;Npas2
m/m
 double mutant mice, serum calcium and phosphorus levels 
are not significantly different from wild-type levels (Figure 3.3). ALP and ALT levels, on 
the other hand, are significantly higher in Clock
-/-
;Npas2
m/m
 double mutant mice (Figure 
3.3). The presence of ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice at this 
age is consistent with elevated ALP levels, but parallel increases in ALT levels suggest 
liver dysfunction, rather than increased osteoblast activity. Elevated ALT and aspartate 
aminotransferase, another liver function marker, levels were also found in Bmal1
-/-
 mice, 
but upon histological inspection there did not appear to be any liver pathology 
95
.The 
normal serum levels of calcium and phosphorus in Clock
-/-
;Npas2
m/m
 double mutant mice 
strongly suggests that systemic mineral imbalances are not at play here. Systemic mineral 
imbalance is the cardinal sign of metastatic calcification. A classic example of metastatic 
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calcification is hyperparathyroidism, in which elevated parathyroid hormone levels cause 
systemic increases in serum calcium and phosphate, leading to diffuse ectopic 
calcification in soft tissues 
97
. Thus, the unremarkable serum calcium and phosphorus 
levels in Clock
-/-
;Npas2
m/m
 double mutant mice suggest that metastatic calcification is not 
the cause of age-dependent arthropathy in this mutant mouse model.  
 
Systemic influences on arthropathy 
While these experiments do not identify of a specific mechanism responsible for 
age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice, the findings 
presented here bring us a step closer to that goal. These results show that mechanical 
stress, disruption of centrally-regulated circadian rhythms, and systemic effects leading to 
metastatic calcification are unlikely to play a role in this pathogenesis, which leaves 
specific, local mechanisms open to investigation. However, the results presented in this 
chapter do not completely rule out the involvement of systemic factors. Systemic factors 
may interact with local mechanisms to induce site-specific ectopic calcification. Local 
mechanisms could include cell-autonomous pathways and tissue-specific changes in gene 
expression, and the next chapter discusses a potential in vitro model system in which to 
study cell-autonomy as well as local changes in gene expression.  
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Figure 3.1. Mechanical stress does not seem to contribute to arthropathy development in 
Clock
-/-
;Npas2
m/m
 double mutant mice. Representative X-ray images of various joints from 
animals used in the study. Ectopic calcification of 20-21 week-old Clock
-/-
;Npas2
m/m
 double 
mutant mice with running wheels is indistinguishable from age-matched Clock
-/-
;Npas2
m/m
 
double mutant mice without running wheels. Red arrows highlight ectopic calcification. 
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Vgat-Cre-;Clock
fl/fl
;Npas2
m/m 
Vgat-Cre+;Clock
fl/fl
;Npas2
m/m 
B. 
Figure 3.2. Disruption of centrally regulated circadian rhythms is not sufficient to 
cause age-dependent arthropathy. (A) (Top) Cartoon depicting Clock and Npas2 
expression in transgenic mice. Grey: Clock
fl/fl
;Npas2
m/m
 tissue; white with grey spots: 
Clock
-/-
;Npas2
m/m
 tissue (white) mixed with Clock
fl/fl
;Npas2
m/m
 tissue (grey spots). 
(Bottom) Double-plotted actograms of representative mice of the indicated genotypes. 
Note that Vgat-Cre+;Clock
fl/fl
;Npas2
m/m
 mice are behaviorally arrhythmic in DD. 
Yellow: lights on; LD: light:dark; DD: constant darkness. (B) Sterna and hindlimb X-
ray images of 25 week-old mice. Note that Vgat-Cre+;Clock
fl/fl
;Npas2
m/m
 mice do not 
develop ectopic calcification (red circles).  
 
Vgat-Cre-;Clock
fl/fl
;Npas2
m/m 
Vgat-Cre+;Clock
fl/fl
;Npas2
m/m 
A. 
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Figure 3.3. Normal serum calcium and phosphorus levels in Clock
-/-
;Npas2
m/m
 double 
mutant mice. Serum chemistry analysis of male, 37-49 week-old Clock
-/-
;Npas2
m/m
 double 
mutant and wild-type mice. N = 4 for each genotype. **p<0.01. 
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Chapter IV 
Gene dysregulation in Clock
-/-
;Npas2
m/m
 double mutant mice 
 
Summary 
 
Clock, Npas2, and Bmal1 are transcription factors integral to the circadian 
oscillator loop, but they are also capable of regulating clock output gene expression that 
does not feed back into the oscillator loop. CLOCK/NPAS2:BMAL1 could regulate the 
expression of a gene(s) involved in ectopic calcification. The studies described in this 
chapter aim to elucidate changes in gene expression in Clock
-/-
;Npas2
m/m
 double mutant 
mice. The first strategy employs in vitro micromass cultures and the second targets in 
vivo intersternebral tissue. Quantitative real-time polymerase chain reaction (RT-PCR) 
analyses were conducted using RNA extracted from micromass cultures and 
intersternebral tissue. Genes examined were markers of chondrocyte maturation and 
genes involved in calcification and apoptosis. No changes in gene expression were 
identified. Consistent with this finding, micromass cultures generated from Clock
-/-
;Npas2
m/m
 double mutant embryos did not differentially stain for cartilage or calcification 
markers as compared to wild-type micromass cultures. The findings of this chapter show 
that generalized chondrocyte maturation dysfunction is likely not involved in mediating 
age-dependent arthropathy of the costosternal junction in Clock
-/-
;Npas2
m/m
 double 
mutant mice, and that intersternebral tissue is possibly too general of an area in which to 
detect changes in gene expression associated with site-specific arthropathy. 
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Figure 4.1. Representative primer validation data.  
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Figure 4.2. Micromass culture stains reveal no difference in chondrogenic differentiation 
between Clock
-/-
;Npas2
m/m
 double mutant and wild-type MEFs.  
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Figure 4.3. Gene expression profiles of chondrogenesis markers do not significantly 
differ between Clock
-/-
;Npas2
m/m
 double mutant and wild-type micromass cultures. 
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 4.4. Diagram of instersternebral tissue dissection.  
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 4.5. Chondrocyte marker gene expression in Clock
-/-
;Npas2
m/m
 intersternebral 
tissue does not significantly differ from wild-type. 
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 4.6. Candidate gene expression in Clock
-/-
;Npas2
m/m
 intersternebral tissue does not 
significantly differ from wild-type. 
Elizabeth Yu – Department of Neurobiology, UMMS 
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Introduction 
 
Bmal1, Clock, and Npas2 are core components of the circadian oscillator 
feedback loop. BMAL1 binds to CLOCK or NPAS2 to form a transcriptional activator 
complex that drives rhythmic expression of core clock and clock output genes. 
Approximately 10% of the genome is rhythmically expressed, showing that BMAL1, 
CLOCK, and NPAS2 drive the expression of many clock output genes 
102, 103
. The 
specific genes rhythmically expressed depend on the type of tissue, but generally rate-
limiting steps are rhythmic 
104
. One or more of those genes could play a role in regulating 
downstream genes that affect ectopic calcification. Bmal1
-/-
 mice display age-dependent, 
non-inflammatory arthropathy, prominent in the costosternal junction, calcaneal tendon, 
stifles, and posterior longitudinal ligament of the spine 
64
. Clock
-/-
;Npas2
m/m
 double 
mutant mice display a similar age-dependent, non-inflammatory arthropathy, which is 
also prominent in the costosternal junction, calcaneal tendon, and stifles. The similarity in 
arthropic phenotypes suggests that CLOCK:BMAL1 or NPAS2:BMAL1 drives the 
expression of a clock output gene that directly or indirectly regulates ectopic 
calcification. Identification of the gene(s) could provide novel insight into a calcification 
pathway regulated by circadian oscillator genes.  
The costosternal junction and calcaneal tendon, the two sites with the most 
prominent arthropathy, are very different tissues. Costosternal tissue is comprised mainly 
of hyaline cartilage and chondrocytes, and connects cartilage to bone 
105
. Calcaneal 
tendon is comprised mainly of fibrous connective tissue, fibroblasts and tenocytes, and 
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connects muscle to bone 
106
. How do two different tissues develop the same type of age-
dependent ectopic calcification? It seems that separate mechanisms could be at play in 
these two different tissues since they have so little in common. To focus the molecular 
studies, we decided to concentrate on one of the two tissues: the costosternal junction. 
The histology at the costosternal junction shows the presence of chondrocytes in these 
areas, as identified morphologically (Figure 2.8). Physiologically, chondrocytes undergo 
maturation during development and in the growth plate that culminate in the calcification 
of the surrounding cartilage matrix. The presence of chondrocytes in a site that develops 
ectopic calcification raises the possibility that chondrocytes are involved in age-
dependent arthropathy of the costosternal junction. 
One of the difficulties associated with using a mouse model is the large amount of 
time and money required to maintain animals for in vivo studies. In an attempt to 
circumvent those obstacles, efforts were made to use an established in vitro cell culture 
system in which mouse embryonic fibroblasts (MEFs) are differentiated into 
chondrocytes 
107, 108
. In this system, referred to as micromass culture, MEFs are harvested 
from embryonic day 12.5-13.5 fetuses and plated in high-density cultures. Treatment of 
these cultures with bone morphogenic protein 2 (BMP2) stimulates MEF chondrogenic 
differentiation. BMP2 is a potent chondrogenic factor for mesenchymal cells in vitro and 
plays a role in the chondrogenesis of condensed mesenchyme in vivo 
109-111
. The beauty 
of this in vitro micromass system is that MEFs undergo normal chondrogenic 
differentiation under these conditions, enabling the assessment of chondrocyte 
differentiation and calcification. Micromass cultures can be stained for alcian blue and 
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safranin-O to assess cartilage formation, alkaline phosphatase (ALP) to assess enzyme 
activity, and von Kossa to assess phosphate as an index of calcium phosphate deposition. 
RNA from cultures can also be collected at various time points to assess temporal 
changes in gene expression.  
Establishing an in vitro assay has additional benefits. Should the Clock
-/-
;Npas2
m/m
 double mutant MEFs in micromass culture exhibit an accelerated 
differentiation and calcification phenotype compared to wild-type, this result would show 
that chondrocytes are cell-autonomous in their ability to mediate ectopic calcification. 
Micromass cultures would also provide a system in which genes could be manipulated to 
study the molecular pathway of arthropathy. We could knockdown gene expression using 
RNA interference (RNAi) and restore gene expression using viral vectors to test the 
functional importance of genes in this phenotype. Clearly, establishing an in vitro assay 
has great potential to enhance the investigation of arthropathy in Clock
-/-
;Npas2
m/m
 double 
mutant mice.  
While in vitro systems can be an invaluable source of information, especially in 
terms of their ability to facilitate genetic manipulation, nothing can replace the value of 
studying an in vivo system. There are infinite complexities of the in vivo environment that 
may not be reliably replicated in vitro. Keeping in line with the focus on the costosternal 
junction, intersternebral tissue was collected from 6-7 week-old Clock
-/-
;Npas2
m/m
 double 
mutant, Clock
-/-
 single knockout, Bmal1
-/-
, and wild-type mice to study differences in 
gene expression. Mice of 6-7 weeks of age were used in this study because costosternal 
junction calcification is first beginning to consistently appear in Clock
-/-
;Npas2
m/m
 double 
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mutant mice at this age. In 4-5 week-old Clock
-/-
;Npas2
m/m
 double mutant mice, 
costosternal junction lesions appear inconsistently, making it difficult to be sure if 
calcification has begun in all mutants. By selecting 6-7 week-old Clock
-/-
;Npas2
m/m
 
double mutant, we can be confident that calcification has begun in all Clock
-/-
;Npas2
m/m
 
double mutants and that the pathology is still relatively in its infancy.  
Clock
-/-
 single knockout tissues were also included in this analysis to further 
screen genes of interest. Clock
-/-
 mice do not develop ectopic costosternal junction 
calcification (Figure 2.6), so genes dysregulated in both Clock
-/-
 single knockout and 
Clock
-/-
;Npas2
m/m
 double mutant costosternal junction tissue probably do not contribute to 
costosternal junction arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice. In other 
words, genes dysregulated in Clock
-/-
 single knockout tissue are not involved in 
costosternal junction arthropathy because Clock
-/-
 mice do not develop costosternal 
junction arthropathy. Bmal1
-/-
 tissues were also analyzed to determine if Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 costosternal junction tissues exhibit the same 
changes in gene expression. Because we hypothesize that disruption of the 
CLOCK/NPAS2:BMAL1 transactivator complex leads to the same age-dependent 
arthropathy in Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice, we expect to see 
similar changes in calcification-related gene expression in both mutants.  
Chondrocyte maturation marker gene and candidate gene expression in 
intersternebral tissue were evaluated. Some of these genes were chosen based on the 
phenotypes of mutant mice in which these genes are disrupted and all were chosen based 
on their potential to be involved in ectopic calcification pathology. Ank
-/-
 and ank/ank 
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mutant mice develop age-progressive calcification of joints and spine 
73
. Enpp1
-/-
 mice 
develop progressive ankylosing intervertebral and peripheral joint hyperostosis 
26, 69-72
. 
ANK and ENPP1 both generate extracellular PPi 
25-27
. ANK transports PPi from the 
intracellular space to the extracellular space while ENPP1 hydrolyzes ATP to form PPi. 
TNAP decreases extracellular PPi by hydrolyzing it to form Pi, which can crystallize with 
calcium to form HA. PPi inhibits HA formation, such that too little PPi leads to HA 
deposition. However, too much PPi leads to CPPD deposition 
25-27
. The finding that 
ectopic calcification in Bmal1
-/-
 sternum consists of CPPD crystals suggests that Ank, 
Enpp1, and/or TNAP dysregulation could lead to extracellular PPi dysregulation that 
could cause arthropathy. 
HDAC4
-/-
 mice display premature ossification of developing bones secondary to 
ectopic and precocious chondrocyte hypertrophy 
80
. Because HDAC4 regulates 
chondrocyte hypertrophy, its down regulation could lead to inappropriate chondrocyte 
hypertrophy and calcification. Mglap
-/-
 mice exhibit spontaneous calcification of arteries 
and cartilage, including the growth plate 
84
. MGP inhibits ectopic calcification, so it is 
possible that down regulation of Mglap leads to arthropathy. Prrx1 and Sox7 were found 
to be directly regulated by Bmal1 in mouse liver 
112
. Prrx1 encodes paired related 
homeobox 1, a transcription factor that mediates inhibition of osteoblast progenitors 
113
. 
Prrx1
-/-
 mice have defects of skeletogenesis, such as loss of craniofacial, limb, and 
vertebral structures 
114
. Sox7 is a transcription factor that positively regulates caspases 
and thus induces apoptosis 
115
. Apoptosis is the last step in chondrocyte maturation, so 
assessing apoptosis markers, such as Sox7 and Bax, in addition to chondrocyte marker 
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genes could prove to be complementary. Bax, or Bcl-2 associated protein X, promotes 
apoptosis by competing with Bcl-2 
116
. 
To establish an in vitro system in which to study arthropathy, micromass cultures 
were generated from Clock
-/-
;Npas2
m/m
 double mutant and wild-type MEFs. Micromass 
cultures were stained to assess cartilage deposition and calcification, and RNA was 
collected and analyzed by RT-PCR to assess changes in chondrogenic maturation gene 
expression profiles. To study in vivo changes in gene expression, intersternebral tissue 
was collected from Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice and expression 
levels of chondrogenic and candidate genes were measured by RT-PCR. 
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Experimental procedures 
 
Generation, maintenance, and genotyping of study animals 
Please see “Chapter II: Experimental procedures” for details.  
 
MEF generation 
To generate Clock
-/-
;Npas2
m/m
 double mutant fetuses for MEF collection, Clock
+/-
;Npas2
m/m
 three-allele mutants were intercrossed. Overnight, timed pairings of one male 
with three to four females per cage were performed, during which the male was removed 
the following morning before noon. Pregnant mice were identified and sacrificed when 
embryos were 13.5 days old (E13.5, where day 0.5 is the morning following the pairing 
with the male). E13.5 embryos were removed and each fetus was used to generate a 
separate line 
107, 108
, whose
 
genotype was confirmed by PCR. Liver and heart were 
removed and the rest of the embryo was sheared in an 18-gauge syringe in the presence 
of 1 ml 0.25% trypsin-EDTA. After 15 minutes incubation at room temperature, 
Dulbecco’s modified eagle medium (DMEM) with 15% fetal bovine serum (FBS) was 
added to inactivate trypsin. One hundred microliters of cell suspension was used to 
genotype each embryo. The rest of the cell suspension was plated one embryo per 100 
mm plate and incubated at 37
o
C with 5% CO2. These cells will be referred to as passage-
0 (P0) cells, as they have not yet been split. Cells were always grown in a 37
o
C incubator 
with 5% CO2. The next day, the cells were washed with 1X PBS and fed fresh DMEM 
supplemented with 15% FBS (DMEM+15%FBS). Media were changed every other day 
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until the cells reached 80-90% confluence, at which point they were split 1:5 (generating 
passage-1, or P1, cells). Once P1 cells reached ~90% confluence, they were frozen down 
and stored at -80
o
C. It generally did not take longer than 3-4 days for cells to reach 80-
90% confluence. To freeze down MEFs, cells were collected by trypsin digestion and cell 
suspensions were spun at 1500 rpm for 5 minutes to obtain cell pellets. Each pellet was 
resuspended in 1 ml media and cell suspensions were mixed 1:1 in freezing media (20% 
FBS, 20% dimethyl sulfoxide (DMSO), in DMEM). Cell suspensions were placed in 
cryogenic tubes and slowly frozen to -80
o
C in a freezing container before being moved to 
-150
o
C.  
 
Micromass culture and RNA collection 
The following micromass culture protocol has been described previously 
107, 108
. 
To revive frozen P1 MEFs prior to initiating an experiment, quick-thawed MEFs were 
pelleted (1500 rpm x 5 minutes), plated in DMSO-free DMEM+15%FBS, and grown to 
~90% confluence before being split 1:5, generating P2 cells. The day after splitting, cells 
were collected by 0.25% trypsin-EDTA digestion and counted using a hemacytometer. 
Cells were plated in 10 ul high-density droplets (1x10
7
 cells/ml): 12-15 droplets per 60 
mm plate for RNA collection and 2-3 droplets per well of a 12-well plate for 
histochemical staining. Great care was taken to ensure droplets did not touch one another 
or smear. Micromass cultures were incubated for 2.5-3 hours in a 37
o
C incubator with 5% 
CO2 to allow adherence of the cells to the plates. Then, without disturbing the droplets, 
1X Nutrient Mixture F12 Ham’s (F12) media supplemented with 15% FBS 
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(F12+15%FBS) were slowly added to the cells. For +BMP2 treated micromass cultures, 
100 ng/ml BMP2 was added to F12+15%FBS. 2.5 ml and 0.75 ml media were added to 
60 mm and each well of a 12-well plate, respectively, so the 10 ul droplets did not 
significantly dilute the final BMP2 concentration in the media. Media were changed 
every other day and +BMP2 media were made fresh each time. Micromass cultures were 
harvested for RNA on culture days 1, 3, 6, 9, and 12 in 500 ul TRIzol reagent 
(Invitrogen) and cell suspensions were frozen at -80
o
C until processing. Table 4.2 shows 
the number of cultures collected for each genotype and treatment across five time points.  
 
Micromass histochemical staining 
Alcian blue, safranin-O, and alkaline phosphatase stains were all performed on 
culture Day 9. Von Kossa stains were performed on culture Day 15.  
Micromass cultures were fixed in 4% paraformaldehyde for 10 minutes prior to 
alcian blue and safranin-O histological analysis, while cultures for von Kossa and 
alkaline phosphatase (ALP) analysis were fixed in 2% paraformaldehyde for 10 minutes 
prior to staining. Alcian blue staining was performed using 1% alcian blue solution 
overnight at room temperature. Safranin-O staining was performed using 0.1% safranin-
O solution for 10 minutes at room temperature. Von Kossa staining was performed using 
3% silver nitrate solution for 15 minutes in sunlight (through windows in the lab). ALP 
enzymatic activity was detected by colorimetric reaction using a 0.1M Tris maleate 
buffer (pH 8.4) containing 0.05% Napthol AS MX phosphate disodium salt, 2.8% N,N 
dimethyl formamide, and 0.1% fast red salt for 30 minutes at 37
o
C. Images were captured 
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using a Nikon SMZ 745t microscope, Pixelink PL-B681 microscopy camera, and 
Pixelink Capture OEM software. Table 4.3 shows the number of MEF lines stained for 
each genotype and treatment. For each stain, there were 3-11 replicate micromass 
cultures for each genotype and treatment of a given MEF line. For instance, there were 9 
replicate micromass droplet/cultures of a wild-type MEF line treated with BMP2 that was 
stained for von Kossa, but this wild-type MEF line was only counted once toward the 
sample size.  
 
Intersternebral RNA collection 
13 Clock
-/-
;Npas2
m/m
 double mutant, 9 Clock
-/-
, 8 Bmal1
-/-
, and 9 wild-type mice, 
all 6-7 weeks of age, were used in this experiment. Mice were asphyxiated in a CO2 
chamber and decapitated. Sterna were removed, quick frozen in 2-methylbutane on dry 
ice, and stored at -80
o
C until sectioned. For sectioning, unfixed tissue was embedded in 
O.C.T. mounting media and sectioned in a cryostat at 60 um. Sections were then 
dissected using scalpels under a dissecting microscope and intersternebral tissues from 
three animals were pooled together in 500 ul TRIzol reagent (Invitrogen) to form one 
sample. For each animal, intersternebral tissues adjacent to ribs 3-6 were collected. For 
each genotype, there were 3-4 samples. In other words, one of the wild-type samples 
consists of intersternebral tissues pooled together from 3 separate wild-type sterna, and 
from each wild-type sterna, intersternebral tissue from 4 rib junctions was collected. One 
Bmal1
-/-
 sample only contained pooled tissue from 2 animals and one Clock
-/-
;Npas2
m/m
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double mutant sample contained pooled tissue from 4 animals. See Figure 4.4 for a 
diagram of the tissue area collected. 
 
RNA isolation 
Total RNA was extracted using Trizol (Invitrogen) according to the 
manufacturer’s protocol and each sample was treated with 1 ul RQ1 DNase (Promega) 
for 2 hours at 37
o
C before the DNase activity was stopped using 1 ul ethylene glycol 
tetraacetic acid (EGTA) for 10 minutes at 95
o
C. Random hexamers (Promega) with 0.7ug 
RNA were used to prime reverse-transcription reactions with Superscript II (Invitrogen) 
using protocols from the manufacturers. cDNA was stored at -80
o
C. PCR reactions were 
assembled by creating a master mix for each primer pair and combining 20ul of master 
mix and 5ul cDNA in each well of a 96-well optical reaction PCR plate (Applied 
Biosystems).  
 
Real-time polymerase chain reaction (RT-PCR) 
Quantitative RT-PCR was performed using SYBR green 2x master mix, a two-
step cycling protocol (anneal and elongate at 60
o
C, denature at 95
o
C), and an ABI SDS 
7000 instrument (Applied Biosystems, Foster
 
City, CA). Each
 
sample was assessed in 
duplicate. In some cases, micromass sample cDNA did not amplify accurately, as 
evidenced by the sample’s amplification curve being indistinguishable from those of 
negative controls (no-transcriptase and premix only controls, which lack cDNA). These 
cDNA samples amplified with other primer sets in separate experiments, showing that the 
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cDNA quality was good; lack of amplification was most likely due to pipetting error. 
Samples that did not amplify were excluded, explaining any discrepancies in sample 
number shown in Table 4.2 and Figure 4.3. All intersternebral tissue sample cDNA 
amplified appropriately, so none were excluded from those statistical analyses. The data 
for each transcript
 
were normalized to glyceraldehyde-3-phosphate dehydrogenase
 
(GAPDH) using the 2
-##Ct method. Primers used for RT-PCR reactions are listed in Table 
4.1 and a representative primer validation data set is shown in Figure 4.1. All primers 
were validated prior to use and evaluated based on amplification plot, slope (~3.3), and 
dissociation peak. 
 
Statistical analysis 
Micromass culture RT-PCR Ct values were normalized to GAPDH values and 
then further normalized to the average wild-type BMP2 untreated value (over all sample 
days). 2
-##Ct values were analyzed by two-way ANOVA (Prism 5 for Mac OS X 
software). Bonferroni post-tests were performed for comparisons among treatments and 
genotypes.  
Intersternebral tissue RT-PCR 2
-##Ct values were analyzed by one-way ANOVA. 
Dunnett post-tests were performed for comparisons of mutant tissue to wild-type tissue 
values. P-values less than 0.05 were considered statistically significant. P-values between 
0.05 and 0.1 were considered to indicate a trend, and are noted. 
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Results and discussion 
 
Assessing phenotype of micromass cultures 
To assess changes in gene expression, an in vitro micromass culture system was 
employed. MEFs cultured from Clock
-/-
;Npas2
m/m
 double mutant and wild-type E13.5 
embryos were plated in high density cultures and treated with or without BMP2 to 
stimulate chondrogenic differentiation and as a control, respectively. The cultures treated 
with BMP2 underwent chondrogenic differentiation, as evidenced by their stronger alcian 
blue, safranin-O, alkaline phosphatase (ALP), and von Kossa stains compared to cultures 
not treated with BMP2 (Figure 4.2A). In this experiment, it appeared that Clock
-/-
;Npas2
m/m
 double mutant MEFs underwent accelerated chondrogenic differentiation, as 
evidenced by increased alcian blue, safranin-O, alkaline phosphatase, and von Kossa 
staining (Figure 4.2A). However upon replication, it was concluded that there is no 
consistent difference between the staining of Clock
-/-
;Npas2
m/m
 double mutant and wild-
type micromass cultures treated with BMP2 (Figure 4.2B). Different wild-type MEF lines 
treated with BMP2 in separate experiments generated micromass cultures with highly 
variable staining intensity (Figure 4.2A&B). However, when the same MEF line was 
used in separate experiments, consistent staining results between experiments were 
obtained, showing that the variability is within the genotypes and not a complete result of 
experimental protocol variability. These data show that there appears to be significant 
variation in staining intensity within genotypes and that this variability nullifies any 
significance of the initially promising results. 
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The staining results that show a lack of altered chondrogenic differentiation in 
Clock
-/-
;Npas2
m/m
 double mutant MEFs are supported by micromass culture RNA 
analyses. In this experiment, multiple RNA samples of both genotypes and both 
treatments across five time points were collected, and chondrocyte maturation markers 
were measured and analyzed by RT-PCR and 2-way ANOVA, respectively (Table 4.2). 
Samples were analyzed as four groups (wild-type +BMP2, Clock
-/-
;Npas2
m/m
 +BMP2,  
wild-type –BMP2, Clock
-/-
;Npas2
m/m
 –BMP2) across time. Days in culture, and genotype 
and BMP2 treatment had significant effects on Col2a1, Sox9, Ihh, Col10a1, ALP, and 
osteocalcin (Ocn) gene expression, but there were only significant interactions in Col2a1, 
Ocn, and Hist4h4 expression (Table 4.4). In other words, Sox9, Ihh, Col10a1, ALP, and 
H3f3a expression differences between groups did not change over time but Col2a1, Ocn, 
and Hist4h4 expression differences between groups did change over time.  
Bonferroni post-tests were performed to compare individual genotypes with and 
without BMP2 treatment over time. Col2a1, Sox9, Ihh, Col10a1, ALP, and Ocn 
expression levels are not significantly different between wild-type and Clock
-/-
;Npas2
m/m
 
double mutant MEFs treated with BMP2 (Figure 4.3A). However, cells of both genotypes 
treated with BMP2 express statistically higher levels of these genes than cells not treated 
with BMP2, showing that BMP2 successfully stimulated chondrogenic differentiation 
regardless of cells’ genotype. In fact, the rise of Col2a1, Sox9, and Ihh expression over 
time is consistent with an increase in proliferative and pre-hypertrophic chondrocytes. 
The rise of ALP and Ocn towards the end of the time course signifies the presence of 
mature hypertrophic chondrocytes and thus an increase in calcification markers. The 
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expression pattern of Col10a1 is less clear. Col10a1 expression rises over time, which is 
consistent with the patterns of Ihh, ALP, and Ocn gene expression. However, the peak of 
Col10a1 expression around Day 6 is unexpected and could be due to a surge of 
hypertrophic chondrocyte production of Type X collagen that does not persist to later 
days. The reason for this surge is unclear, as other markers of hypertrophic chondrocytes 
do not exhibit the same mid-course peak, but primary cultures can behave differently 
depending on the experimental parameters and this could simply be an interesting 
characteristic of MEFs from these mice collected and cultured under these conditions. 
H3f3a and Hist4h4 are genes encoding histones 3 and 4, respectively, which are 
essential elements of the nucleosome core around which DNA is wound. Histone gene 
expression is an indirect measure of cell proliferation, as increased histone gene 
expression indicates increased cell proliferation. H3f3a and Hist4h4 levels are not 
significantly different in cells of either genotype treated or untreated with BMP2, 
showing that neither BMP2 treatment nor genotype affects cell proliferation (Figure 
4.3B). There is a significant interaction of genotype and BMP2 with days in culture for 
Hist4h4 expression (Table 4.4), showing that over time, genotype and BMP2 treatment 
affect Hist4h4 expression. Both H3f3a and Hist4h4 expression increases over time, 
suggesting that cells are proliferating. The pattern of chondrocyte marker gene expression 
suggests that BMP2 treated cells are maturing, so they could be dying prematurely after 
proper maturation. The gradual increase in cell proliferation could reflect the surviving 
MEFs’ attempt to fill the space left by the dead MEFs. To test the hypothesis that MEFs 
are dying over time, RT-PCR for an apoptotic marker, such as Bax, could be performed. 
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If Bax expression rises as H3f3a and Hist4h4 levels rise, then that pattern of gene 
expression would be consistent with an increase in cell death followed by a compensatory 
rise in cell proliferation.  
Those follow-up studies were not conducted because the main purpose of this 
particular experiment was to determine if micromass culture is an appropriate in vitro 
system in which to study ectopic calcification of Clock
-/-
;Npas2
m/m
 double mutant mice. 
The results presented here show that Clock
-/-
;Npas2
m/m
 double mutant MEFs are not 
phenotypically distinct from wild-type MEFs when stimulated to undergo chondrogenic 
differentiation. There are a number of conclusions that can be drawn from this finding. 
First, the lack of phenotypic differences in vitro could indicate that the process of ectopic 
calcification in Clock
-/-
;Npas2
m/m
 double mutant mice is not chondrocyte cell-
autonomous. By creating an in vitro system, all systemic in vivo signals have been 
removed. Perhaps the development of ectopic calcification requires a combination of site-
specific and systemic factors interacting with one another. Or ectopic calcification may 
require a combination of cell types interacting with one another. To test that hypothesis, 
chondrocytes and osteoblasts could be co-cultured. However, in vitro studies will always 
be limited by the parameters by which they are set. If multiple factors, such as different 
cell types or paracrine signals, that are not included in the in vitro system are required to 
instigate ectopic calcification, then phenotypic differences in the cell cultures will not be 
observed. Second, these findings could indicate that chondrocytes are not involved in this 
pathology at all. Perhaps the wrong cell type was chosen to study in vitro. Future studies 
could focus on using primary osteoblasts or mesenchymal stem cells isolated from bone 
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marrow of Clock
-/-
;Npas2
m/m
 double mutant mice. Third, it’s possible that the 
chondrocytes in the micromass culture do not accurately represent the chondrocytes 
localized to sites of ectopic calcification in adult Clock
-/-
;Npas2
m/m
 double mutant mice. 
MEFs are fibroblasts isolated from whole embryos and include chondrocytes indigenous 
to other areas of the animal that are not affected by arthropathy, such as articular cartilage 
of the shoulder. In fact, most cartilage in Clock
-/-
;Npas2
m/m
 double mutant mice do not 
appear abnormal. Clock
-/-
;Npas2
m/m
 double mutant mice develop to young adulthood 
without any problems in endochondral bone ossification, which involves intermediate 
cartilage scaffolding structures. It is possible that the chondrocytes in micromass culture 
simply do not represent those chondrocytes of interest, or non-pathologic chondrocytes 
constitute the majority of the chondrocytes in micromass culture and dilute any potential 
pathologic phenotype of the chondrocytes that are actually involved in age-dependent 
arthropathy. In the end, micromass cultures did not recapitulate the ectopic calcification 
phenotype of Clock
-/-
;Npas2
m/m
 double mutant mice, and efforts to investigate in vivo 
tissue gene dysregulation were pursued instead. 
 
Investigating changes in intersternebral tissue gene expression  
Intersternebral tissue was collected from 6-7 week-old Clock
-/-
;Npas2
m/m
 double 
mutant, Clock
-/-
, Bmal1
-/-
, and wild-type mice to study differences in gene expression 
(Figure 4.4). Presumably, many genes in Clock
-/-
;Npas2
m/m
 double mutant tissue are 
disrupted. To exclude some of those genes, Clock
-/-
 tissue was included in the analyses 
because a hallmark of the age-dependent arthropathy of Clock
-/-
;Npas2
m/m
 double mutant 
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mice is that single Clock
-/-
 and Npas2
m/m
 mice do not exhibit arthropathy in the 
costosternal junction (Figure 2.6). Detecting changes in gene expression in Clock
-/-
;Npas2
m/m
 double mutant tissue but not Clock
-/-
 tissue would identify genes specifically 
affected by both Clock and Npas2 disruption.  
Unfortunately, chondrogenic gene expression levels are not significantly different 
among the four genotypes (Figure 4.5, one-way ANOVA, p > 0.05). To assess any 
changes in apoptosis, Bax and Sox7 gene expression levels were evaluated. No 
differences are present in Sox7 levels, but Bax is significantly less in Clock
-/-
 tissue 
compared to wild-type tissue (Figure 4.6, one-way ANOVA, Dunnett’s multiple 
comparisons test, p < 0.05). We then investigated a select group of candidate genes (Ank, 
Enpp1, HDAC4, Mglap, and Prrx1) based on the interesting, and potentially related, 
calcification phenotypes exhibited by their mutant mouse models. Unfortunately, there 
are no significant changes in expression of these genes in Clock
-/-
;Npas2
m/m
 double 
mutant or Bmal1
-/-
 tissue compared to wild-type and Clock
-/-
 tissue (Figure 4.6, one-way 
ANOVA, p > 0.05). A possible explanation for the lack of gene expression change in 
intersternebral tissue could be that too large a tissue area was analyzed compared to the 
smaller, localized areas that actually develop calcific lesions. Unaffected gene expression 
in the intersternebral space could be overpowering any detectable changes in gene 
expression related to the development of costosternal junction calcification.  
 
 
 
 104 
Concluding remarks 
Specific gene dysregulation was not identified in the studies outlined in this 
chapter. The most appealing hypothesis to explain age-dependent arthropathy of the 
costosternal junction is that chondrocyte differentiation is dysregulated, causing 
inappropriate chondrocyte maturation and eventual apoptosis and tissue calcification. 
However, in vitro culturing of chondrocytes was unable to duplicate the increased 
calcification phenotype observed in vivo and in vivo tissues failed to show signs of 
chondrogenic gene dysregulation. To address the possibility of localized, site-specific 
changes in gene regulation, other experimental strategies must be employed and these are 
discussed in the next chapter. 
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Table 4.1. RT-PCR primer sequences. 
 
Gene Forward primer (5’ !  3’) Reverse primer (5’ !  3’) Design* 
Col2a1 ACTCAAGTCACTGAACAACCAGATT ATCAATCCAGTAGTCTCCGCTCT Primer3  
Sox9 GACTACGCTGACCATCAGAACTC GAGCTGTGTGTAGACTGGTTGTTC Primer3 
Ihh CTCTTGCCTACAAGCAGTTCA CCGTGTTCTCCTCGTCCTT 14149643a1 
Col10a1 TTCTGCTGCTAATGTTCTTGACC GGGATGAAGTATTGTGTCTTGGG 6753480a1  
ALP CCAACTCTTTTGTGCCAGAGA GGCTACATTGGTGTTGAGCTTTT 6671533a1 
Ocn CTGACCTCACAGATGCCAAG GGGTTAAGCTCACACTGCTC Primer3 
Hist4h4 GAAGCGCATCTCGGGTCTC CATAGCCGTAACCGTCTTGC 28316746a1 
H3f3a TGTGGCCCTCCGTGAAATC GGCATAATTGTTACACGTTTGGC 6680159a1 
Gapdh AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 6679937a1 
Ank CAGTCAAGGAGGATGCAGTAGA CACTGTAGGCTATCAGGGTGT 31560341a1 
Enpp1 CTGGTTTTGTCAGTATGTGTGCT CTCACCGCACCTGAATTTGTT 12597623a1 
Prrx1 GAGCGTGTCTTTGAGCGGA CATGTGGCAGAATAAGTAGCCAT 6755116a1 
Sox7 ATGCTGGGAAAGTCATGGAAG CGTGTTCTGGTCACGAGAGA 6755612a1 
Bax TGAAGACAGGGGCCTTTTTG AATTCGCCGGAGACACTCG 6680770a1 
HDAC4 ATTGAGAGTGAGGAGGAAGAAGC GCCTCCATAGATGCCTGGTA Primer3 
Mglap GGCAACCCTGTGCTACGAAT CCTGGACTCTCTTTTGGGCTTTA 6678876a1 
*“Primer3” refers to Primer3 (v. 0.4.0) online software 
117
. Serial numbers refer to MGH PrimerBank 
number 
118
. 
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Figure 4.1. Representative primer validation data. Amplification plot (above), dissociation 
curve (bottom left), and standard curve (bottom right) for the Col2a1 RT-PCR primer set. The 
bottom two samples of the amplification plot that did not amplify represent the no-transcriptase 
and premix controls, neither of which contain cDNA and are not expected to amplify. All 
standard cDNA samples were evaluated in duplicate. 
Dissociation curve Standard curve 
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Wild-type 
+BMP2 -BMP2 
Alcian blue 
+BMP2 -BMP2 
Alkaline phosphatase 
+BMP2 -BMP2 
Safranin-O Von Kossa 
Clock
-/-
; 
Npas2
m/m 
Wild-type 
Clock
-/-
; 
Npas2
m/m 
+BMP2 
Alkaline phosphatase Safranin-O 
+BMP2 
Wild-type 
Clock
-/-
; 
Npas2
m/m 
+BMP2 -BMP2 
A. 
B. 
Figure 4.2. Micromass culture stains reveal no difference in chondrogenic differentiation 
between Clock
-/-
;Npas2
m/m
 double mutant and wild-type MEFs. (A) Initial staining results 
of micromass culture experiments show increased alcian blue, alkaline phosphatase, safranin-
O, and von Kossa staining in Clock
-/-
;Npas2
m/m
 double mutant MEFs treated with BMP2 
(“+BMP2”). BMP2 untreated cultures (“-BMP2”) of both genotypes show much less staining 
intensity, indicating that BMP2 treatment stimulated chondrogenic differentiation. (B) 
Replicate micromass culture experiments showed high variability of staining intensity among 
MEFs of identical genotype, indicating that the degree of variation within genotypes nullifies 
any significance of the initial staining results in (A).  
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 Table 4.2. Micromass culture RNA collection sample size. 
 Wild-type 
+BMP2 
Clock
-/-
;Npas2
m/m
 
+BMP2 
Wild-type  
-BMP2 
Clock
-/-
;Npas2
m/m
  
-BMP2 
Day 1 2 2 2 2 
Day 3 3 5 3 5 
Day 6 3 3 3 3 
Day 9 3 5 3 5 
Day 12 4 5 4 5 
Note that any discrepancies between the sample size listed here and the sample size shown in Figure 4.3 are 
due to samples excluded from statistical analysis (see Experimental Procedures). 
 
Table 4.3. Micromass culture staining sample size. 
 Wild-type 
+BMP2 
Clock
-/-
;Npas2
m/m
 
+BMP2 
Wild-type  
-BMP2 
Clock
-/-
;Npas2
m/m
  
-BMP2 
Alcian blue 3 2 3 2 
Safranin-O 6 3 6 3 
Alkaline phosphatase 6 3 5 3 
Von Kossa 4 2 4 2 
 
 
Table 4.4. Summary of 2-way ANOVA results for micromass culture RNA samples. 
 Genotype&BMP2 treatment Days in culture Interaction 
Sox9 p < 0.01 p < 0.0001 ns (p = 0.100) 
Col2a1 p < 0.0001 p < 0.0001 p < 0.0001 
Ihh p < 0.01 p < 0.01 ns* (p = 0.081) 
Col10a1 p < 0.01 p < 0.0001 ns (p = 0.325) 
ALP p < 0.01 p < 0.0001 ns* (p = 0.056) 
Ocn p < 0.05 p < 0.0001 p < 0.05 
Hist4h4 ns* (p = 0.066) p < 0.01 p < 0.05 
H3f3a ns (p = 0.274) p < 0.0001 ns (p = 0.270) 
ns: not significant; *indicates a trend towards significance (0.05 < p < 0.10). 
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Figure 4.3. Gene expression profiles of chondrogenesis markers do not significantly differ 
between Clock
-/-
;Npas2
m/m
 double mutant and wild-type micromass cultures. Quantitative 
RT-PCR analysis of chondrogenesis markers (A) and histone genes (B) in Clock
-/-
;Npas2
m/m
 
double mutant and wild-type MEFs, treated (“+BMP2”) and untreated (“-BMP2”) with BMP2. 
Numbers above error bars indicate sample size. 
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Wild-type 
Clock
-/-
; 
Npas2
m/m 
Figure 4.4. Diagram of intersternebral tissue dissection. Dotted black lines circumscribe 
intersternebral tissue isolated for RNA collection. Note that growth plate and parts of 
articulating rib cartilage were included in the dissection to ensure complete inclusion of 
ectopic calcification, when present. Trabecular bone was minimized in the collection as much 
as possible. Red arrows highlight ectopic calcification. 
Rib cartilage 
Trabecular bone 
Growth plate 
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Figure 4.5. Chondrocyte marker gene expression in Clock
-/-
;Npas2
m/m
 intersternebral tissue does 
not significantly differ from wild-type. Quantitative RT-PCR analysis of chondrocyte maturation 
marker genes in 6-7 week-old wild-type (n=3), Clock
-/- 
(n=3), Clock
-/-
;Npas2
m/m
 (n=4), and Bmal1
-/- 
(n=3) intersternebral tissue. One-way ANOVA did not reveal significant differences in gene expression, 
although there is a trend toward higher Col10a1 expression in Clock
-/-
;Npas2
m/m
 and Bmal1
-/-
 tissue 
compared to wild-type tissue. 
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Figure 4.6. Candidate gene expression in Clock
-/-
;Npas2
m/m
 intersternebral tissue does not 
significantly differ from wild-type. Quantitative RT-PCR analysis of candidate genes in 6-7 week-old 
wild-type (n=3), Clock
-/- 
(n=3), Clock
-/-
;Npas2
m/m
 (n=4), and Bmal1
-/- 
(n=3) intersternebral tissue. One-
way ANOVA did not reveal significant differences in gene expression, with the exception of Clock
-/-
 
tissue that exhibited significantly less Bax expression compared to wild-type when analyzed by Dunnett 
post-test. *p<0.05 
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Chapter V 
Investigating protein expression in the costosternal junction of  
Clock
-/-
;Npas2
m/m
 double mutant mice 
 
Summary 
 
The lack of changes in gene expression profiles in micromass culture and grossly 
dissected intersternebral tissue suggests that the mechanism of arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice may be much more localized and complicated. Specific 
chondrocytes and/or additional cells most likely interact with systemic factors to initiate 
ectopic calcification at the costosternal junction. To establish the distribution of 
osteoclasts, osteoblasts, and chondrocytes, a series of histological stains and 
immunohistochemistry (IHC) was performed. Site-specific changes in chondrocyte 
maturation marker protein expression in costosternal junction tissue were also assessed 
by IHC. The anatomical distribution of osteoclasts, osteoblasts, and chondrocytic proteins 
does not differ between Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice, suggesting 
that the distribution of cells does not contribute to arthropathy in Clock
-/-
;Npas2
m/m
 
double mutant mice, or that the markers used do not adequately distinguish the 
subpopulations of affected cells. Instead, varying levels of gene or protein expression 
could be involved, in which case more quantitative methods must be employed. 
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Figure 5.2. TRAP and ALP stains of 6-7 week-old Clock
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Figure 5.3. SOX9 IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. 
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Figure 5.4. RUNX2 IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. 
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Figure 5.5. TUNEL IHC of Clock
-/-
;Npas2
m/m 
and wild-type sterna.  
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Figure 5.6. Type II collagen IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna.  
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Figure 5.7. Type X collagen IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna.  
Elizabeth Yu – Department of Neurobiology, UMMS 
 
Figure 5.8. Quantitative analysis of SOX9- and TUNEL-positive cells around 
costosternal junction lesions.  
Elizabeth Yu – Department of Neurobiology, UMMS 
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Introduction 
 
Attempts to reveal genotype-related changes in gene expression during 
chondrogenic differentiation in vitro and in intersternebral tissue proved to be unfruitful 
(see Chapter IV). While positive results from those experiments could have been 
informative, the negative results show us that the mechanism of age-dependent 
arthropathy in the costosternal junction is more complicated than originally anticipated. 
Chondrocytes may or may not be involved in this pathology and any changes in gene 
expression are probably localized to the small areas that develop calcification. These 
local changes could be interacting with systemic factors to ultimately generate ectopic 
calcification. Thus, studies to investigate in vivo protein expression changes were 
conducted. Histological stains and immunohistochemistry (IHC) were used to study the 
distribution of calcification-related cell types in the costosternal junction and assess 
varying levels of protein expression. TUNEL analyses were also conducted to assess 
apoptosis.  
To identify the distribution of the three main cell types involved in bone 
homeostasis, stains and IHC were performed to locate osteoblasts, osteoclasts, and 
chondrocytes. Alkaline phosphatase (ALP) is specific to osteoblasts and mature 
chondrocytes, as these cells types calcify their surrounding extracellular matrix to form 
bone and cartilage, respectively. Tartrate-resistant acid phosphatase (TRAP) is secreted 
exclusively by osteoclasts to resorb bone, so staining for TRAP activity is a useful 
method to localize osteoclasts. Chondrocytes express a number of markers, but type X 
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collagen is a protein specifically produced and secreted by hypertrophic chondrocytes. 
IHC for type X collagen thus evaluates hypertrophic chondrocyte presence. 
Identifying the type of tissue present in costosternal junctions is also important. 
The articulating rib cartilage, also known as costal cartilage, consists of hyaline cartilage 
105
. Hyaline cartilage is one of three types of cartilage, the other two types being elastic 
cartilage and fibrocartilage. Hyaline cartilage is the most common of the three forms and 
consisted mainly of type II collagen. Elastic cartilage is more pliable and distensible and 
contains elastic fibers as well as type II collagen in its matrix. Fibrocartilage is 
characterized by a matrix containing type I and type II collagen fibers. 
The RNA analyses of micromass culture and intersternebral tissue did not provide 
evidence for abnormal chondrogenic differentiation in Clock
-/-
;Npas2
m/m
 double mutant 
samples. However, the limitations of those experiments prevent us from concluding that 
chondrocyte differentiation is not involved. To further explore this hypothesis, IHC for 
chondrocyte-related proteins was performed. IHC is particularly useful in this regard 
because we can observe anatomical distribution of protein expression, including relative 
protein expression levels, and which cells are producing which proteins. Proteins of 
interest studied here include SOX9, RUNX2, type II collagen, and type X collagen. 
TUNEL IHC was also performed to assess apoptosis, as apoptosis is the last stage of 
chondrocyte maturation.  
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Experimental procedures 
 
Generation, maintenance, and genotyping of study animals 
Please see “Chapter II: Experimental procedures” for details.  
 
Specimen collection, fixation, embedding, and sectioning 
Please see “Chapter II: Experimental procedures” for details. Briefly, tissue 
sections were immersed in PLP fixative and then decalcified, paraffin-embedded, and 
sectioned at 6 um. Histology and IHC described in this chapter were performed on slide-
mounted sections prepared in this fashion. 
 
TRAP and ALP histology stains 
Two tartrate-resistant acid phosphatase (TRAP) stains were conducted. In one, 
slides were stained for TRAP and counterstained with toluidine blue made in 
isopropanol. In the other, TRAP was co-stained with alkaline phosphatase (ALP). Sterna 
of 2 Clock
-/-
;Npas2
m/m
 double mutant and 2 wild-type mice, 6-7 weeks of age, were 
stained for TRAP alone. Sterna of 6 Clock
-/-
;Npas2
m/m
 double mutant and 4 wild-type 
mice, 6-7 weeks of age, were stained for TRAP and ALP. Three sections per mouse were 
analyzed. In both TRAP stains, TRAP stains osteoclasts red. ALP stains osteoblasts and 
hypertrophic chondrocytes blue. In the single TRAP stain, 6 um thick slide-mounted 
sections were incubated in TRAP staining solution “A” (0.5mg/ml Naphthol AS MX 
Phosphate, 2.8% N,N-dimethylformamide, 1 mg/ml fast red AS TR salt, 9.7 mg/ml 
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sodium tartrate, 50% Tris HCl buffer) at 37
o
C for 30-45 minutes. Slides were then 
washed with distilled water and dried on a hot plate for 5 minutes prior to counterstaining 
with 0.5% methyl green for 2 minutes. After slides were washed thoroughly with tap 
water, they were dried on the hot plate again and coverslipped.  
For the TRAP/ALP co-stain, slides were first stained for ALP. Six um thick slide-
mounted sections were incubated overnight in 1% magnesium chloride in 100 mM Tris-
maleate buffer, pH 9.2 and then incubated for 2 hours at room temperature in ALP 
substrate solution (0.2mg/ml Naphthol AS-MX phosphate, 0.4mg/ml fast blue BB salt, 
made in 100 mM Tris-maleate buffer, pH 9.2). After washing slides for 10 minutes with 
tap water, slides were incubated at 37
o
C in the dark for 45 minutes in filtered TRAP 
staining solution “B” (0.016 mg/ml Naphthol AS-BI Phosphate, 1% N,N-
dimethylformamide, 0.14 mg/ml fast red-violet LB diazonium salt, 0.004% magnesium 
chloride, 9.7 g/ml L(+) tartaric acid, made in 0.2 M acetate buffer, pH 6.0). Slides were 
washed with tap water and coverslipped. 
Images were captured using a Zeiss Axioskop 40 microscope, Zeiss AxioCam 
HRc camera, and Zeiss AxioVision 4 (version 4.7.2.0) software. 
 
Immunohistochemistry (IHC) 
Sterna of 7 Clock
-/-
;Npas2
m/m
 double mutant and 3 wild-type mice, 6-7 weeks of 
age, were used for SOX9 and RUNX2 IHC. Six-micron thick slide-mounted sections 
were deparaffinized, rehydrated, and endogenous peroxidase was blocked using 10% 
hydrogen peroxide in methanol solution. Antigen heat retrieval was performed using the 
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Retriever 2100 (PickCell Laboratories) and then slides were placed in 50 mM ammonium 
chloride for 30 minutes at room temperature before incubating in blocking solution (1% 
bovine serum albumin (BSA), 0.2% gelatin, 0.05% saponin, made in 1X PBS) for 30 
minutes at room temperature. Slides were incubated overnight at 4
o
C in primary antibody 
diluted in antibody dilution buffer (0.1% BSA, Triton X-100, made in 1X PBS). SOX9 
primary antibody (rabbit, anti-human, Santa Cruz sc-20095) was diluted 1:50. RUNX2 
primary antibody (rabbit, anti-mouse, Covance 572) was diluted 1:1000. Negative control 
slides were not treated with primary antibody; they were treated with antibody dilution 
buffer only. The next day, slides were acclimated to room temperature and washed in 
wash buffer (0.1% BSA, 0.2% gelatin, 0.05% saponin, made in 1X PBS) three times for 
10 minutes at room temperature and then incubated for 60-90 minutes at room 
temperature in secondary antibody (goat, anti-rabbit HRP, DakoCytomation) that was 
diluted 1:600 in antibody dilution buffer. The slides were then washed three times in 
wash buffer for 10 minutes each and incubated in DAB reagent (DakoCytomation) for 10 
minutes for color development. After color development, slides were washed with 1X 
PBS and distilled water before counterstaining with 0.025% toluidine blue made in 
distilled water for five seconds. Lastly, slides were washed in running tap water, 
dehydrated through ascending concentrations of ethanol to xylene, and coverslipped.  
Sterna of 4 Clock
-/-
;Npas2
m/m
 double mutant and 2 wild-type mice, 6-7 weeks of 
age, were used for type II collagen IHC. Slides were deparaffinized, rehydrated, and 
treated with preheated 1 mg/ml pepsin in Tris HCl for 15 minutes. After rinsing with 
distilled water, endogenous peroxidase activity was blocked by incubating slides in 3% 
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hydrogen peroxide for 10 minutes. Slides were washed with Tris HCl buffer and then 
blocked with 1% BSA in Tris HCl for 20 minutes at room temperature. Primary type II 
collagen antibody was diluted 1:200 and slides incubated overnight at 4
o
C (anti-mouse, 
Chemicon International MAB8887), while negative control slides were not treated with 
primary antibody. The next morning, slides were washed with Tris HCl and then 
incubated in secondary biotinylated antibody (Dako K0690) for 30 minutes at room 
temperature, rinsed with Tris HCl again, and stained with DAB+ (Dako K3468) for 5 
minutes. Slides were rinsed several times with water and then counterstained with 
0.025% toluidine blue made in distilled water before being thoroughly rinsed and 
coverslipped.  
Sterna of 4 Clock
-/-
;Npas2
m/m
 double mutant and 2 wild-type mice, 6-7 weeks of 
age, and two 4-5 week-old wild-type mice, were used for terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining. Slides from 4-5 week-old wild-
type mice were used as positive and negative controls. Slides were deparaffinized, 
rehydrated, and treated with 20 ug/ml proteinase K at room temperature for 15 minutes 
prior to incubation in 10% hydrogen peroxide in methanol at room temperature for 15 
minutes. Slides were washed with 1X PBS at room temperature three times for 2 minutes. 
The positive control slide was washed with 1X RQ1 RNAse-free buffer (Promega), 
treated with 5-10 units of DNAse 1 (Promega) in 1X RQ1 buffer at room temperature for 
10 minutes, washed with distilled water, then washed with 1X PBS for 5 minutes. Slides 
(positive and experimental) were then incubated in mastermix solution (0.3 nmol/ul 
biotin-dUTP, 25 mM cobalt chloride, 5X TdT buffer (Promega), 25 U/ul TdT enzyme 
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(Promega), made in distilled water) and the negative control slide was incubated in mix 
solution without enzyme for 1 hour in a humidity chamber at 37
o
C. After washing the 
slides with 1X PBS three times for 2 minutes at room temperature, they were blocked 
with 2% FBS in 1X PBS at room temperature for 10 minutes. Slides were then incubated 
in ABC Reagent (Vectastain Elite) at room temperature for 10 minutes, washed with 1X 
PBS, and then distilled water. For color development, slides were incubated with DAB 
mix (0.05% DAB, 0.015% hydrogen peroxide, made in 1X PBS) at room temperature for 
10-30 minutes. Finally, slides were washed with tap water, counterstained with 0.025% 
toludine blue made in water for 5 seconds, washed in running tap water, dehydrated, and 
coverslipped.  
Three sections per mouse were analyzed for all IHC. Images were captured using 
a Zeiss Axioskop 40 microscope, Zeiss AxioCam HRc camera, and Zeiss AxioVision 4 
(version 4.7.2.0) software.  
 
Quantitative analysis 
To quantitatively analyze SOX9 and TUNEL IHC slides, concentric 1 cm rings 
were drawn around equal sized, 20X-magnified printed images of Clock
-/-
;Npas2
m/m
 
double mutant costosternal junction lesions (Figure 5.1). The area of interest was 
intersternebral tissue medial to the lesion. Calcified tissue on the surface of sternebrae (as 
identified by von Kossa and alizarin red staining, Figure 2.8A&B) and rib cartilage were 
excluded from the areas quantified, as there was excessive, consistent staining in those 
regions on all slides (both wild-type and Clock
-/-
;Npas2
m/m
 double mutant mice). Positive 
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and total cells were counted manually. There were a total of 7 Clock
-/-
;Npas2
m/m
 double 
mutant sterna that were labeled with SOX9, and 4 Clock
-/-
;Npas2
m/m
 double mutant sterna 
that were labeled with TUNEL, with 3 serial sections per sterna. In the majority of 
sections, multiple costosternal junctions in each section contained lesions. For each 
mouse, the ratios calculated from all of its lesions were averaged, so that each mouse is 
an n = 1 (i.e. n = 7 for SOX9 and n = 4 for TUNEL statistical analysis). A total of 47 
SOX9 images and 54 TUNEL images were analyzed. For SOX9 images, there were 
304/886 positive/total cells in the first ring, 360/872 in the second ring, and 393/938 in 
the third ring. For TUNEL images, there were 247/915 positive/total cells in the first ring, 
258/885 in the second ring, and 283/917 in the third ring. Statistical analysis of data is 
graphically represented in Figure 5.8.  
 
Statistical analysis 
SOX9 and TUNEL positive:total cell proportions were analyzed by one-way 
ANOVA (Prism 5 for Mac OS X software). P-values less than 0.05 were considered 
statistically significant.  
 
 124 
Results and discussion 
 
Assessing distribution of cell types in costosternal junction 
To elucidate the mechanism of age-dependent arthropathy, identifying the cell 
type(s) involved is an important first step. Based on the histology of the costosternal 
junction, we presumed chondrocytes were involved, but the micromass culture results 
suggest that chondrocytes alone are probably not the cause of ectopic calcification. To 
identify cells present in costosternal junction around calcific lesions, then, histological 
and immunohistochemical stains were performed. TRAP and ALP stains were performed 
on 6-7 week-old sterna of Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice. Because 
co-staining TRAP with ALP on this tissue leads to significant ALP-related background 
staining (Figure 5.2B), TRAP stains were also performed separately on other slides 
(Figure 5.2A). 
In the TRAP stained slides, osteoclasts are present in the sternebral trabecular 
bone but there is no red staining in the intersternebral cartilage of either Clock
-/-
;Npas2
m/m
 
double mutant or wild-type mice. This distribution of osteoclasts suggests that they are 
not actively involved in the pathogenesis of arthropathy. However, the absence of 
osteoclasts around costosternal junction lesions could reflect a defect in osteoclast 
function in Clock
-/-
;Npas2
m/m
 double mutant mice. Perhaps osteoclasts normally remove 
ectopic calcification in wild-type mice but are unable to perform this function in Clock
-/-
;Npas2
m/m
 double mutant mice. This defect could be due to dysfunctional osteoclast 
migration, secondary to impaired signaling pathways. To argue against this possibility is 
 125 
the absence of osteoclasts in wild-type intersternebral cartilage. If pathological ectopic 
calcification were being actively prevented by osteoclasts in wild-type mice, one would 
expect to see residual osteoclasts in the area. Since osteoclasts are not detectable by 
TRAP staining in wild-type intersternebral tissue, it is unlikely that osteoclasts are 
normally there and thus they are probably not involved in ectopic calcification 
development in Clock
-/-
;Npas2
m/m
 double mutant mice. 
In TRAP/ALP co-stained slides, TRAP is still localized to sternebral trabeculae, 
although the distinction between red-orange background staining and pure red TRAP 
staining is difficult to appreciate (Figure 5.2B). ALP, which stains blue and is specific to 
osteoblasts and mature chondrocytes, is localized to costal cartilage, the calcified tissue 
on the sternebral surfaces that face the intersternebral cartilage, and the growth plate 
(Figure 5.2B). ALP-positive cells juxtapose costosternal junction lesions such that it is 
possible that these ALP-positive cells contribute to the development of ectopic 
calcification. The ALP-positive cells of the costal cartilage and sternebral surface form a 
pocket of sorts in which the calcific lesion seems to grow.  
 
Investigating changes in chondrocytic protein levels in costosternal junction 
The presence of chondrocytes in the costosternal junction led to the hypothesis 
that inappropriate chondrocyte differentiation could contribute to the development of 
ectopic calcification. RNA analyses of chondrocyte maturation marker genes in the 
intersternebral cartilage did not yield results to clearly support or refute this hypothesis, 
so to assess site-specific changes in chondrocyte maturation, IHC was conducted. To 
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investigate the distribution of maturing chondrocytes, IHC for SOX9, type II collagen, 
type X collagen, and RUNX2 was performed. SOX9 and RUNX2 are transcription 
factors and thus are nuclear stains. Type II and X collagen are extracellular proteins so 
the majority of type II and X collgen staining is extracellular, although in some cases type 
II and X collagen is visible in the cytoplasm of chondrocytes.  
SOX9 is present in nearly every cell of the costosternal junction, including costal 
cartilage and intersternebral cartilage, indicating that all of these cells are resting or 
proliferating chondrocytes (Figure 5.3). RUNX2, on the other hand, is more selectively 
expressed and only present in medial costal cartilage chondrocytes and cells on sternebral 
surfaces that face the intersternebral cartilage (Figure 5.4). TUNEL labeling is present in 
the same distribution as SOX9 (Figure 5.5). SOX9-, RUNX2-, and TUNEL-positive cells 
are similarly distributed in Clock
-/-
;Npas2
m/m
 double mutant and wild-type costosternal 
tissue. A common criticism of IHC provides a possible explanation for this lack of 
detectable difference. IHC relies on signal amplification and so while cells that express a 
given protein will be labeled, it is not possible to detect changes in protein expression 
levels between labeled cells. Thus, it is possible that there are changes in the expression 
levels of these proteins in Clock
-/-
;Npas2
m/m
 double mutant costosternal junction tissue 
compared to wild-type, but the IHC methods used were unable to detect those changes.   
Type II and X collagen are present throughout the costosternal junction (Figure 
5.6 & 5.7). Both types of collagen are in the intersternebral cartilage, costal cartilage, and 
growth plates. Type X collagen IHC was performed with two types of counterstain: in the 
first experiment, methyl green was the counterstain (Figure 5.7A) but due to inconsistent 
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counterstaining, another experiment using toluidine blue as a counterstain was performed 
(Figure 5.7B). In both experiments, type X collagen stains the same areas in Clock
-/-
;Npas2
m/m
 double mutant and wild-type tissue, although the intensity of staining seems 
less prominent in the toluidine blue counterstained slides. This variability is most likely 
due to repeat freeze-thaw cycles of the primary type X collagen antibody, which was 
used first on the methyl green counterstained slides and then subjected to a freeze-thaw 
cycle prior to usage on the toluidine blue counterstained slides. Type II collagen is the 
main component of hyaline cartilage and is present, as expected, throughout the 
intersternebral space and in the costal cartilage (Figure 5.6).  
 
Quantitative analysis of chondrocyte proteins around costosternal junction lesions 
Preliminary inspection of the SOX9 and type II collagen IHC suggested that there 
is a sparsity of SOX9 and type II collagen expression around the immediate periphery of 
calcific lesions. This down-regulation of SOX9 expression could lead to decreased 
expression of type II collagen, because SOX9 has been shown to increase transcription of 
Col2a1 
4, 10
. Decreasing type II collagen, which is an unelastic fiber, could promote 
flexibility allowing calcific lesions to expand and enlarge with age. TUNEL-positive cells 
appeared more prevalently in areas immediately surrounding the calcific lesions – the 
same areas in which SOX9 and type II collagen seem reduced. These findings led to the 
hypothesis that chondrocytes around lesions could have dysregulated chondrocyte 
differentiation programs. More specifically, instead of remaining as resting chondrocytes, 
dysregulated chondrocytes may differentiate to hypertrophic chondrocytes and apoptose, 
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leading to the calcification of cartilage matrix and the formation of ectopic calcification. 
The down-regulation of SOX9 and type II collagen could be indicative of chondrocytes 
maturing into hypertrophic chondrocytes, which do not express SOX9 or make type II 
collagen. An increase in TUNEL-positive cells could indicate apoptosis of cells at the 
periphery of the lesions, which is the last step of chondrocyte differentiation.  
To critically examine the possibility of differences in SOX9 and TUNEL 
expression in cells adjacent to calcific lesions, 47 images of costosternal junctions 
immunohistochemically stained for SOX9 and 54 images of costosternal junctions 
immunohistochemically stained for TUNEL were analyzed. Images came from four to six 
6-7 week-old Clock
-/-
;Npas2
m/m 
double mutant mice. Type II and X collagen were not 
examined because quantifying an extracellular stain is not compatible with this 
quantitative analysis. In this quantitative analysis, individual cells were counted as either 
positively or negatively stained. Type II and X collagen are occasionally labeled within 
cells, but the majority of the stains are extracellular, making it difficult to differentiate 
positively labeled cells from negative ones. For SOX9 and TUNEL quantitative analysis, 
concentric 1 cm rings were manually drawn around equal sized, 20X-magnified printed 
images of the lesions (Figure 5.1) and the proportion of positively labeled cells was 
counted. Statistically, there is no difference in the proportion of SOX9- or TUNEL-
labeled cells distributed around calcific lesions (Figure 5.8), refuting the initial 
observation that there may have been a difference in SOX9- and TUNEL-labeled cell 
distribution.  
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Concluding remarks 
While these histology results do not show us definitively whether or not abnormal 
chondrocyte maturation is involved in the pathology of costosternal junction 
calcification, conclusions can still be drawn from these results. The absence of drastic 
differences in the distribution of osteoclasts, osteoblasts, and cells expressing 
chondrocyte markers in Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice suggest that 
gross alterations in the distribution of cell types in costosternal junction may not 
contribute to the pathology of arthropathy. It is also possible that the chondrocyte 
markers used are unable to distinguish the subpopulation of cells involved in age-
dependent arthropathy. It is likely that the cause of this site-specific arthropathy is much 
more discrete and could involve interactions with systemic factors, and future studies 
must be equally focused in order to elucidate changes in gene and protein expression 
patterns.   
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Figure 5.1. Sample image of TUNEL IHC quantitative analysis. Chondrocytes on 
sternebral surfaces facing the intersternebral space (ISS) and rib cartilage were excluded 
from the analysis. Only cells in the intersternebral space were included. The purpose of 
this quantitative analysis is to determine if the distribution of cells around the lesions 
differs as one moves further away from the lesions. This same technique was applied to 
SOX9 IHC quantitative analysis. In decalcified tissues, ectopic calcification (EC) appears 
as holes with acellular debris in them. Red lines border the excluded areas. Dotted black 
lines delineate concentric areas. Yellow arrow identifies a negative TUNEL-stained cell. 
Green arrow identifies a positive TUNEL-stained cell. Red arrow highlights ectopic 
calcification. 20X magnification. ST: sternebral trabeculae. 
Ring 1 
Ring 3 
Ring 2 
ISS 
ST 
EC 
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Figure 5.2. TRAP and ALP stains of 6-7 week-old Clock
-/-
;Npas2
m/m 
costosternal junction. 
(A) Single TRAP staining (red) of 6-7 week-old costosternal junction reveals normal osteoclast 
distribution in trabecular bone but none around costosternal junction calcific lesions. 5X 
magnification. (B) Double TRAP (red) and ALP (blue) staining reveals ALP-positive cells in 
costal cartilage and growth plate and on the surface of sternebrae. Orange staining is from the 
ALP staining process. Images on the right are 20X magnifications of the boxed sections 
indicated on the 5X images on the left. Red arrows highlight ectopic calcification. ST: sternebral 
trabeculae; R: rib cartilage; ISS: intersternebral space; M: muscle. 
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Figure 5.3. SOX9 IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. Wild-type 
and Clock
-/-
;Npas2
m/m
 costal cartilage, intersternebral cartilage, and sternebral surface 
cartilage all stain strongly for SOX9 (brown). Images on the right are 20X magnifications of 
the boxed sections indicated on the 5X images on the left. Black arrowhead identifies a 
positively labeled cell. Red arrows highlight ectopic calcification. Slides are counterstained 
with toluidine blue made in water. ST: sternebral trabeculae; R: rib cartilage; ISS: 
intersternebral space; M: muscle. 
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Figure 5.4. RUNX2 IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. Wild-
type and Clock
-/-
;Npas2
m/m
 costal cartilage and sternebral surface cartilage stain strongly for 
RUNX2 (brown). The negative control (bottom) shows nonspecific background staining. 
Images on the right are 20X magnifications of the boxed sections indicated on the 5X 
images on the left. Black arrowhead identifies a positively labeled cell. Red arrows highlight 
ectopic calcification. Slides are counterstained with toluidine blue made in water. ST: 
sternebral trabeculae; R: rib cartilage; ISS: intersternebral space; M: muscle. 
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Figure 5.5. TUNEL IHC of Clock
-/-
;Npas2
m/m 
and wild-type sterna. 6-7 week-old wild-
type and Clock
-/-
;Npas2
m/m
 costal cartilage, intersternebral cartilage, sternebral surface 
cartilage, and growth plate stain with TUNEL (brown). Positive and negative controls are of 
4-5 week-old wild-type mice. Images on the right are 20X magnifications of the boxed 
sections indicated on the 5X images on the left. Black arrowhead identifies a positively 
labeled cell. Red arrows highlight ectopic calcification. Slides are counterstained with 
toluidine blue made in water. ST: sternebral trabeculae; R: rib cartilage; ISS: intersternebral 
space; M: muscle. 
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Figure 5.6. Type II collagen IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. 
Wild-type and Clock
-/-
;Npas2
m/m
 costal cartilage, intersternebral cartilage, and growth plate 
all stain strongly for type II collagen (brown). The negative control (bottom) shows 
nonspecific background staining. Images on the right are 20X magnifications of the boxed 
sections indicated on the 5X images on the left. Red arrows highlight ectopic calcification. 
Slides are counterstained with toluidine blue made in water. ST: sternebral trabeculae; R: rib 
cartilage; ISS: intersternebral space; M: muscle. 
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Figure 5.7. Type X collagen IHC of 6-7 week-old Clock
-/-
;Npas2
m/m 
and wild-type sterna. 
(A) Wild-type and Clock
-/-
;Npas2
m/m
 sterna type X collagen IHC (brown) with methyl green 
counterstain. 5x magnification. (B) Wild-type and Clock
-/-
;Npas2
m/m
 sterna type X collagen 
IHC (brown) with toluidine blue (made in distilled water) counterstain. Images on the right 
are 40X magnifications of the boxed sections indicated on the 5X images on the left. In both 
type X collagen IHC preparations, costal cartilage, intersternebral cartilage, and growth plate 
stain for type X collagen. Red arrows highlight ectopic calcification (EC). ST: sternebral 
trabeculae; R: rib cartilage; M: muscle. 
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Figure 5.8. Quantitative analysis of SOX9 and TUNEL positive cells around 
costosternal junction lesions. Quantitative analysis reveals no significant difference 
in the percentage of positively labeled SOX9 or TUNEL cells distributed around 
costosternal junction lesions of Clock
-/-
;Npas2
m/m 
 double mutant mice.  
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Chapter VI 
Discussion 
 
Dissertation conclusions 
 
Summary of results 
Clock
-/-
;Npas2
m/m 
double mutant mice exhibit age-dependent, site-specific ectopic 
calcification. The two sites with the most prominent arthropathy are the costosternal 
junction and calcaneal tendon. Costosternal junction ectopic calcifications in a Bmal1
-/-
 
mouse are composed of CPPD crystals. This arthropathy phenotype is unlikely due to 
mechanical stress, disruption of centrally regulated circadian rhythms, or metastatic 
calcification (see Chapter III). In vitro micromass culture results suggest that mutant 
chondrocytes alone do not exhibit irregular differentiation, and RNA analyses of 
intersternebral tissue suggest that any gene dysregulation associated with arthropathy 
could be sub-localized to the specific areas that develop calcification. Based on the 
unaltered distribution of osteoclast and osteoblast markers, these cell types probably do 
not contribute to the development of ectopic calcification in the costosternal junction, but 
the presence of chondrocytes suggests that chondrocytes are involved. Chondrocyte-
related protein expression in the costosternal junction of Clock
-/-
;Npas2
m/m
 double mutant 
mice appears normal. These results together suggest that arthropathy in the costosternal 
 139 
junction of Clock
-/-
;Npas2
m/m
 double mutant mice is likely due to dysregulation of genes 
that have not yet been evaluated, and local factors that could be interacting with systemic 
factors. 
 
A novel role of the circadian transcriptional activator complex 
While the experiments in this dissertation do not identify the mechanism of age-
dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice, the results nevertheless 
enable exciting conclusions to be drawn. First, the striking similarity of phenotypes 
between Clock
-/-
;Npas2
m/m
 double mutant and Bmal1
-/-
 mice strongly suggests that 
disruption of the transcriptional activator complex (CLOCK/NPAS2:BMAL1) leads to 
site-specific, age-dependent arthropathy. The absence of such dramatic ectopic 
calcification in Per1
-/-
;Per2
-/-
 and Cry1
-/-
;Cry2
-/-
 double mutant mice further supports this 
hypothesis, as disrupting the negative repressor complex does not yield the same striking 
arthropathy 
37
 (Figure 2.6). However, CLOCK/NPAS2:BMAL1 drive the expression of 
Pers and Crys, so presumably Per and Cry expression is diminished in Clock
-/-
;Npas2
m/m
 
double mutant mice. It is possible that the high bone mass phenotype observed in Cry1
-/-
;Cry2
-/-
 and Per1
-/-
;Per2
-/-
 double mutant mice is also present in Clock
-/-
;Npas2
m/m
 double 
mutant and Bmal1
-/-
 mice. Preliminary attempts to evaluate HBM in distal femur of 
Clock
-/-
;Npas2
m/m
 double mutant mice by micro-CT were inconclusive, but future 
attempts should be made to elucidate any HBM phenotype in Clock
-/-
;Npas2
m/m
 double 
mutant mice. The implications of CLOCK/NPAS2:BMAL1 regulating ectopic 
calcification create a novel role for these core clock transcription factors. It has long been 
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suggested that core clock genes are involved in non-oscillator functions 
119
, but data 
supporting the idea of this particular complex being involved in ectopic calcification is 
new.  
Another reason why this conclusion is so striking is that BMAL1 is capable of 
forming transcription factor heterodimers with proteins other than CLOCK and NPAS2 
120
. It is this ability to interact with alternate binding partners that probably explains the 
wide array of phenotypes observed in Bmal1
-/-
 mice, which range from premature aging 
96
 to glucose intolerance 
53
 to increased sensitivity to chemotherapeutics 
59
. BMAL1 can 
bind to hypoxia inducible factor 1! (HIF-1!) and HIF-2!, which are bHLH-PAS 
domain-containing transcription factors important for regulating hypoxia responses 
120
. 
Since hypoxia can cause tissue damage that can in turn lead to dystrophic calcification, it 
seems reasonable to hypothesize that BMAL1’s interaction with HIFs could contribute to 
age-dependent arthropathy. However, the unexpected finding that Clock
-/-
;Npas2
m/m
 
double mutant mice exhibit a very similar arthropathy shows that arthropathy in Bmal1
-/-
 
mice is due to disruption of the circadian transactivator complex, not hypoxia-related 
ones. CLOCK and NPAS2 are the binding partners of BMAL1 that regulate arthropathy. 
This conclusion is surprising but strongly suggests that the CLOCK/NPAS2:BMAL1 
transactivator complex regulates a pathway involving age-dependent arthropathy.  
Another fascinating conclusion is that these results show an overlapping role of 
Clock and Npas2 in specific peripheral tissues. Previous studies have shown that Clock 
and Npas2 have overlapping roles in the SCN 
39
. Peripheral liver, lung, and fibroblastic 
tissue from Clock
-/- 
mice, when cultured ex vivo, are arrhythmic 
52
, showing that the 
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presence of Npas2 in these tissues is insufficient to drive rhythmicity in the absence of 
imposed rhythmicity from the SCN. A unique feature of ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice is that it only appears in double mutants, not in single 
Clock
-/-
 or Npas2
m/m
 mice. This shows that Clock and Npas2 are capable of compensating 
for one another’s absence to prevent arthropathy. In the SCN, a subset of neurons express 
Npas2, and through network connections are able to maintain rhythmicity in the absence 
of Clock 
39, 121, 122
. This sparse distribution of Npas2-expressing cells could also be 
characteristic of peripheral tissues that develop arthropathy. Npas2 has very low 
expression in peripheral tissues 
37
, suggesting that Npas2-expressing cells in tissues that 
can develop arthropathy may form network connections in order to prevent arthropathy in 
Clock
-/- 
mice, or just a few Npas2-expressing cells in these tissues is sufficient to prevent 
arthropathy. Such an overlapping role of Clock and Npas2 has only been otherwise 
described in the SCN, making peripheral tissues that develop age-dependent arthropathy 
in Clock
-/-
;Npas2
m/m
 double mutant mice distinct from other peripheral tissues, such as 
liver, lung, and fibroblasts. These unique features of peripheral tissues that develop 
arthropathy add another layer of novelty to this already surprising phenotype. 
 
Local and systemic factors likely regulate calcification in Clock
-/-
;Npas2
m/m
 double 
mutant mice 
The three most obvious, systemic mechanisms to explain this arthropathy have 
essentially been ruled out: mechanical stress, centrally-regulated circadian rhythms, and 
systemic electrolyte imbalance (see Chapter III). This leads to the conclusion that local 
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factors likely play an important role in the development of ectopic calcification. This 
conclusion is further supported by the unique site-specificity of arthropathy. Diverse 
tissues develop ectopic calcification but why certain tissues calcify earlier and more 
intensely than others is unclear, and is most likely due to local, yet unidentified factors. 
Differential expression of transcription factors could play a role. If peripheral tissues 
express varying levels of Clock, Npas2, and Bmal1, one would expect that tissues that 
normally express high levels of Clock, Npas2, and Bmal1 would be more severely 
affected by disruption of those genes than tissues that do not normally express such high 
levels of Clock, Npas2, or Bmal1. It would be very interesting to explore expression 
levels of these three genes in peripheral tissues. If they are most highly expressed in 
costosternal junction and calcaneal tendon, then that finding would suggest that local, 
differential expression of these genes in tissues contributes to the site-specificity of 
arthropathy. 
Of the three types of ectopic calcification (metastatic calcification, dystrophic 
calcification, and heterotopic ossification (HO)), dystrophic calcification is the most 
likely process behind age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 double mutant 
mice. The lack of systemic mineral imbalance in Clock
-/-
;Npas2
m/m
 double mutant mice 
rules out metastatic calcification. The presence of osteoblasts would be indicative of 
ossification, but the lack of alkaline phosphatase staining and characteristic bone 
morphology in the calcific lesions suggests against HO. Thus, dystrophic calcification 
remains as a likely mechanism to explain arthropathy in Clock
-/-
;Npas2
m/m
 double mutant 
mice. Dystrophic calcification can be caused by trauma, illness, or aging. We have shown 
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that aging contributes to ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice. 
Future studies investigating trauma and illness could explore dystrophic calcification as a 
mechanism of arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice. 
To further support the hypothesis of local and systemic factors being involved, the 
micromass culture experiments show that potential chondrocyte-mediated ectopic 
calcification is not cell autonomous. The micromass culture results could also be 
interpreted to mean that chondrocytes are not involved at all, or that the chondrocytes in 
micromass culture do not represent the type of chondrocytes that cause ectopic 
calcification. These conclusions mean that other in vivo factors most likely interact with 
chondrocytes to initiate ectopic calcifications, if chondrocytes are the cells mediating 
arthropathy. Whether these unknown factors are systemic hormones, local signals, or 
other cell types has yet to be determined. But the micromass culture results show that 
chondrocytes, in general, are not solely responsible for arthropathy; it is more likely that 
a combination of systemic and local factors cause ectopic calcification in certain 
locations. These locations are extremely specific, too. Isolating intersternebral cartilage 
and analyzing gene expression profiles yielded no significant differences between Clock
-/-
;Npas2
m/m
 double mutant and wild-type mice, suggesting that any gene dysregulation 
occurs immediately in the areas that develop calcification and that this dysregulation 
could be rather subtle. Even IHC is not able to detect noticeable changes in protein 
expression or cell distribution. Thus, it is likely that a complicated combination of 
factors, both systemic and very local, interact to initiate ectopic calcification at the 
costosternal junction of Clock
-/-
;Npas2
m/m
 double mutant mice.  
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Additional possible mechanisms 
 
Aging  
The finding that Clock
-/-
;Npas2
m/m
 double mutant mice phenocopy the arthropathy 
of Bmal1
-/-
 mice opens multiple doors of exploration. Many studies have been conducted 
with Bmal1
-/-
 mice studying various aspects of its mutant phenotype, one of which is 
premature aging. Interestingly, aging can cause dystrophic calcification so it seems likely 
that premature aging could play a role in age-dependent arthropathy. 
Aging is a collection of complex processes coordinated in an organism 
123
. It can 
be defined as the age-related deterioration of physiological functions necessary for 
survival and fertility of an organism. The exact output measurements to define aging are 
nebulous, but it is generally accepted that any symptoms characteristic of older 
populations can be defined as signs of “aging” 
123
. These symptoms include, but are not 
limited to, arteriosclerosis, cancer, dementia, sterility/reduced fertility, ectopic 
calcification, shortened lifespan, growth retardation, organ atrophy, weight loss, and 
cataracts 
93, 123
.  
Several studies have linked aging phenotypes with circadian mutant mice. Bmal1
-
/-
 mice exhibit premature aging characterized by premature death, ectopic calcification, 
sarcopenia, cataracts, reduced subcutaneous fat stores, organ shrinkage, and altered levels 
of immune cells in peripheral blood 
64, 95, 96
. Clock
-/-
 mice have also been shown to exhibit 
signs of premature aging, such as premature death, cataracts, and skin inflammation 
124
. 
A subset of aging phenotypes have been observed in Per1
-/-
;Per2
-/-
 double knockout mice 
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as well: reduced fertility (females) and an increased incidence of spontaneous cancer 
67
. 
Under conditions of irradiation, there is an increased tumor incidence in Cry1
-/-
 knockout, 
Cry1
-/-
;Cry2
-/-
 double knockout, Per2
-/-
 knockout, and Per1
-/-
;Per2
-/-
 double knockout 
mice compared to wild-type mice 
67
. Clearly, core circadian oscillator genes play a role in 
aging, although the exact mechanism remains unclear 
119, 125, 126
. 
Our observation that Clock
-/-
;Npas2
m/m
 double mutant mice exhibit ectopic 
calcifications similar to that of Bmal1
-/-
 mice, and the finding that Bmal1
-/-
 mice display 
signs of premature aging raises the possibility that ectopic calcification in Clock
-/-
;Npas2
m/m
 double mutant mice could be due to premature aging. In the course of studying 
Clock
-/-
;Npas2
m/m
 double mutant mice, it was observed that they also suffer from weight 
loss, premature death, organ shrinkage, and sterility, all of which are consistent with 
premature aging (our unpublished data). It would be interesting to investigate whether or 
not the phenotype observed in Clock
-/-
;Npas2
m/m
 double mutant mice is due to accelerated 
aging. Possible future experiments could include thoroughly characterizing the aging 
phenotype in Clock
-/-
;Npas2
m/m
 double mutant mice, namely assessing skin and organ 
atrophy, cataracts, and arteriosclerosis. Evaluating beneficial effects of treating Clock
-/-
;Npas2
m/m
 double mutant mice with anti-aging therapies, such as caloric restriction 
127
 
could also be done. Antioxidant administration was shown to increase lifespan and 
decrease weight loss and cataract development, but had no effect on arthropathy in 
Bmal1
-/-
 mice 
128
, so it is possible that anti-aging therapies will not affect arthropathy.  
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Osteoclasts 
Another possible mechanism of age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 
double mutant mice is osteoclast dysfunction. In the TRAP stain performed, osteoclasts 
are localized to the sternebral trabecular bone, where they should be located. No TRAP 
staining is evident around the calcific lesions, suggesting that osteoclasts are not involved 
because they are not around.  
To argue against this conclusion, perhaps the lack of ectopic calcification 
clearance in Clock
-/-
;Npas2
m/m
 double mutant mice is due to a defect in macrophage 
recruitment. Osteoclasts originate from mononuclear, hematopoietic stem cells from 
which macrophages also differentiate 
5
. Circadian oscillators are present in spleen, lymph 
nodes, and peritoneal macrophages and generate rhythmic secretions of TNF! and IL-6 
129
. Osteoclasts, a type of multi-nucleated macrophage, are not present around calcific 
lesions. This may be due to a defect in inflammatory immune response, as we do not see 
other inflammatory cells around the lesions either. Further supporting this idea is the fact 
that Bmal1
-/-
 mice exhibit altered levels of immune cells in peripheral blood 
95
. 
Specifically, 4-5 month-old Bmal1
-/-
 mice have significantly lower levels of monocytes (a 
type of macrophage), lymphocytes, and white blood cells.  
In order to test the hypothesis of osteoclast or inflammatory response dysfunction, 
one could induce an inflammatory response in wild-type and Clock
-/-
;Npas2
m/m
 double 
mutant mice and measure changes in inflammatory markers, such as IL-6 and TNF!. If 
Clock
-/-
;Npas2
m/m
 double mutant mice are unable to properly respond to the immune 
challenge, then it is possible that an abnormal immune response could play a role in the 
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development of arthropathy in these double mutant mice. Alternatively, wild-type mice 
could be irradiated to see if destroying their immune system is sufficient to induce 
ectopic calcification. Bone marrow transplants from Clock
-/-
;Npas2
m/m
 double mutant to 
wild-type mice could also be performed to assess the effect of the mutant immune system 
on arthropathy.  
 
FGF23, PHEX, and Klotho 
X-linked hypophosphatemia (XLH) is a disease in which people suffer from 
osteomalacia and rickets. A mouse model, the Hyp mouse, has been developed to study 
this disease. Hyp mice and XLH patients carry an inactivating mutation in phosphate-
regulating gene with homology to endopeptidases on the X chromosome (PHEX) 
130
. 
When PHEX is inactivated, it leads to elevated levels of fibroblast growth factor 23 
(FGF23) that causes hypophosphatemia and impaired bone mineralization 
131
. Despite 
having hypophosphatemia, Hyp mice and XLH patients exhibit paradoxical ectopic 
calcification of tendon and ligament insertion sites. Klotho, a molecule whose disruption 
leads to an accelerated aging phenotype in mice, facilitates FGF23 binding to its receptor 
132
. FGF23
-/-
 mice phenocopy Klotho mutant mice (kl/kl); both mutants exhibit 
accelerated aging characterized by ectopic soft tissue calcification, hyperphosphatemia, 
decreased lifespan, osteopenia, emphysema, and arteriosclerosis 
93, 98, 133
. The aging 
phenotype is due to hyperactivity of vitamin D, which FGF23 normally inhibits 
134
. 
The effect of disrupting FGF23 activity is systemic, as serum phosphate level 
changes are detected in patients and mice with the PHEX mutation, and kl/kl mutant and 
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FGF23
-/-
 mice.  However, serology profiles of Clock
-/-
;Npas2
m/m
 double mutant mice do 
not show any significant changes in phosphate levels. This suggests that systemic 
changes in FGF23, PHEX, and Klotho activity are not involved in age-dependent 
arthropathy. It is possible that local, site-specific changes in FGF23 function contribute to 
arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice, though, particularly in the calcaneal 
tendon, which is ectopically calcified in Hyp mice and XLH patients 
135
. A possible 
future experiment could be localizing FGF23 receptors in tissues that develop arthropathy 
in Clock
-/-
;Npas2
m/m
 double mutant mice. If FGF23 receptors are exclusively disrupted in 
tissues that develop ectopic calcification, then it would functionally inhibit FGF23 
function in a site-specific manner and possibly cause ectopic calcification. FGFR3, an 
FGF23 receptor, is located in the calcaneal tendon of Hyp mice, which develop ectopic 
calcification of the calcaneal tendon entheses 
135
. It would be interesting to investigate the 
expression levels of FGF23 receptors in Clock
-/-
;Npas2
m/m
 double mutant mouse tissues 
to see if receptors are down regulated in tissues with the most prominent arthropathy. 
 
Future experiments 
 
Based on the results presented in this dissertation, there are many avenues that 
could be pursued to further investigate age-dependent arthropathy in Clock
-/-
;Npas2
m/m
 
double mutant mice. A few of these possibilities are discussed here. 
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Chromatin-immunoprecipitation (ChIP) 
The overall hypothesis presented in this dissertation is that CLOCK or NPAS2, 
and BMAL1 form a transcription factor activator complex that drives the expression of a 
gene that prevents age-dependent arthropathy. The attempts to identify genes 
dysregulated in Clock
-/-
;Npas2
m/m
 double mutant mice were specific and focused, but did 
not yield any promising leads. One way to identify direct targets of 
CLOCK/NPAS2:BMAL1-mediated transcription is to perform chromatin-
immunoprecipitation (ChIP) studies. These studies would not necessarily identify the 
gene(s) directly involved in calcification, as the calcification pathway could be further 
downstream, but ChIP could narrow down the list of potential, direct target genes. Such 
was the rationale behind evaluating Prrx1 and Sox7 expression levels, which were 
identified in a liver Bmal1 ChIP screen 
112
. Isolating tissues that undergo arthropathy and 
performing ChIP on them may identify direct targets that can be linked to calcification 
pathways. 
 
Needle-biopsy tissue collection & RNA analysis 
The in vivo tissue collection technique employed clearly was not localized enough 
to detect gene dysregulation. In order to better isolate the tissue that could exhibit 
changes in gene expression, more refined techniques will be needed. Unfortunately, 
attempts to use laser-capture microscopy to isolate individual cells in costosternal 
junction tissue were unsuccessful. Another idea is to section tissue and use a blunted 
needle tip to punch out areas of interest under a dissecting microscope, rather than using a 
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scalpel to dissect out the entire intersternebral region. Then microarray analysis could be 
performed, which would survey many genes at once, rather than performing single RT-
PCR experiments for individual genes. This tissue isolation technique could be applied to 
any of the tissue areas that develop arthropathy, not just costosternal junction and 
calcaneal tendon. Studies investigating arthropathy in other joints affected in Clock
-/-
;Npas2
m/m
 double mutant mice should be pursued in parallel to determine if separate 
processes are occurring in different locations. 
 
Osteoblast & chondrocyte cultures (MC3T3 & ATDC5) 
Micromass culture of Clock
-/-
;Npas2
m/m
 double mutant MEFs did not generate an 
in vitro system in which to study arthropathy in Clock
-/-
;Npas2
m/m
 double mutant mice. 
However, other in vitro systems could be explored, as an in vitro system in which to 
manipulate gene expression would be invaluable to studying this phenotype.  
Two cell lines are commonly used to study calcification: MC3T3-E1 and ATDC5. 
MC3T3-E1 is a clonal osteogenic cell line established from newborn mouse calvaria with 
high ALP activity that can differentiate into osteoblasts and mineralize in vitro 
136
. 
ATDC5 is a clonal cell line derived from a mouse teratocarcinoma stem cell line that, 
when treated with insulin, undergoes chondrogenesis 
137
. It would be very interesting to 
see if MC3T3-E1 or ATDC5 cells have increased mineralization phenotypes when Clock 
and Npas2, or Bmal1 are knocked down with RNAi. If there is a phenotype in vitro, then 
these cell lines could be used as a model in which to evaluate and manipulate genes 
involved in arthropathy caused by Clock and Npas2 disruption.  
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Immunohistochemistry (IHC) and in-situ hybridization (ISH) 
The site-specificity of arthropathy suggests that changes in gene or protein 
expression in vivo are best assessed by in-situ hybridization (ISH) or 
immunohistochemistry (IHC), respectively, as these methods preserve anatomical detail. 
Our IHC results did not show obvious changes in expression of markers of different cell 
populations in Clock
-/-
;Npas2
m/m
 double mutant mice (see Chapter V), but that could be 
due to the inherent limitations of the technique. ISH can be quantitative and differences 
in gene expression patterns can be measured as well as visualized anatomically in the 
tissue. This type of powerful analysis would nicely complement array screens of tissue 
gene expression. 
Specific IHC experiments of interest are localizing CLOCK and NPAS2 
expression. Preliminary attempts of CLOCK IHC were unsuccessful (data not shown) so 
further optimization using this particular CLOCK primary antibody for paraffin-
embedded tissue IHC is necessary. The mutant Npas2 allele contains a LacZ insertion 
92
 
and so assessing $-galactosidase activity is a way to localize mutant Npas2 expression. 
Unfortunately, preliminary attempts to detect $-galactosidase activity in Clock-/-
;Npas2
m/m
 double mutant costosternal junction and calcaneal tendon tissue were 
unsuccessful. The expression of $-galactosidase is too low in these tissues, as $-
galactosidase activity was detected in brain sections from the same animals processed in 
parallel. These results suggest that NPAS2 levels are simply too low to measure directly 
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using IHC. In fact, currently there is not a reliable NPAS2 primary antibody available for 
IHC on mouse tissues.  
An alternative method to identify cells that express Clock and Npas2 is to perform 
BMAL1 IHC. CLOCK or NPAS2 binds to and stabilizes BMAL1, such that in Clock
-/-
 
tissue, only cells that contain NPAS2 stain positively for BMAL1 
51
. In the SCN, only a 
subset of neurons express Npas2, and that elite subset is responsible for maintaining 
behavioral rhythmicity, even in the absence of Clock, through SCN network connections 
39, 122
. By staining for BMAL1 in Clock
-/-
 costosternal juntion or calcaneal tendon tissue, 
we can identify cells that express Npas2, which possibly are a restricted subset of cells 
that prevent age-dependent arthropathy. Single Clock
-/-
 and Npas2
m/m
 mice do not develop 
arthropathy, so the identification of cells that express both Clock and Npas2 is of 
particular interest.  
 
Calcaneal tendon experiments  
Aside from the initial characterization of arthropathy in Clock
-/-
;Npas2
m/m
 double 
mutant mice, calcification of the calcaneal tendon has not yet been extensively studied in 
this mouse model. Future experiments focusing on this tissue are of interest, as 
pathological calcification of the human calcaneal tendon is a significant health problem 
8
.  
Tendons and ligaments consist of dense connective tissue with a high fibrillar 
collagen content and minimal vascularization 
138
. They contain relatively few fibroblasts 
and tenocytes but an abundant extracellular matrix. At bone insertion sites, collagen 
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fibers intertwine with fibrocartilage. This fibrocartilage gradually becomes more 
mineralized as it inserts into the bone 
138
.   
Primary tendon stem/progenitor cells (TSPCs) can be cultured ex vivo and have 
the ability to undergo osteogenesis, adipogenesis, or chondrogenesis 
90
. A potential future 
experiment could be culturing TSPCs from Clock
-/-
;Npas2
m/m
 double mutant calcaneal 
tendon, stimulating chondrogenesis or osteogenesis, and assessing their phenotype. 
Establishing a cell culture system in which to study tendon differentiation would enable 
us to knock down and rescue gene expression to test candidate gene effects. If TSPCs 
contribute to calcaneal tendon calcification in Clock
-/-
;Npas2
m/m
 double mutant mice, then 
one could expect to see abnormal chondrogenic or osteogenic differentiation in cell 
culture.  
Safranin-O staining of calcaneal tendon confirms the presence of fibrocartilage at 
the tendon insertion site to bone (Figure 2.9). However, calcification develops above the 
insertion site, suggesting that chondrocytes may not be involved in calcaneal tendon 
calcification. Thus, the pathology of calcification in the calcaneal tendon appears distinct 
from the hypothesized mechanism in costosternal junction. Investigation of tendon-
specific genes is necessary. Tenomodulin and thrombospondin-4 are tendon-specific 
markers 
139
. Tenomodulin is a late marker of tendon differentiation and may play a role in 
tenocyte proliferation 
140
 while thrombospondin-4’s exact function is unclear, but it may 
be involved in coupling muscle and tendon formation 
141
. We could collect tendon 
tissues, extract RNA, and perform microarrays to screen for candidate tendon-specific 
genes dysregulated in Clock
-/-
;Npas2
m/m
 double mutant tendon. Evaluating the expression 
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patterns of these types of genes could shed light on the mechanism of age-dependent 
calcification of the calcaneal tendon in Clock
-/-
;Npas2
m/m
 double mutant mice. 
 
Health implications 
 
CPPD crystal deposition disease 
The identification of CPPD crystals in costosternal junction of a Bmal1
-/-
 mouse 
potentially links this circadian mutant mouse model to human clinical pathology. 
Calcium pyrophosphate dihydrate crystal deposition disease (CPPD-CDD) is a broad 
term used to describe abnormal CPPD crystal deposition in articular joints. It occurs most 
commonly in the elderly, with 10-15% of people 65-75 years old and 30-50% of people 
85 years and older suffering from it 
23
. While in most cases the process is asymptomatic, 
in other cases CPPD-CPP can induce or enhance osteoarthritis (OA), cause severe joint 
destruction, and calcification of spinal tissues can restrict mobility similar to anklyosing 
spondylitis. The knee is most frequently affected in CPPD-CDD, but CPPD deposition is 
polyarticular and other sites, such as the wrist, shoulder, ankle, elbow, and hands, are 
commonly affected as well. CPPD crystal deposition in synovial joint space stimulates 
phagocytosis of these crystals by monocyte-macrophages and neutrophils 
23
. 
Interestingly, Bmal1
-/-
 mice have a significant increase in segmented neutrophils in 
peripheral blood 
95
, indicating an inflammatory response. However, the overall changes 
in the immune system of Bmal1
-/-
 mice are relatively mild so it is unclear if the immune 
response in Bmal1
-/-
 mice contributes to arthropathy.  
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Pseudogout, pyrophosphate arthropathy, and chondrocalcinosis (CC) all fall under 
CPPD-CDD 
142
. Pseudogout is characterized by acute synovitis associated with 
intraarticular CPPD deposition 
23, 142
. It differs from gout in that gout is due to 
hyperuremia and monosodium urate crystal deposition in synovial joint space 
23
. 
Pyrophosphate arthropathy refers to structurally abnormal cartilage or bone due to 
articular CPPD deposition, and CC describes any radiographic calcification of articular 
fibrocartilage or hyaline cartilage 
142
. CC could also refer to other types of crystal 
deposition in joints, not just CPPD.  
There are not many effective treatment options for CPPD-CDD. The most 
common treatments include joint aspiration (to remove the crystals), non-steroidal anti-
inflammatory drugs (NSAIDs), or intraarticular glucocorticoid injection to reduce 
inflammation 
23
. Unfortunately, there is no effective way to remove CPPD deposits and 
in some cases joint replacement is the only solution 
23
. The identification of CPPD crystal 
deposition in the costosternal junction of a Bmal1
-/-
 mouse raises the possibility of this 
circadian mutant mouse model becoming a model in which to study CPPD-CDD, 
specifically CPPD-CC, for which there is no murine model 
143
. There are mutant mice 
used to study extracellular PPi levels, which in excess can precipitate CPPD crystal 
deposition, but none of these models develop ectopic CPPD calcification visible on X-
ray, which defines CPPD-CC. Experimenting with different treatments in Clock
-/-
;Npas2
m/m
 double mutant mice could prove to be a fruitful exploration if it yields 
therapies applicable to people suffering from CPPD-CDD.  
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Even though they are not animal models for CPPD-CDD, mutant mice have 
nonetheless shed light on the regulation of extracellular PPi. The three genes that regulate 
PPi levels are tissue non-specific alkaline phosphatase (Akp2 that encodes TNAP), 
ankylosis protein (Ank that encodes ANK), and ectonucleotide pyrophosphatase 1 (Enpp1 
that encodes NPP1). Akp2
-/-
 mice have high extracellular PPi levels and hypophosphatasia 
79
. Ank
-/-
 mice have decreased extracellular PPi levels and ectopic HA deposition 
28
. 
Enpp1
-/-
 mice have ossification of the posterior longitudinal ligament (OPLL) due to low 
extracellular PPi levels and HA deposition. Given the phenotypes in mice lacking each of 
these genes and the identification of CPPD crystal deposits in a Bmal1
-/-
 mouse, it seems 
likely that Clock
-/-
;Npas2
m/m
 double mutant mice could have dysfunctional TNAP, ANK, 
or NPP1. Initial studies described in this dissertation were unable to detect changes in 
alkaline phosphatase activity, or Ank or Enpp1 expression. Closer, more localized 
inspection of these genes and proteins in calcification sites is necessary to determine if 
they are involved in age-dependent arthropathy of Clock
-/-
;Npas2
m/m
 double mutant mice. 
If these genes are involved, it could identify a novel pathway in which circadian genes 
contribute to the regulation of extracellular PPi levels. 
 
DISH, OPLL, and AS 
Diffuse idiopathic skeletal hyperostosis (DISH) is a disorder of robust ectopic 
calcification of the midthoracic spine, specifically of the anterior longitudinal ligament 
144
. It is not common in the general population, but is generally seen in the middle-aged 
and elderly. Pain is usually minimal or absent in DISH, although in some cases 
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calcification can limit mobility. An important feature of DISH is that the intervertebral 
disc spaces are preserved, unlike in degenerative spondylitis. DISH can occur in locations 
other than the spine, such as ligamentous and tendinous insertion sites, particularly the 
pelvis and calcaneus 
144
.  
Ossification of the posterior longitudinal ligament (OPLL) of the spine causes 
spinal canal stenosis and myelopathy. OPLL is particularly relevant in the elderly Asian 
population. It is due to ectopic endochondral ossification of the posterior longitudinal 
ligament of the cervical spine 
145
. The Enpp1
-/-
 mouse is the animal model for OPLL, 
highlighting the importance of extracellular PPi regulation in ectopic calcification.  
Anylosing spondylitis (AS) is an inflammatory disorder of unknown cause that 
primarily affects the axial skeleton, although peripheral joints, such as sacroiliac joints 
and costovertebral junctions, are also frequently involved 
146
. A classic radiological 
finding of AS is “bamboo spine”, which is the complete fusion of vertebrae, typically 
from the lumbar region upwards 
145
. The ank mutant is an animal model for AS, but 
despite the similarity of the mutant mouse phenotype remains controversial due to the 
lack of an association of ANKH mutations with clinical AS 
143
. 
DISH, OPLL, and AS are all age-related, calcific rheumatic diseases that can 
associate with one another. The fact that Clock
-/-
;Npas2
m/m
 double mutant mice exhibit 
profound calcification of their cervical, thoracic, and sacral vertebrae suggest that their 
pathology may be related to DISH, OPLL, and/or AS. DISH patients can develop 
calcaneal tendon calcification, similar to Clock
-/-
;Npas2
m/m
 double mutant mice. Micro-
CT images indicate Clock
-/-
;Npas2
m/m
 double mutant intervertebral spaces appear to 
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remain intact despite robust costovertebral calcification. Initial attempts to evaluate 
changes in Enpp1 and Ank expression in sterna of Clock
-/-
;Npas2
m/m
 double mutant mice 
did not reveal genotype-specific differences, but it is possible that different processes are 
occurring in the different tissues affected in Clock
-/-
;Npas2
m/m
 double mutant mice and 
that Enpp1 and/or Ank could be dysregulated in the spine. Closer inspection of spinal 
calcification in Clock
-/-
;Npas2
m/m
 double mutant mice could link this circadian mutant 
mouse model to these human pathologies and provide valuable insights to their 
pathology.  
 
Concluding remarks 
 
Clock
-/-
;Npas2
m/m
 double mutant mice exhibit a unique, age-dependent, site-
specific arthropathy that, to date, is only shared phenotypically by Bmal1
-/-
 mice. 
Whether this arthropathy is a reflection of premature aging, CPPD-CDD, chondrocyte 
maturation dysfunction, or processes relevant to human clinical pathology remains to be 
seen. Future studies are required to elucidate the mechanism of arthropathy in this 
circadian mutant mouse model. This line of investigation could have profound clinical 
relevance, as understanding this novel mechanism of regulation of calcification by 
“circadian genes” may reveal more approaches for treatment of pathological conditions in 
humans.  
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